Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.7216250093471491,-2.5371626669020966,0.0,0.0,0.0,17/29,18.06%,GRIA4;GABRB2;GABRB3;GRIK2;GLRA3;GRIK3;GRIK4;GABRG3;GRID2;GABRA2;GRID1;GABRA1;GABRB1;GLRA2;GABRE;GRIA2;GABRG2
prerank,glutamate receptor activity (GO:0008066),-0.7479443639180099,-2.3022338654610373,0.0,0.0005387608500448968,0.001,10/19,5.68%,GRIA4;GRM7;GRIK2;GRIK3;GRIK4;GRID2;GRM1;GRM5;GRID1;GRM3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6857300810753,-2.0484188104717655,0.0,0.03088895540257408,0.073,10/19,18.06%,GRIK2;GRIK3;GRIK4;GABRG3;GRID2;GABRA2;GRID1;GABRA1;GABRE;GABRG2
prerank,ligand-gated anion channel activity (GO:0099095),-0.7017756132882395,-2.046289933101458,0.005025125628140704,0.023974857826997906,0.076,11/17,18.06%,GABRB2;GABRB3;GLRA3;GABRG3;GABRA2;GABRA1;GABRB1;GLRA2;GLRA1;GABRE;GABRG2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6884011172814768,-1.831199026714277,0.019455252918287938,0.15408560311284047,0.473,8/12,18.06%,GABRB2;GABRB3;GABRG3;GABRA2;GABRA1;GABRB1;GABRE;GABRG2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.7126512466739721,1.817695049680701,0.0,0.10727879247123584,0.099,9/26,12.19%,LGALS3;MGAT5;PPP1R14A;PPP1R9B;CABIN1;SAG;PPP1R14B;BOD1L1;PPME1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6868600639181056,1.8176118104914463,0.001160092807424594,0.05363939623561792,0.099,16/32,17.41%,MFSD12;SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC6A19;SLC6A14;SLC36A4;SLC36A3;SLC6A7;SFXN1;SLC1A5;SLC7A8;SFXN2;SLC43A2;SLC38A7
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.7614165125994594,1.7734228435734525,0.0,0.07012489874839957,0.226,8/16,4.94%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.7614165125994594,1.7734228435734525,0.0,0.07012489874839957,0.226,8/16,4.94%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6595268598619439,-1.762212003800686,0.00816326530612245,0.21622268781801857,0.656,6/11,20.83%,KCND2;KCND3;KCND1;KCNK2;KCNQ1;KCNIP2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.6384865644418783,1.7560597245045797,0.0,0.07558725928248544,0.29,21/47,20.29%,SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;PDPN;SLC7A11;SLC6A19;SLC6A14;SLC36A4;SLC36A3;SLC7A6;SLC1A5;SLC38A11;SLC7A8;SLC43A2;SLC38A7;SLC38A10;SLC16A2;SLC38A2;SLC25A44
prerank,phosphatase inhibitor activity (GO:0019212),0.7190075087047748,1.7508394513863197,0.0012422360248447205,0.07102709042820354,0.316,7/20,12.19%,LGALS3;MGAT5;PPP1R9B;CABIN1;SAG;BOD1L1;PPME1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5733415703066547,-1.7451435825553308,0.023148148148148147,0.20888527814597854,0.696,7/17,4.54%,GRIA4;GRIK2;GRIK3;GRIN2A;GRIA3;GRIK4;GRIN2B
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6413903165339018,-1.73785097552595,0.02100840336134454,0.19058665070338224,0.716,8/13,18.06%,GLRA3;GABRG3;GABRA2;GABRA1;GLRA2;GLRA1;GABRE;GABRG2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6697651382431586,-1.7206640680806053,0.01953125,0.18952409458246036,0.755,7/11,26.42%,KCNJ3;KCND3;KCNH2;KCNQ1;KCNE3;KCNE4;KCNJ5
prerank,death domain binding (GO:0070513),0.8018229902529601,1.7117206397963336,0.006561679790026247,0.11515246531316141,0.507,7/11,10.19%,BCL2;BCL2L1;MCL1;DAPL1;RACK1;BAX;DAP
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.65597539543058,-1.6935651844113002,0.02112676056338028,0.20903920981741994,0.822,8/10,34.44%,SLC6A11;SLC6A1;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,receptor antagonist activity (GO:0048019),0.7250466292287596,1.6886223490673156,0.0037313432835820895,0.14824649647687982,0.655,4/17,11.60%,DKK2;WFIKKN1;LRPAP1;CCL5
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.6859924115743913,1.6863001509813067,0.0011890606420927466,0.13658635249395876,0.666,8/22,4.94%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,translation initiation factor activity (GO:0003743),0.6290594060214442,1.682910878697518,0.0,0.1304077064443922,0.689,25/36,27.56%,EIF3L;EIF4A1;EIF1;AGO2;EIF3A;EIF4G1;EIF4G2;EIF2A;EIF2S1;EIF4G3;EIF5B;EIF3M;EIF4E2;EIF2B2;EIF3E;EIF2S2;EIF4A2;EIF3B;EIF2B4;EIF3H;EIF3I;EIF3G;EIF1B;EIF4E;EIF2D
prerank,ephrin receptor activity (GO:0005003),-0.572223993177754,-1.679915973089974,0.004608294930875576,0.1915294821909608,0.851,8/17,17.97%,EPHA6;EPHA4;EPHB1;EPHA5;EFNA3;EPHA2;EPHB6;EPHB4
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.572223993177754,-1.679915973089974,0.004608294930875576,0.1915294821909608,0.851,8/17,17.97%,EPHA6;EPHA4;EPHB1;EPHA5;EFNA3;EPHA2;EPHB6;EPHB4
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5239306212247892,-1.6796348543257396,0.0,0.15351092487279258,0.851,6/22,8.28%,CHRM2;HTR2A;HTR2C;CHRM3;HRH2;HTR1F
prerank,serotonin receptor activity (GO:0099589),-0.5239306212247892,-1.6796348543257396,0.0,0.15351092487279258,0.851,6/22,8.28%,CHRM2;HTR2A;HTR2C;CHRM3;HRH2;HTR1F
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5239306212247892,-1.6796348543257396,0.0,0.15351092487279258,0.851,6/22,8.28%,CHRM2;HTR2A;HTR2C;CHRM3;HRH2;HTR1F
prerank,cation transmembrane transporter activity (GO:0008324),0.6021669471367822,1.6742226044927189,0.0,0.13474717386295343,0.73,17/48,17.41%,MFSD12;SLC3A2;SLC38A1;SLC6A6;SLC38A6;SLC7A1;SLC6A14;SLC36A4;SLC36A3;SLC6A7;SLC22A3;SFXN1;SLC1A5;SLC8B1;SLC7A8;SFXN2;SLC38A7
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7459639456259718,1.6672636751049181,0.0053475935828877,0.1380353270100076,0.762,5/14,21.90%,RDH12;DHRS3;DHRS9;AKR1A1;RDH10
prerank,semaphorin receptor activity (GO:0017154),0.7725789364200532,1.6476120772508354,0.004166666666666667,0.1711766759191702,0.848,5/11,10.06%,PLXNC1;NRP2;PLXNA2;NRP1;PLXND1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.6715947501255738,1.6474683146309483,0.002466091245376079,0.14854996095099568,0.848,7/21,13.30%,CDK14;CDK6;CDK8;CDK5;CDK13;CDK11B;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.6715947501255738,1.6474683146309483,0.002466091245376079,0.14854996095099568,0.848,7/21,13.30%,CDK14;CDK6;CDK8;CDK5;CDK13;CDK11B;CDK2
prerank,phosphotyrosine residue binding (GO:0001784),0.6086734257964814,1.6463024341787473,0.0034285714285714284,0.14129551967111736,0.852,10/37,8.22%,BCAR3;LCK;STAP1;SH3BP2;ABL2;FGR;NCK2;GRB2;CRKL;SAMSN1
prerank,chemoattractant activity (GO:0042056),0.6443816911449692,1.6459509074438545,0.004860267314702308,0.13425770088548078,0.854,7/26,11.60%,LGALS3;GPNMB;FGF2;VEGFA;DEFB130A;FGF7;CCL5
prerank,GTPase inhibitor activity (GO:0005095),0.7362319311924208,1.6404597328953239,0.005298013245033113,0.1371878136138281,0.877,6/13,12.62%,IQGAP1;IPO5;RTKN;CPEB2;CDC42SE1;IQGAP2
prerank,ligand-gated ion channel activity (GO:0015276),-0.45912642985219493,-1.6366657222132173,0.0,0.18802753666566896,0.919,9/30,5.46%,GRIA4;GRIK2;GRIK3;GRIN2A;GRIA3;GRIK4;GRID2;GRIN2B;GRID1
prerank,wide pore channel activity (GO:0022829),0.666278606207995,1.6316268244357468,0.006097560975609756,0.14763136578610436,0.911,7/23,18.60%,GJB2;PANX3;PANX1;PRF1;GJD2;GJC2;GJB6
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.47777959207533627,-1.623300590434485,0.0189873417721519,0.19274961705723895,0.937,11/28,18.06%,GRIK2;GRIK3;GRIK4;GABRG3;GRID2;GABRA2;GRID1;GABRA1;GABRE;CHRNA7;GABRG2
prerank,cAMP binding (GO:0030552),-0.6064380591927809,-1.6226807571393467,0.03225806451612903,0.18269979048189167,0.937,7/11,20.93%,PDE10A;RAPGEF2;HCN1;PDE4D;POPDC3;PDE2A;PDE4B
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.7264400842758888,1.6154153430590443,0.009433962264150943,0.17223659341712177,0.945,4/12,9.34%,CDK6;CDK8;BRD4;CDK13
prerank,ligand-gated channel activity (GO:0022834),-0.45912983022331183,-1.615258620942195,0.0,0.1805132405992533,0.942,9/29,5.46%,GRIA4;GRIK2;GRIK3;GRIN2A;GRIA3;GRIK4;GRID2;GRIN2B;GRID1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5902277186282381,1.6109175503101194,0.005605381165919282,0.17457994842959962,0.95,11/42,8.22%,BCAR3;LCK;STAP1;SH3BP2;ABL2;FGR;FBXW7;NCK2;GRB2;CRKL;SAMSN1
prerank,cholesterol transfer activity (GO:0120020),0.6889687219552838,1.6089564052537042,0.008827238335435058,0.1711629107568592,0.955,7/16,19.36%,ABCG1;ABCA1;APOA2;OSBPL2;GRAMD1B;NPC2;STARD4
prerank,GABA receptor activity (GO:0016917),-0.520203536417293,-1.6084555798682014,0.0481283422459893,0.1783837174498653,0.947,10/21,18.06%,GABRB2;GABRB3;GABRG3;GABRA2;GABBR1;GABRA1;GABRB1;GABRR2;GABRE;GABRG2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5966188132719042,1.6015208041348152,0.003472222222222222,0.18019584965950303,0.964,10/35,10.34%,LCK;PEAK1;ABL2;ITK;FGR;TEC;PTK2B;TXK;PKDCC;FYN
prerank,channel activity (GO:0015267),0.5884460169849177,1.595261334759404,0.0011198208286674132,0.1864256080176751,0.97,7/41,9.92%,BCL2;PDPN;PANX3;PANX1;TMEM120B;PRF1;BAX
prerank,alanine transmembrane transporter activity (GO:0022858),0.7168815422862787,1.586755837346831,0.014322916666666666,0.1998731850922805,0.981,5/12,5.04%,SLC3A2;SLC6A6;SLC6A14;SLC36A4;SLC36A3
prerank,gap junction channel activity (GO:0005243),0.6469949136126123,1.5809776052258937,0.01098901098901099,0.20615395335157036,0.987,6/22,18.60%,GJB2;PANX3;PANX1;GJD2;GJC2;GJB6
prerank,phospholipase inhibitor activity (GO:0004859),0.7565052320631589,1.580789114597823,0.013717421124828532,0.19884669144770353,0.987,4/10,10.97%,ANXA5;ANXA1;ANXA4;APOC1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5902556365551694,1.5805851049235669,0.007847533632286996,0.19209652714787154,0.987,23/37,31.01%,EPRS1;AARS1;VARS1;VARS2;CARS1;LARS2;GARS1;RARS1;EARS2;FARSA;SARS2;SARS1;FARSB;FARS2;NARS1;YARS1;LARS1;TARS1;TARS2;RARS2;MARS2;QARS1;NARS2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7347501597449546,1.5724696480688707,0.01756756756756757,0.2052924440552058,0.992,4/11,4.22%,SLC23A1;SLC23A2;SLC5A1;SLC17A5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5550916771048425,1.5658829496629805,0.0075107296137339056,0.21383583159862848,0.993,26/55,24.09%,SLC38A1;SLC6A6;SLC38A6;SLC7A1;PDPN;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC36A3;SLC46A1;SLC7A6;SLC16A9;SLC38A11;SLC16A3;SLC7A8;SLC38A7;SLC19A1;SLC38A10;SLC13A3;SLC16A2;SLC38A2;SLC7A2;SLC19A2;SLC16A13;SLC16A1
prerank,SH2 domain binding (GO:0042169),0.6009379884284436,1.5634346741392975,0.008027522935779817,0.21284315617850402,0.994,11/31,9.42%,SH3PXD2B;LCK;LAX1;SKAP1;DAG1;SQSTM1;BLNK;INPPL1;DLC1;LILRB1;RACK1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6781070204216731,1.559541790078688,0.013020833333333334,0.21532649830594097,0.996,8/15,23.14%,CXXC1;KMT2A;RBBP5;WDR5;PRDM9;SETD1A;SETMAR;KMT2D
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.563948108755191,1.556395680703856,0.004434589800443459,0.21703301996474375,0.997,21/44,27.03%,CXXC1;KMT2A;DOT1L;TTLL12;KMT5A;RBBP5;SMYD3;WDR5;PRDM9;KMT5B;EED;SETD1A;SMYD2;SMYD1;EHMT1;SETMAR;NSD3;KMT2D;SMYD5;NSD1;SETDB1
prerank,neuropeptide binding (GO:0042923),-0.5083250835833929,-1.5558964229182304,0.02403846153846154,0.2319750288621884,0.983,5/18,18.00%,GPR37;SORL1;GPR149;OPRD1;SSTR2
prerank,cholesterol binding (GO:0015485),0.5631868787640617,1.552475246917894,0.007658643326039387,0.2193049465089268,0.997,16/47,19.53%,OSBPL8;ABCG1;ABCA1;SIDT1;VDAC2;APOA2;SOAT1;CAV1;ANXA6;SOAT2;OSBPL2;NPC1;GRAMD1B;NPC2;STARD4;SULT2B1
prerank,carboxypeptidase activity (GO:0004180),0.5719903111648357,1.5515257084171712,0.014656144306651634,0.2152324711860653,0.997,13/35,14.37%,CTSZ;CPVL;CTSA;CPA4;CPA3;AGBL5;CPXM2;AGBL2;CPA6;AEBP1;SCPEP1;BLMH;CPD
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.501417503416428,-1.5446984214926758,0.02843601895734597,0.2353405349514299,0.986,10/18,30.79%,ACVR2B;BMPR1B;ACVR1B;ENG;ACVR2A;AMHR2;LTBP1;BMPR2;TGFBR1;BMPR1A
prerank,sterol transfer activity (GO:0120015),0.6524091839654931,1.5374370910961856,0.013853904282115869,0.24504072806312102,1.0,7/17,19.36%,ABCG1;ABCA1;APOA2;OSBPL2;GRAMD1B;NPC2;STARD4
prerank,protein phosphatase binding (GO:0019903),0.5111449523100331,1.5349207661672286,0.0030425963488843813,0.2449882664666705,1.0,27/117,13.23%,LGALS3;IQGAP1;CTNNB1;LCK;SKAP1;ANK1;SLC9A1;SIRPA;KCNN4;ADCY8;TRAF2;PPP1R9B;PTPA;SPHK1;MFHAS1;TRAF3;CD22;IKBKE;LILRB1;MVP;RACK1;VCP;JUP;BOD1L1;JAK1;PPME1;GTF2F1
prerank,androgen receptor binding (GO:0050681),0.5978195463870812,1.5344932232820667,0.018270401948842874,0.23978441832416741,1.0,16/25,31.50%,RNF14;DAXX;RNF6;PRKCB;KDM3A;PRMT2;PRPF6;TMF1;CALR;SMARCA4;NSD1;SNW1;KDM1A;TRIM68;TGFB1I1;EP300
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.6655798978072796,1.5309438478566542,0.026348808030112924,0.24345295482710239,1.0,4/15,12.97%,SH3PXD2B;VEPH1;SESTD1;PLEKHF1
prerank,protein tyrosine kinase binding (GO:1990782),0.5168625903684747,1.5293616703295392,0.0031413612565445027,0.2411804412392325,1.0,26/71,16.70%,ITGAX;CD247;SIRPA;CD4;NRG1;TRIM6;ALKAL2;TJP2;SQSTM1;NEDD9;ANGPT4;LRP4;BLNK;NCK1;ANGPT1;TREM2;PTPN2;RACK1;SOCS5;ANGPT2;GAS6;CPNE3;CBL;CBLB;PIK3R2;DUSP3
prerank,GABA-A receptor activity (GO:0004890),-0.5073758545397147,-1.5274256054116568,0.05092592592592592,0.24811108363806725,0.987,9/18,18.06%,GABRB2;GABRB3;GABRG3;GABRA2;GABRA1;GABRB1;GABRR2;GABRE;GABRG2
prerank,protein kinase C binding (GO:0005080),0.5633574718692043,1.5252433870461837,0.005506607929515419,0.24617230181081307,1.0,14/43,16.74%,NELL2;PLEK;HDAC9;HDAC7;SQSTM1;NELL1;HSPB1;PRKCB;RACK1;YWHAG;PRKD2;TIRAP;CAVIN2;PKP2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.5357493849763911,-1.5201850924700664,0.05963302752293578,0.2476055073331338,0.988,7/15,19.87%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;CMKLR1;CCR9
prerank,CCR chemokine receptor binding (GO:0048020),0.5879530135186514,1.5169273426598118,0.019836639439906652,0.263814907304756,1.0,8/28,13.81%,CCL4;NES;CCL13;DEFB130A;CCR2;CCL7;CCL5;CCL14
prerank,nucleotidase activity (GO:0008252),0.6471220062707963,1.5121094702065805,0.03303684879288437,0.2702912865997064,1.0,9/15,34.22%,NT5DC2;NT5C3B;BPNT1;ACP3;BPNT2;NT5M;NT5C3A;NT5C2;NT5DC1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6665906800056757,1.509005019387854,0.038560411311053984,0.2724693434303844,1.0,5/14,9.57%,CYBA;CYBB;MICAL1;CYB5R4;NCF4
prerank,receptor tyrosine kinase binding (GO:0030971),0.525168853399722,1.4999391384805907,0.010845986984815618,0.2922663616295871,1.0,22/56,16.70%,STAP1;ITGAX;NRG1;ALKAL2;SQSTM1;ANGPT4;LRP4;BLNK;TRAT1;NCK1;ANGPT1;PTPN2;RACK1;SOCS5;ANGPT2;GAS6;CPNE3;CBL;SH2B1;CBLB;PIK3R2;DUSP3
prerank,aspartic-type peptidase activity (GO:0070001),0.7058865112968867,1.4964222021199276,0.028727770177838577,0.2961827531271076,1.0,4/10,12.24%,CTSD;NAPSA;CTSE;DDI2
prerank,peptidase inhibitor activity (GO:0030414),0.5601168006199668,1.489551792183838,0.02546296296296296,0.3112823053064456,1.0,12/33,22.66%,RENBP;CST7;HRG;A2M;TFPI;CAST;CSTB;PROS1;TIMP2;SERPINF2;TIMP1;USP14
prerank,water transmembrane transporter activity (GO:0005372),0.689897557512603,1.4887210030049485,0.041891891891891894,0.3070527364787379,1.0,3/11,17.05%,PDPN;SLC5A1;AQP4
prerank,beta-tubulin binding (GO:0048487),0.567838240033725,1.4884533466486911,0.022988505747126436,0.3016500478062198,1.0,15/31,23.35%,FGF13;UXT;ARL8B;EML4;HTT;SMC3;VAPB;RACGAP1;ARL8A;IFT74;GJB6;CCT5;TAOK1;GABARAP;PEX14
prerank,protein heterodimerization activity (GO:0046982),0.4830061165895969,1.4867673294151034,0.0,0.30032156637314594,1.0,50/178,17.29%,BCL2;CYBA;ABCG1;HIF1A;ZHX2;CD3E;BCL2L1;ATF3;SDCBP;RRAGD;CYBB;ADCY8;IRAK2;MCL1;RALGAPA2;PDGFA;APOA2;TPM2;HEXA;PPP2R1A;ATP1A1;BHLHE40;P4HB;GTF2A2;BHLHE41;NOLC1;TPM4;SRI;BAX;HIP1;PRMT5;METTL3;FZD4;QTRT1;LSM6;DDIT3;GCA;RCC1;SMC3;VAPB;ATP1A2;BARD1;NR4A2;NPAS4;TCOF1;PIK3R2;BMP6;FXR2;ITGA3;DGKD
prerank,manganese ion binding (GO:0030145),0.5295198654541002,1.4832633565231836,0.02197802197802198,0.3041592099548746,1.0,12/48,11.63%,FAM20C;ABL2;MGAT5;LARGE1;B4GALT7;ATP13A2;DYRK2;GYG1;PAPOLA;NEK4;PIM1;PCK2
prerank,serine-type peptidase activity (GO:0008236),0.5017391162533693,1.4811472449331966,0.003048780487804878,0.3048587703483055,1.0,30/96,24.84%,PLAU;MMP8;ST14;GZMB;GZMA;TMPRSS2;MMP9;RHBDF2;PRSS8;KLK1;KLK6;CLPP;HP;HPR;F11;RHBDF1;MASP1;CD5L;GZMM;FURIN;KLK3;PRSS53;TMPRSS7;MASP2;TPP1;PREP;TMPRSS4;PARL;CORIN;F9
prerank,histone methyltransferase activity (GO:0042054),0.5612099583829646,1.479576231565289,0.019630484988452657,0.30367493392454903,1.0,18/32,27.03%,DOT1L;TTLL12;KMT5A;PRMT5;PRMT7;SMYD3;PRDM9;KMT5B;CARM1;EED;PRMT2;PRMT6;SMYD2;SMYD1;EHMT1;NSD3;NTMT1;SETDB1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5472245835149516,1.4732513433496088,0.027745664739884393,0.3165508099966741,1.0,14/38,15.32%,STAP1;CD3E;LAT;DEDD2;CD3G;NCK2;BLNK;TRAT1;NCK1;SPAG9;CARD10;SAV1;SORBS1;SH2B1
prerank,lipase activator activity (GO:0060229),0.6996126311092495,1.4691688645243197,0.058423913043478264,0.32310690189501823,1.0,6/10,16.10%,LCK;PDPK1;ARHGAP6;FYN;CCL5;APOH
prerank,mannose binding (GO:0005537),0.6776046539687999,1.4689087557847769,0.03337783711615487,0.31807529261868056,1.0,5/12,19.47%,LMAN1;MBL2;CLEC6A;LMAN2;CLEC4D
prerank,Toll-like receptor binding (GO:0035325),0.6920070279924673,1.4669940929803484,0.046831955922865015,0.3181758102152684,1.0,2/11,0.36%,S100A8;S100A9
prerank,tRNA binding (GO:0000049),0.5383855936109556,1.4650793850317285,0.03262092238470191,0.3185443676479024,1.0,21/43,27.15%,PUS1;AARS1;THG1L;IGHMBP2;CARS1;EEF1A1;XPOT;TRMT10C;EIF2A;ALKBH1;YRDC;SARS2;SARS1;FARS2;NSUN2;MRPS27;TERT;AIMP1;RPUSD4;NAT10;ELP5
prerank,5'-nucleotidase activity (GO:0008253),0.6438906593630347,1.462648199290425,0.061197916666666664,0.3202683154494257,1.0,7/13,34.22%,NT5DC2;NT5C3B;ACP3;NT5M;NT5C3A;NT5C2;NT5DC1
prerank,MAP-kinase scaffold activity (GO:0005078),0.6803999395941883,1.4618280056869777,0.048209366391184574,0.3174238399252117,1.0,3/11,8.52%,IQGAP1;AKAP13;SPAG9
prerank,protein phosphatase regulator activity (GO:0019888),0.5220614321737428,1.4577001525742386,0.021436227224008574,0.32472446642744657,1.0,15/53,17.09%,LGALS3;MGAT5;PPP1R9B;PTPA;PPP2R5C;CABIN1;PPP2R1A;SAG;RCAN1;BOD1L1;PPME1;PPP2R2D;RCAN3;PPP1R15B;PPP2R2C
prerank,nucleosomal DNA binding (GO:0031492),0.597946563506733,1.4522440724494063,0.046192259675405745,0.33531369241934217,1.0,12/21,26.81%,HDAC1;HNRNPC;SMARCB1;GATAD2B;SMARCC1;H1-0;ACTB;RCC1;SMARCD2;HDAC2;SMARCA4;H3-3A
prerank,lipoprotein particle binding (GO:0071813),0.5967029142045825,1.4489053496083746,0.04710144927536232,0.3394896518410406,1.0,4/20,7.32%,COLEC12;LPL;APOA2;TREM2
prerank,mannosyltransferase activity (GO:0000030),-0.4536452286569177,-1.444964324480974,0.07291666666666667,0.35200478898533377,1.0,5/21,7.61%,TMTC2;POMT2;TMTC3;TMTC1;PIGV
prerank,phospholipase activator activity (GO:0016004),0.6922112246965457,1.4441836657825113,0.06267409470752089,0.348517671126092,1.0,5/10,11.60%,LCK;PDPK1;ARHGAP6;FYN;CCL5
prerank,ion channel activity (GO:0005216),-0.3215363874849299,-1.441927229657751,0.0,0.34364653604402184,1.0,21/80,12.18%,GRIA4;TRPM3;UNC80;GRIK2;GRIK3;GRIN2A;GRIA3;CALHM2;GRIK4;GRID2;TMEM63A;GRIN2B;GRID1;ABCC9;TRPM4;MCOLN1;LRRC8A;TRPM6;TRPV4;GRIN1;GABRB1
prerank,MHC class II protein complex binding (GO:0023026),0.6672269878346244,1.4409280583783066,0.0625,0.3534522022097471,1.0,6/11,22.90%,CD4;PKM;ANXA11;HSPA8;HSP90AB1;CD74
prerank,syntaxin-1 binding (GO:0017075),-0.4287960477507065,-1.4392697413295552,0.06043956043956044,0.33534869799461237,1.0,7/22,10.36%,SNAP25;CPLX1;LRRK2;UNC13B;SYT1;STXBP3;STXBP1
prerank,ankyrin binding (GO:0030506),0.5914516430994413,1.4247118253670654,0.05596107055961071,0.39890293280588807,1.0,4/19,12.68%,PTPRC;CDH1;PLEC;CACNA1D
prerank,chemokine activity (GO:0008009),0.5453314243040694,1.4203848465159046,0.04302325581395349,0.40718346549502754,1.0,7/31,13.89%,CCL4;CCL13;CCL7;CCL5;CCL28;CCL14;CXCL16
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5005317460161263,1.4097925792629682,0.03917301414581066,0.4380454201486714,1.0,16/53,19.68%,SLC3A2;SLC38A1;SLC38A6;SLC7A1;SLC7A11;SLC36A4;SLC36A3;SLC6A7;SFXN1;SLC7A6;SLC1A5;SLC7A8;SLC43A2;SLC38A7;SLC25A18;SLC38A2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5699618673076834,-1.4070908266353765,0.1198501872659176,0.37578569290631547,1.0,5/10,18.06%,GABRG3;GABRA2;GABRA1;GABRE;GABRG2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.45927119142825107,1.4060787673296085,0.006054490413723511,0.44553291887236424,1.0,47/134,24.18%,MFSD12;SLC3A2;SLC27A1;SLC26A1;SLC38A1;SLC6A6;SLC38A6;SLC25A24;SLC7A1;SLC25A25;PDPN;SLC23A1;SLC23A2;SLC6A14;SLC36A4;SLC25A1;SLC36A3;SLC6A8;SLC35D2;SLC6A7;SLC22A3;SLC46A1;SFXN1;SLCO5A1;SLC1A5;SFXN5;SLC52A2;SLC2A8;SLC26A4;SLC35B1;SLC7A8;SFXN2;SLC25A21;SLC38A7;SLC19A1;SLC13A3;SLC25A18;SLC17A9;SLC38A2;SLC13A5;SLC2A6;SLC26A6;SLC7A2;SLC19A2;MPC2;SLC16A1;SLCO2A1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.6678475631554402,1.4041248073310824,0.08583106267029973,0.44628258870635606,1.0,6/10,26.15%,CYBA;CYBB;NCF4;NCF2;NOX4;NCF1
prerank,mRNA binding (GO:0003729),0.4513312312748631,1.403943647023763,0.001,0.44071774764672444,1.0,96/249,24.89%,RBM47;SNRNP35;PKM;EIF4A1;ADARB1;SHFL;AGO2;EIF3A;LUC7L2;EIF4G1;UNK;PABPC5;RPS14;NCL;CPEB4;PTBP3;RPS7;SNIP1;RBM25;RPL41;RPS26;CPEB2;ETF1;RBM4B;FUBP1;GRSF1;HNRNPM;NOCT;EIF4G2;CELF1;LSM14A;DENR;EIF2A;HNRNPC;HNRNPLL;RPS2;PABPC1;LARP4;CPEB3;METTL3;SHMT1;RBPMS;YTHDF3;DXO;LARP1;HNRNPK;PCBP4;EIF4G3;YBX3;DCP1A;HNRNPA2B1;RBFOX2;MRPS7;SYNCRIP;RBM15;TPR;EIF4A3;EIF4ENIF1;PCBP1;YTHDF2;NOVA2;ZC3H12B;C1QBP;DHX36;PUM1;FXR2;THOC2;PPIE;HNRNPU;DHX33;CNBP;CELF6;GNL3;RPL13A;DHX9;EIF2S2;TARDBP;RPS3;RNF20;CCT5;RPS13;ZC3H12D;PABPC4;UPF3B;SAMD4A;HDLBP;CALR;SLC4A1AP;RBMS2;PPP1R8;CPEB1;G3BP1;SF3B1;EDC3;KHSRP;HNRNPL
prerank,protein kinase activator activity (GO:0030295),0.4926944558785771,1.4036904503104413,0.03767491926803014,0.435526198639914,1.0,25/60,26.09%,IQGAP1;FGF13;ERCC6;LTF;ALS2;CD24;NRG1;DAXX;STK3;GPRC5C;GAS6;GPRC5B;PAK2;CAB39;STK11;DBF4;EPO;MARK2;TAOK1;ABI1;MAP2K2;CALM3;NCKAP1L;PARP16;RPLP1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5292201608857373,-1.402576716148852,0.0958904109589041,0.36977572273426296,1.0,3/10,7.28%,SLCO2B1;SLCO1B1;SLCO4A1
prerank,Tat protein binding (GO:0030957),0.6618394411871553,1.3997162042955067,0.07114093959731543,0.4432446375875769,1.0,6/10,25.84%,MDFIC;SMARCB1;ACTB;NPM1;DNAJA1;SMARCA4
prerank,snoRNA binding (GO:0030515),0.5374428655809658,1.3980782316670661,0.07052023121387284,0.4429339977274445,1.0,14/30,29.46%,TSR1;NUDT5;NUDT1;DDX21;BMS1;GAR1;ISG20;RRP9;DKC1;WDR3;SNU13;BYSL;NOP14;XRCC5
prerank,frizzled binding (GO:0005109),0.526302426139487,1.3915220390611478,0.053003533568904596,0.4603867738554577,1.0,8/34,14.88%,SDCBP;CCDC88C;ZNRF3;WNT6;BAMBI;MYOC;FZD1;LRP6
prerank,solute:anion antiporter activity (GO:0140323),0.6200983279949698,1.3878949715786948,0.09831824062095731,0.4676158760675827,1.0,6/14,21.80%,SLC26A1;SLC7A11;SLC26A11;SLC26A4;SLC4A2;SLC26A6
prerank,serine-type endopeptidase activity (GO:0004252),0.4788373861182045,1.3878704524793244,0.02481902792140641,0.46159407035788624,1.0,16/80,13.53%,PLAU;MMP8;GZMB;GZMA;MMP9;RHBDF2;KLK1;KLK6;CLPP;HP;HPR;F11;RHBDF1;MASP1;CD5L;GZMM
prerank,ribosome binding (GO:0043022),0.5033589667785178,1.3844364434406236,0.05257393209200438,0.4678021585601738,1.0,24/46,27.29%,SHFL;EIF6;EEF2;CPEB4;IGHMBP2;CPEB2;ETF1;EIF2A;EIF2S1;NAA16;RACK1;SEC61B;CPEB3;YTHDF3;EFL1;C1QBP;RPSA;MRPS27;CPEB1;GTPBP6;PYM1;TMCO1;GEMIN5;NAA15
prerank,RNA binding (GO:0003723),0.43475985283392704,1.3842479156908456,0.0,0.46269040455106575,1.0,562/1321,29.67%,LGALS3;APOBEC1;RFTN1;RBM47;MYO5A;DDX31;SNTB2;FAU;C1D;LRP1;PUS1;TSR1;FLNA;EPRS1;SLC3A2;SNRNP35;MRPS12;RPS12;LGALS1;AARS1;EIF3L;TMSB4X;PKM;MSN;EIF4A1;EIF1AX;EIF1;ADARB1;FNDC3B;RBM28;SHFL;AGO2;SYNE1;ESF1;EIF3A;SRPK1;RPS27A;LUC7L2;ALDOA;THG1L;VIM;MACF1;ANXA11;BRIX1;SIDT1;EIF4G1;TRUB2;RPS6;MBNL3;CNOT4;UNK;PABPC5;C4BPA;GTPBP4;IMMT;BICC1;RPS14;ZC3H7B;CMSS1;NCL;CCDC9;RPL10A;EEF2;NSA2;CPEB4;HNRNPA3;DYNC1H1;NUDT5;RRP7A;LLPH;GRWD1;RPL18;ZNF346;HNRNPUL1;RPS24;GOLGB1;DDX50;HSPB1;NUDT1;IGHMBP2;PRDX1;DDX56;DDX21;PTBP3;RPS7;ASCC3;SNIP1;RBM25;RPS20;RPL36A;NOC2L;CARS1;RPL41;MRPL4;UBAP2;EEF1A1;RPS26;IPO5;CPEB2;MRPL23;RPL17;RPL23;ACTN1;RPS25;TPT1;ETF1;ZCCHC9;TRIM28;KNOP1;RBM4B;FUBP1;GRB2;XPOT;GRSF1;CRKL;HNRNPM;MEX3A;PATL1;AKAP1;MAK16;MRPL21;NOCT;TRMT10C;HEATR6;EIF4G2;RPL35A;NFX1;RPS28;CELF1;LSM14A;CHCHD1;OTUD4;RRP12;DENR;PUS7;EIF2A;EIF2S1;RPL28;DUSP14;CAST;POLR1G;UBE2L3;P4HB;NOL8;XRN2;ZFR;SAMSN1;BTF3;KRI1;PATL2;CHD3;NPM3;NOC3L;DDX17;HNRNPC;PPAN;CSTB;PSMA1;SON;HNRNPLL;RPL27A;RNASEL;RPL11;TBCA;RPS2;PABPN1;LRRFIP1;ZNF326;SELENOH;CDK13;BMS1;RACK1;NOLC1;PABPC1;RCC1L;LARP4;DDX49;UBTF;VCP;SEC61B;WDR43;BCCIP;CPEB3;NOL6;CHERP;FAM120A;PLEC;SYF2;METTL3;UTP11;ARHGEF1;SRSF11;BRCA1;DHX34;MSI2;UTP20;MRM1;LONP1;ARL6IP4;RBPMS;RNASEH1;JUN;ENO1;S100A16;HUWE1;DDX1;ALKBH1;RPL32;NVL;YWHAG;TAF15;DIAPH1;YTHDF3;CFAP65;DXO;TRAP1;EXOSC9;SMNDC1;MRPS15;SRSF7;EXOSC10;SRP14;FTSJ3;IBA57;LARP1;RPL21;DHX29;DAP3;MRM3;SEC63;CDK11B;RBM19;HNRNPK;SAFB2;HSPA8;PPARGC1B;MRPL12;GAR1;RPL9;PCBP4;AGFG1;GTF2F1;RPL36;RPL37;EIF4G3;ILF3;H1-0;PKN2;YY1;YBX3;CPNE3;DCP1A;DDX39B;R3HDM1;RBM11;DDX18;PPIA;DCN;POLR2D;LSM6;RPS18;SUMO2;SLC16A3;HNRNPA2B1;RPL38;MBNL2;ISG20L2;RBFOX2;RCAN3;MRPS7;MKRN2;SYNCRIP;FNDC3A;PUF60;EIF5B;RBM15;HSPD1;RPS19;RPS27;WBP11;TPR;EIF4A3;EIF4ENIF1;YRDC;DEK;HELZ2;PCBP1;SRF;YTHDF2;HSPA9;NOVA2;SART1;ZC3H12B;C1QBP;ZC3HAV1;BARD1;PSMA6;FARSA;DUSP11;TFRC;PNN;DDX52;DHX36;CHTOP;CKAP4;TCOF1;EIF4E2;RPS23;RPL14;SARS2;SARS1;PUM1;FXR2;MRPL11;RPS16;MYBBP1A;THOC2;RBM15B;ZNF638;UBAP2L;SRP9;PSPC1;UTP4;PPIE;RBM39;RAE1;PRPF6;ZYX;RPL30;HNRNPU;FLNB;UTP14A;RPL12;DHX33;PPP1R10;DRG2;CNBP;GSPT1;CELF6;PURA;HNRNPF;GNL3;MEX3B;KIN;CWC22;RPL13A;DHX9;ACIN1;RPL31;KRR1;FARS2;RPS9;SNRNP40;EIF3E;CCAR2;CCAR1;LYAR;NOC4L;NSUN2;RNMT;AGO3;RPP25L;BST2;FAM98A;SRSF2;ADAR;IFIT2;ATXN2;EIF2S2;RPL4;TARDBP;RRBP1;TOP1;UBC;RAD51AP1;RPS3;ZGRF1;HMGB1;SRFBP1;DUT;MTDH;ANXA7;MRPS28;MRPS35;FASTKD3;ZRANB2;CHD2;PPIG;EIF5A;PRRC2C;MARK2;CPSF7;RALY;PRPF8;RPS13;RRP9;AHNAK;HSP90AB1;EIF4A2;YARS1;ZC3H12D;RPSA;SRPK2;NPM1;PABPC4;SND1;DKC1;MRPL15;RPL15;CCDC86;TES;UPF3B;MRPS27;GIGYF2;WDR3;SAMD4A;HDLBP;USP36;CALR;TERT;CANX;SF3A3;NOL10;PFN1;MRPS30;PPRC1;SREK1;LSM4;SLC4A1AP;MRPS14;ACTN4;RBMS2;GTF2E2;RSRC2;MRPL1;EIF3B;RBM26;POLDIP3;SNU13;SRRM1;RBM22;RPP38;SUCLG1;FASTKD5;EIF4B;HSPE1;PPP1R8;XRN1;PIN4;PDAP1;G3BP1;SNRPG;DIMT1;SUMO1;DQX1;RPL7A;AIMP1;RPUSD4;EDF1;SF3B2;SF3B1;TNPO1;EDC3;USO1;MRPL37;EIF3H;FASN;KHSRP;HDAC2;HNRNPL;RRP1B;RRP1;SNRPF;PYM1;DNTTIP2;NUP98;YWHAZ;TXN;RPL23A;ACAA2;RPL8;GANAB;EIF3I;LSM3;NAT10;EIF3G;NUP42;HMGB3;SLTM;R3HDM2;SNW1;MAP4;MTPAP;RPL29;GEMIN5;ATP5F1C;FASTKD2;MRPL39;EIF1B;RPL37A;TARBP2;SNRPA;NOL3;ARC;SF3B5;RC3H1;ELP5;SUPV3L1;KDM1A;NAA15;MAPRE1;EIF4E;PRPF40A;BYSL;FUS;CS;GTPBP10;MRPL41;MRPL27;NQO1;HNRNPUL2;NOP14;SRSF1;SMG1;DNAJC2;SRSF10;CSTF2;TRMT6;MRPL42;DDX41;NUDT21;WBP4;OASL;RARS2;RIDA;SERPINH1;TRA2B;TIAL1;HSP90B1;MEX3C;TENT4B;LBR;RO60;APTX;SAFB;RPS15A;ZC3H15;DDX59;ZC3H12C;CSNK1E;TRIP6;PURB;XRCC5;ERI3;PRPF31;MAZ;NXF1;TRMT2A;SUGP1;HDGF;DHX57;HMGB2
prerank,E-box binding (GO:0070888),0.5166885528980604,1.3826066295815773,0.06704545454545455,0.4629596604914078,1.0,8/34,13.08%,MITF;TCF15;PPARG;GATA3;BHLHE40;BHLHE41;PRMT5;TFAP4
prerank,ferrous iron binding (GO:0008198),0.5638979240096726,1.3818858133910497,0.07692307692307693,0.46003877695701206,1.0,9/21,22.58%,FTL;ACP5;HEPH;ALKBH1;CDO1;FTH1;EGLN1;ALKBH3;EGLN3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.645112812771834,1.3804422977612492,0.0738255033557047,0.4591815577950402,1.0,6/11,21.07%,GNPTAB;SGMS1;PIGN;DPAGT1;AASDHPPT;SAMD8
prerank,sterol binding (GO:0032934),0.48816852359021207,1.377611466854149,0.05692803437164339,0.46415538561971753,1.0,16/56,19.53%,OSBPL8;ABCG1;ABCA1;SIDT1;VDAC2;APOA2;SOAT1;CAV1;ANXA6;SOAT2;OSBPL2;NPC1;GRAMD1B;NPC2;STARD4;SULT2B1
prerank,semaphorin receptor binding (GO:0030215),-0.426355406138297,-1.3736374573609456,0.08771929824561403,0.4065489374438791,1.0,9/23,24.55%,SEMA6D;SEMA6A;RIT2;SH3BP1;SEMA6C;SEMA4B;SEMA3B;SEMA4A;SEMA7A
prerank,mRNA 5'-UTR binding (GO:0048027),0.5534275581200943,1.3735409149363595,0.0884109916367981,0.4730179260437158,1.0,11/24,21.13%,RPS14;NCL;RPS7;RPL41;SHMT1;LARP1;SYNCRIP;DHX36;GNL3;CCT5;RPS13
prerank,protein phosphatase 2A binding (GO:0051721),0.5619980954261177,1.3719572761479335,0.08323424494649227,0.4730108959786784,1.0,7/23,15.80%,ADCY8;PTPA;SPHK1;MFHAS1;BOD1L1;PPME1;FOXO1
prerank,SUMO transferase activity (GO:0019789),0.5954103314244547,1.370659554716459,0.08010335917312661,0.47197404313059926,1.0,10/16,31.93%,NSMCE2;HDAC4;TRIM28;EGR2;RANBP2;PIAS1;MDM2;PIAS4;MUL1;PIAS3
prerank,actin binding (GO:0003779),0.43866582255291925,1.3685187137105432,0.013052208835341365,0.47403809352759624,1.0,35/170,12.92%,GAS2L3;LCP1;MYO9B;MICAL2;ABL2;MYO1F;MRTFA;TMSB4X;TNNT3;DAG1;COTL1;ADCY8;SYNE1;ALDOA;MACF1;PDLIM1;SCIN;TPM2;SPATA32;MICAL1;CAP1;MSRB1;FXYD5;TLNRD1;KCNMA1;MTSS1;TMSB10;P4HB;CORO7;ABLIM1;PARVA;BCL7B;GSN;IQGAP2;UTRN
prerank,potassium ion leak channel activity (GO:0022841),-0.4646977780958611,-1.3638964257963369,0.12280701754385964,0.4118218420214153,1.0,8/15,20.96%,KCNK12;KCNK1;KCNK5;KCNK2;KCNK10;KCNK6;KCNK4;KCNK7
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6064251941228138,1.3587483181918558,0.10682110682110682,0.5045525609627671,1.0,4/13,7.00%,ITGA5;PDGFA;ERN1;VEGFA
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.5265646747086303,-1.357571339038091,0.13135593220338984,0.41006435199042207,1.0,5/10,24.15%,KAT2B;CDKN2C;CDKN2D;CDKN1B;HEXIM2
prerank,phosphatase binding (GO:0019902),0.4548767317958206,1.3562961204241066,0.02889576883384933,0.5084048247678173,1.0,22/105,14.50%,LGALS3;IQGAP1;CTNNB1;LCK;SKAP1;ANK1;SIRPA;KCNN4;TRAF2;TRAF3;CD22;IKBKE;MVP;RACK1;VCP;JUP;JAK1;PPME1;SYTL2;GTF2F1;SH2D4A;RCAN3
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3781340538669156,-1.3534395938238934,0.08,0.40495224619738235,1.0,16/32,25.26%,KCNB2;KCNA6;KCNB1;KCNQ3;KCNH1;KCNC2;KCNS3;KCNH2;KCNC1;KCNC3;KCNG2;KCNQ1;KCNG1;KCNE3;KCNE4;KCNG3
prerank,pseudouridine synthase activity (GO:0009982),0.6052457056128165,1.3516915779771168,0.11024643320363164,0.5199576702986596,1.0,6/13,24.42%,PUS1;TRUB2;PUS7;DKC1;RPUSD1;RPUSD4
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3073257134444895,-1.3495796219488039,0.021739130434782608,0.3998873179921475,1.0,30/80,21.43%,KCND2;KCNB2;KCNA6;KCNJ3;KCND3;KCNB1;KCNQ3;KCNH7;KCND1;HCN1;KCNK1;KCNN3;KCNH1;KCNN2;KCNC2;KCNJ13;KCNS3;KCNK2;KCNH2;KCNC1;KCNC3;KCNJ12;KCNK6;KCNH4;KCNG2;KCNN1;KCNQ1;KCNIP2;KCNG1;LRRC55
prerank,alpha-actinin binding (GO:0051393),0.5295851644144665,1.3487009883755865,0.09887359198998748,0.5256866325299342,1.0,6/24,13.27%,DAG1;PDLIM1;PPARG;MAGI1;CACNA1D;PALLD
prerank,ATPase binding (GO:0051117),0.46113490264991813,1.3466644327823656,0.04206098843322818,0.5275360804090129,1.0,13/71,9.41%,LCK;ANK1;ABCA1;TCIRG1;ATP1B3;ATP6V0A1;ATP6V1G1;CAV1;CLPP;TOR1AIP2;CHMP4A;ATXN3;SNX10
prerank,thioesterase binding (GO:0031996),0.6205091962125016,1.34577235166795,0.1262002743484225,0.5254512503688794,1.0,4/11,13.01%,TRAF2;TRAF3;TRAF1;CDC42
prerank,protein tyrosine kinase activator activity (GO:0030296),0.5553385430419051,1.3439935386667206,0.10933660933660934,0.5271905601912157,1.0,8/19,13.50%,ERCC6;CD24;NRG1;ALKAL2;ANGPT4;CCL5;GAS6;PAK2
prerank,rRNA binding (GO:0019843),0.489049642293002,1.342430367004596,0.08387799564270153,0.5273185183962754,1.0,18/42,26.68%,RPS14;DDX21;RPL23;PPAN;RPL11;RCC1L;MRPS7;MRPL11;TST;RPL12;RPS9;RPS3;RPS13;MRPS27;FASTKD5;MDM2;MRPL18;FASTKD2
prerank,copper ion binding (GO:0005507),0.4881166579347385,1.3409984431284925,0.07641921397379912,0.5270542280345722,1.0,7/42,7.56%,P2RX4;ATP7A;AOC2;ATP13A2;RNF7;ATOX1;HEPH
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6207238033881916,1.3392325886767875,0.1133879781420765,0.5282767738593487,1.0,7/11,21.97%,PRMT5;PRMT7;CARM1;PRMT2;PRMT6;PRMT3;FBXO11
prerank,histone methyltransferase binding (GO:1990226),0.6227403390490991,1.3387906760392827,0.10597826086956522,0.5245934960433444,1.0,4/11,21.33%,CTNNB1;PHF1;CBX3;HSP90AB1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4564297312043493,1.3346202454084588,0.04153686396677051,0.5351313910797593,1.0,15/85,10.76%,LPL;AARS1;PLAAT3;CEL;LIPA;GDPD3;PRDX6;PNPLA7;PON1;ABHD12;MGLL;PGLS;PGAP1;ABHD5;PAFAH2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4912709865285214,1.3319056284671935,0.10514285714285715,0.540380009232404,1.0,11/38,17.53%,HRG;SERPINA10;A2M;SERPINB9;TFPI;SERPINE2;SERPINE1;TFPI2;FURIN;SPINK5;SERPINF2
prerank,CoA-ligase activity (GO:0016405),0.5851370870892658,1.331574213238413,0.1141025641025641,0.536218558753265,1.0,5/14,15.04%,ACSBG1;SLC27A5;ACSBG2;ACSL1;AACS
prerank,sialyltransferase activity (GO:0008373),-0.42139898231956036,-1.329840099920018,0.10101010101010101,0.4249745585154145,1.0,4/20,3.97%,ST3GAL6;ST3GAL5;ST8SIA4;ST6GAL2
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4969755682312522,1.329180349397247,0.07909604519774012,0.5395492209582744,1.0,8/38,12.97%,SH3PXD2B;TECPR1;RUFY4;NCF4;WDR45;HIP1;SESTD1;PLEKHF1
prerank,actin monomer binding (GO:0003785),0.5445262996918894,1.3284659419369802,0.12546583850931678,0.537167952040883,1.0,5/22,7.94%,ABL2;MRTFA;TMSB4X;MTSS1;TMSB10
prerank,phospholipase binding (GO:0043274),0.604898879608944,1.324165367240862,0.127129750982962,0.5480341277354682,1.0,8/13,25.22%,LCK;BLNK;PDPK1;ARHGAP6;FYN;SYK;WAS;BTK
prerank,phospholipase activity (GO:0004620),0.4563528086221937,1.3229200761187447,0.0642781875658588,0.5475108385353741,1.0,13/67,8.59%,LPL;PLD3;DDHD1;PLAAT3;PLCB4;GDPD3;PRDX6;PNPLA7;ABHD12;MGLL;NAPEPLD;PLCB2;SMPD4
prerank,ATP binding (GO:0005524),0.4241449041175238,1.3216898842592142,0.004008016032064128,0.5470067077079728,1.0,84/266,22.26%,MYO9B;PEAK1;ABCG1;CDK6;ERCC6;ABCA1;MYO1F;P2RX4;AARS1;ATP7A;SRPK1;MLKL;THG1L;GCK;PTPA;EIF4G1;HSPA4;SPHK1;MAP4K5;MAP4K2;DYRK2;ABCD4;IGHMBP2;CARS1;ERN2;STK3;PI4K2A;SIK1;ERN1;MAP4K3;ATP1A3;ATP1A1;MTHFS;PAPOLA;PDXK;PFKL;P2RY1;PGK1;PIM1;LONP1;NVL;ABCD2;CDK11B;HSPA8;BLM;PFKP;DAPK1;EIF4A3;AK6;ATP1A2;CAD;HSPA9;STK38;ABCD3;DHX36;TLK1;SARS2;PRKAG1;MINK1;KIFC1;NLK;HNRNPU;EIF2B2;STK11;DAPK3;OLA1;NEK6;DHX9;RTEL1;TOP1;PDK3;MCM6;TRIP13;LMTK2;MARK2;PRAG1;HSP90AB1;MARK4;RUNX3;NIM1K;SRPK2;PRPS2;TAOK1;LATS1
prerank,cyclic nucleotide binding (GO:0030551),-0.41359625933565614,-1.3207409546565516,0.12169312169312169,0.43055971266088,1.0,9/21,21.25%,PDE10A;RAPGEF2;HCN1;KCNH1;PDE4D;POPDC3;PDE2A;PDE4B;PDE5A
prerank,kinase activator activity (GO:0019209),0.5059589873593642,1.3193909182928785,0.10928319623971798,0.5505592148988957,1.0,11/30,20.93%,FGF13;MALT1;DAXX;TREM2;GPRC5C;GPRC5B;CAB39;STK11;IL2;EPO;MARK2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5103635703749345,1.319097458207904,0.11239860950173812,0.5466279144412283,1.0,12/29,21.80%,SLC26A1;SLC46A1;SLC1A5;SLC25A14;SLC26A4;SLC25A21;SLC38A7;SLC19A1;SLC13A3;SLC25A18;SLC13A5;SLC26A6
prerank,chloride channel inhibitor activity (GO:0019869),-0.5171258145101572,-1.3173367219016803,0.15849056603773584,0.4250677495813682,1.0,6/10,29.06%,WNK1;WNK3;STX1A;VAMP8;WNK4;WNK2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6255118643001178,1.3152038622684314,0.1471861471861472,0.5557440551316911,1.0,7/10,33.93%,PRDM9;SMYD2;SETMAR;NSD3;NSD1;ASH1L;SETD2
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.49161238052116374,1.312896313976151,0.10380622837370242,0.5594334027743136,1.0,18/35,28.30%,MMP12;AGO2;HDAC1;UBTF;SMARCB1;TBPL1;TBP;DR1;NR3C1;NPM1;TAF1C;POU2F1;SMARCA4;PIH1D1;H3-3A;KLF10;RUVBL2;ZBTB17
prerank,potassium channel activity (GO:0005267),-0.3040396774507556,-1.312199274710442,0.023809523809523808,0.4230690464563084,1.0,35/89,21.43%,GRIK2;KCND2;KCNB2;GRIK3;KCNK12;KCNA6;KCND3;GRIK4;KCNB1;KCNQ3;KCNH7;KCND1;HCN1;KCNMB2;ABCC9;KCNK1;KCNH1;KCNN2;KCNC2;KCNS3;KCNK5;KCNK2;KCNK10;KCNH2;KCNC1;KCNC3;KCNK6;KCNK4;KCNH4;KCNG2;KCNN1;KCNQ1;KCNK7;KCNG1;LRRC55
prerank,sequence-specific mRNA binding (GO:1990825),0.6331607322049778,1.3101270948893726,0.13704206241519673,0.565086761135989,1.0,3/10,18.34%,SHFL;ETF1;DHX9
prerank,intracellular chloride channel activity (GO:0061778),0.562467856234677,1.309304229415086,0.12260536398467432,0.5580726921167464,1.0,5/16,18.11%,TTYH2;ANO9;ANO8;ANO5;ANO6
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.562467856234677,1.309304229415086,0.12260536398467432,0.5580726921167464,1.0,5/16,18.11%,TTYH2;ANO9;ANO8;ANO5;ANO6
prerank,MHC class I protein binding (GO:0042288),0.5876648343175002,1.3042047676939157,0.13395225464190982,0.5718600237976598,1.0,6/13,17.43%,CD8B;CD8A;TAPBP;LILRB1;DERL1;TUBB
prerank,alkali metal ion binding (GO:0031420),0.5791247103124453,1.3013558449845668,0.15465268676277852,0.5775510196353314,1.0,6/13,15.91%,HDAC4;ATP1A1;PDXK;DRG1;ATP1A2;ACAT1
prerank,cadherin binding (GO:0045296),0.4169686649169049,1.298820860122912,0.007,0.5819306025960655,1.0,139/315,28.41%,IQGAP1;TRPC4;CTNNB1;TLN1;NIBAN2;FLNA;P2RX4;SLC3A2;ANXA1;ASAP1;PKM;CAPG;TAGLN2;ALDOA;MACF1;PDLIM1;PRDX6;PKP1;PKP4;TJP2;PAK6;FMNL2;EEF2;CC2D1A;S100A11;PRDX1;UBAP2;TBC1D2;RPS26;FXYD5;STK24;LASP1;NCK1;CRKL;CHMP4B;EIF4G2;EIF2A;CAST;CDH1;SH3GLB2;SCYL1;EEF1D;RPS2;LRRFIP1;RACK1;EVPL;JUP;PLEC;LDHA;RARS1;ENO1;PARVA;EFHD2;NDRG1;RANBP1;PPME1;MRTFB;LARP1;DHX29;HNRNPK;HSPA8;SH3GL1;PKN2;PAK2;ATIC;CCT8;PFKP;PUF60;LYPLA2;CSNK1D;CBL;PCBP1;VAPB;STK38;ZC3HAV1;KDR;GOLGA3;RAB1A;RPL14;PKP2;AFDN;EPS15L1;FLNB;OLA1;YWHAB;EHD4;DNAJB1;EIF3E;VASP;BAIAP2;YKT6;MARK2;AHNAK;HSP90AB1;PI4KA;TMPO;SND1;RPL15;TES;GIGYF2;HDLBP;PROM1;ABI1;PFN1;TBC1D10A;SNX1;UNC45A;EHD1;RPL7A;BAG3;USP8;PDXDC1;USO1;IST1;GIPC1;FASN;HSPA5;ABCF3;GOLGA2;YWHAZ;RPL23A;ESYT2;CLINT1;PAK4;PSMB6;HCFC1;RPL29;PTPRM;CDH4;STX5;MAPRE1;BAIAP2L1;ITGB1;CORO1B;PACSIN2;BSG;CDH18;CDH24;ARHGAP1
prerank,voltage-gated anion channel activity (GO:0008308),0.563245302829668,1.2976795443989122,0.15384615384615385,0.5818274100263073,1.0,6/15,20.34%,VDAC2;CLCN1;ANO6;CLCN4;GPR89A;GPR89B
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5924195505346833,1.2945178997716522,0.16843501326259946,0.5887322007916483,1.0,5/11,22.13%,RDH12;AKR1B10;AKR1A1;RDH13;RDH14
prerank,methyltransferase activity (GO:0008168),0.46239679786959564,1.2941841114133914,0.09866962305986696,0.5851660723864681,1.0,18/46,21.75%,AS3MT;DNMT1;MRM2;MGMT;PRMT5;METTL3;PRMT7;FTSJ3;COQ5;EEF1AKMT3;COQ3;DNMT3B;NSUN3;NSUN2;EHMT1;AMT;PRMT3;GCSH
prerank,tropomyosin binding (GO:0005523),0.5558276160953695,1.293743651799449,0.14285714285714285,0.5819464404437361,1.0,2/16,5.22%,TNNT3;S100A6
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4943427347820291,1.293357840383335,0.11303344867358708,0.5783895954996313,1.0,15/34,29.18%,IQGAP1;LTF;ALS2;STK3;CCNB1;CAB39;CCNT2;DBF4;CKS2;TAOK1;MAP2K2;CALM3;PARP16;RICTOR;STK4
prerank,disordered domain specific binding (GO:0097718),0.5141040885584333,1.2929081950925798,0.13226205191594562,0.5752621547254388,1.0,8/23,25.49%,FN1;FYN;NUMA1;DFFB;HSP90AB1;CALM3;MDM2;HSPA2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5208011811990039,-1.292663693643411,0.15901060070671377,0.4486910874220063,1.0,4/10,10.88%,DPP10;DPP6;PRCP;NAALAD2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5921159732522183,1.291006855061472,0.13272010512483573,0.5773626665743284,1.0,4/12,14.86%,XDH;SDHB;ISCA1;CIAPIN1
prerank,ATPase regulator activity (GO:0060590),0.4737803652209382,1.2908530742609796,0.1161217587373168,0.5733018038027053,1.0,14/38,28.04%,FNIP2;ATP1B3;TOR1AIP2;DNAJC15;SIL1;DNAJC1;DNAJB1;PFN1;DNAJC10;DNAJA1;BAG3;ATP1B2;FNIP1;DNAJB6
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.48700695821899337,1.2908509947755549,0.1382488479262673,0.5687153893722836,1.0,13/34,22.71%,DOT1L;TTLL12;ETFBKMT;KMT5A;SMYD3;PRDM9;KMT5B;EEF1AKMT3;SMYD2;SMYD1;EHMT1;EEF2KMT;NSD3
prerank,ribonuclease activity (GO:0004540),0.4492604562516509,1.2877418225703392,0.11290322580645161,0.5754889351476846,1.0,20/56,21.77%,AGO2;RNASE3;EXOSC4;ERN2;PIWIL2;ERN1;RNASEH2A;RNASEL;RNASEH1;RNASE12;EXOSC9;EXOSC10;ZC3H12B;RNASE7;RNASE6;AGO3;EXOSC5;CNOT6;ZC3H12D;SND1
prerank,lipase activity (GO:0016298),0.4702048450077334,1.2875220616707876,0.13062568605927552,0.5717247443309219,1.0,7/43,8.95%,LPL;DDHD1;CEL;LIPA;ABHD12;MGLL;ABHD5
prerank,metalloendopeptidase activity (GO:0004222),0.4336833280593743,1.283429349132654,0.08139534883720931,0.5814369071882105,1.0,22/76,23.82%,ADAM33;MMP8;MMP12;ADAMTS13;MMP9;ECEL1;ADAMTS10;ADAM17;ADAMTS14;ADAMTSL5;AFG3L2;ADAMTS2;MMP19;MBTPS2;ADAMTSL1;MMP17;MMP28;PITRM1;ADAMTSL4;ECE1;TRABD2B;NLN
prerank,poly-purine tract binding (GO:0070717),0.49894622775720326,1.2832006587897533,0.13372781065088757,0.5776849676086028,1.0,12/27,23.02%,PABPC5;PATL1;ATXN1;PABPC1;LARP4;RBPMS;DDX1;EIF4A3;PPIE;HNRNPU;PABPC4;RBMS2
prerank,endodeoxyribonuclease activity (GO:0004520),0.5272912668053834,1.280372897263533,0.16313823163138233,0.583401303390329,1.0,7/20,21.83%,ERCC1;ZRANB3;RAD50;MBD4;ERCC4;RPS3;SETMAR
prerank,triglyceride lipase activity (GO:0004806),0.5261520783336393,1.2790538356451604,0.16831683168316833,0.5838689038524841,1.0,3/20,8.95%,LPL;CEL;ABHD5
prerank,ADP binding (GO:0043531),0.5037553187496963,1.2745732757157215,0.15721040189125296,0.5955956312623241,1.0,5/25,11.00%,MYO9B;ABCG1;ERN1;PGK1;LONP1
prerank,neuropeptide receptor activity (GO:0008188),-0.36135330226091156,-1.2736816151865282,0.09219858156028368,0.47556420233463037,1.0,8/29,23.66%,SORCS1;GPR37;TACR3;GRPR;NPSR1;SSTR2;NTSR1;GAL
prerank,translation elongation factor activity (GO:0003746),0.5578868549923586,1.2705721767687588,0.1856368563685637,0.6051183981484374,1.0,6/14,21.80%,EEF2;EEF1A1;GTPBP2;EIF5AL1;EIF5A;GFM2
prerank,ATP hydrolysis activity (GO:0140603),0.46336572094545153,1.2691269432916619,0.1323529411764706,0.6058982217807516,1.0,9/41,14.54%,MYO1E;ATP2B1;ABCA4;CHD3;VCP;VWA8;VPS4B;ABCD2;CLU
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5805835856057048,1.2653237056813973,0.1704697986577181,0.6148901063274871,1.0,7/12,27.39%,AGO2;CYFIP2;LARP1;EIF4E2;GEMIN5;CYFIP1;EIF4E
prerank,titin binding (GO:0031432),-0.44823761820699715,-1.2649720654537764,0.17100371747211895,0.48233550638409706,1.0,2/13,4.11%,CAPN3;MYBPC1
prerank,transition metal ion binding (GO:0046914),0.3999122721792424,1.26453920482123,0.009009009009009009,0.6132997723664209,1.0,115/397,24.51%,FAM20C;LITAF;S100A8;ADAM33;S100A9;FTL;LCN2;ANPEP;MMP8;ABL2;EEA1;MMP12;P2RX4;EPRS1;KMT2A;MGAT5;LTF;CD4;RNF125;ATP7A;LARGE1;SORD;B4GALT7;AOC2;ADAM8;ATP13A2;HRG;ADAMTS13;DHH;ZDHHC15;DYRK2;WDFY1;MMP9;HDAC4;RNF7;GYG1;PPARG;MSRB1;ATOX1;TRIM28;APIP;NAPEPLD;HEPH;RASGRP1;NFU1;PAPOLA;SCD5;PDXK;CHD3;KDM3A;TET3;NEK4;BBOX1;SIRT5;RABGGTB;SHMT1;TIMM9;PIM1;RNF2;PCK2;SEC24A;RIOX1;ATAD3A;UPB1;HPF1;BLM;TMEM163;RPS27;FBXL19;SEC24D;TIMP2;CAD;QPCT;MYT1;MELTF;CHORDC1;CBLB;SMPD1;SOD3;XPNPEP1;GALT;BAZ1B;S100B;BMI1;ARHGEF2;B4GALT1;FTH1;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SOD2;HHIP;TIMP1;TRIM24;DUSP12;TNFSF10;DOHH;TES;PITRM1;CALR;USP33;EGR1;ECE1;RXRA;TARS1;ADH5;MDM2;SIRT3;BIRC2;SLC11A2
prerank,DNA replication origin binding (GO:0003688),0.5112845748096954,1.263670285058436,0.16606498194945848,0.6120631193306335,1.0,9/23,21.14%,ORC3;MCM7;MCM2;GRWD1;HSPD1;KAT7;DHX9;MCM6;MCM8
prerank,poly(A) binding (GO:0008143),0.514001198734399,1.2622636939770093,0.17857142857142858,0.612712959712561,1.0,10/21,23.02%,PABPC5;PABPC1;LARP4;RBPMS;DDX1;EIF4A3;PPIE;HNRNPU;PABPC4;RBMS2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5771492299588837,1.2606464077524282,0.20383036935704515,0.6140827559007901,1.0,4/12,11.82%,TRAF2;TRAF3;TRAF1;TRAP1
prerank,endopeptidase activity (GO:0004175),0.4065109490882887,1.2598993943098071,0.017,0.6124381758660978,1.0,83/257,25.94%,PLAU;ADAM33;CTSB;MMP8;CTSZ;MMP12;MALT1;CTSW;GZMB;GZMA;ADAMTS13;MMP9;RHBDF2;ECEL1;KLK1;KLK6;CLPP;USP12;ADAMTS10;HP;HPR;NAPSA;PSEN2;F11;USP9X;PSMA1;ADAM17;RHBDF1;ADAMTS14;USP5;TASP1;MASP1;ADAMTSL5;CD5L;PSMA8;CTSE;DDI2;AFG3L2;ADAMTS2;USP40;TPP2;GZMM;MMP19;CASP7;USP47;CASP4;PSMA6;FURIN;MBTPS2;KLK3;PSMA5;USP18;PRSS53;USP46;ADAMTSL1;CASP9;MASP2;MMP17;TPP1;USP28;MMP28;SENP1;PITRM1;PREP;USP36;USP14;USP33;ADAMTSL4;TMPRSS4;ECE1;PSMA3;TRABD2B;PARL;NLN;CORIN;USP2;USP8;F9;PSMB10;SFRP1;PSMB8;USP1;PSMB6
prerank,kinase binding (GO:0019900),0.39742065450204067,1.253198224711887,0.007,0.632260117330475,1.0,104/434,17.39%,BCAR3;LYST;CSPG4;IQGAP1;CTNNB1;LCK;STAP1;HIF1A;LAX1;SKAP1;CD3E;BCL2L1;FLNA;SMCR8;PTPRC;CD226;CD4;MSN;SASH1;KIF13B;FGR;LAT;HDAC7;TRAF2;RPS6;CD24;TRIM6;NR4A3;TSKS;PTPN23;SQSTM1;PRKCD;EEF2;CAV1;FAM83H;HSPB1;DAXX;RPS7;GYS1;PTPN22;EEF1A1;BLNK;SIK1;GRB2;PPP1R12A;ATP1A4;HTT;RHOD;FBXO5;TPCN2;ILK;PFKL;MVP;PTPN2;SLC12A4;TICAM1;WDR45;CCNB1;NISCH;PRAM1;ATF5;DCTN1;RHOG;CEBPA;IRF5;EXOC2;TRAP1;RHOA;TNIP2;GSN;MAP3K12;SP100;UTRN;CDC42;SMAD1;DCX;SIKE1;GHR;KIF20A;GPRC5B;PAK2;JTB;MAP3K1;ACTB;CAB39;CEP250;IL31RA;UBQLN1;RPS19;ACTA2;EIF4ENIF1;ITGB2;RACGAP1;BARD1;TFRC;CCND2;CHP1;MAP2K3;DUSP3;PRKAG1;ADIPOR1;GSKIP;DGKD;TEX14
prerank,cytokine activity (GO:0005125),0.409422675496916,1.2473562777519949,0.07918781725888324,0.6489334218054268,1.0,33/131,26.13%,CSF1;CCL4;FAM3D;BMP8B;NRG1;GDF6;FGF2;VEGFA;KITLG;CCL13;WNT6;CCL7;CCL5;CCL28;CCL14;CXCL16;FAM3C;BMP6;IL6;IL2;HMGB1;TIMP1;EPO;TNFRSF11B;BMP4;IL34;MIF;IL17D;TNF;AIMP1;BMP5;NDP;CX3CL1
prerank,MHC protein binding (GO:0042287),0.5190542973499988,1.2471362244368014,0.19651741293532338,0.6452763962366534,1.0,9/20,24.56%,CD8B;CD4;CD8A;TAPBP;LILRB1;DERL1;TUBB;CD74;ATP5F1B
prerank,gated channel activity (GO:0022836),0.5508221925329602,1.2470075686886406,0.19718309859154928,0.641301084275203,1.0,3/14,7.11%,PACC1;PIEZO1;PIEZO2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.4934809421032662,1.2458009619476207,0.18009478672985782,0.6415617959878988,1.0,8/27,14.73%,SLC9A1;SLC3A2;SLC23A1;ASIC3;SLC9A8;SLC8B1;SLC9A6;SLC9A7
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5668065932869715,1.2448515973021526,0.2107329842931937,0.6407673156194784,1.0,3/12,9.55%,ITGA5;VEGFA;CADM4
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.47457107350486805,1.2439944271702266,0.17586206896551723,0.6396421842059531,1.0,9/30,13.74%,LTF;CST7;PRDX5;SERPINB9;CAST;CSTB;BIRC6;GAS6;BIRC5
prerank,glycerophospholipid flippase activity (GO:0140333),-0.475066316812477,-1.2422780147629797,0.22794117647058823,0.5181340060717493,1.0,2/11,3.37%,ATP8A2;ABCA3
prerank,lysophospholipase activity (GO:0004622),0.5118901580174628,1.241647215979381,0.19901112484548825,0.6441848095646011,1.0,6/20,16.77%,GDPD3;PNPLA7;ABHD12;MGLL;LYPLA2;PNPLA6
prerank,double-stranded RNA binding (GO:0003725),0.43111118311799007,1.2406591215180278,0.11974789915966387,0.6433226670248797,1.0,23/70,21.33%,RFTN1;SLC3A2;MSN;EIF4A1;ADARB1;AGO2;VIM;SIDT1;ZNF346;ACTN1;ZFR;LRRFIP1;ILF3;HSPD1;TFRC;DHX36;HNRNPU;DHX33;DHX9;AGO3;ADAR;MTDH;HSP90AB1
prerank,protein kinase binding (GO:0019901),0.39082681639791106,1.236078844684525,0.005,0.6551880013587311,1.0,112/479,17.00%,LYST;CSPG4;IQGAP1;LCK;STAP1;HIF1A;LAX1;NELL2;SKAP1;CD3E;CD247;BCL2L1;PLEK;SIRPA;SMCR8;PTPRC;CD226;CD4;MSN;SASH1;KIF13B;FGR;LAT;HDAC9;HDAC7;TRAF2;TNIP1;RPS6;CD24;TRIM6;NR4A3;DUSP9;MAP4K2;TJP2;TSKS;PTPN23;SQSTM1;NEDD9;PRKCD;NELL1;EEF2;CAV1;FAM83H;HSPB1;DAXX;RPS7;GYS1;EEF1A1;BLNK;SIK1;SOX9;GRB2;PPP1R12A;TREM2;RHOD;FBXO5;PRKCB;SPAG9;MAPKAPK3;TPCN2;ILK;MVP;MAPKAPK2;PTPN2;RACK1;SLC12A4;TICAM1;WDR45;CCNB1;NISCH;PRAM1;DUSP6;DCTN1;RHOG;YWHAG;IRF5;EXOC2;TRAP1;RHOA;TNIP2;MAP3K12;UTRN;CDC42;SMAD1;DCX;SIKE1;GHR;KIF20A;GPRC5B;PAK2;JTB;MAP3K1;ACTB;CEP250;IL31RA;PRKD2;RPS19;ACTA2;TPR;ITGB2;RACGAP1;STK38;TFRC;CCND2;TIRAP;CAVIN2;MAP2K3;DUSP3;PKP2;PRKAG1;ADIPOR1;GSKIP
prerank,zinc ion binding (GO:0008270),0.39244808402366116,1.2360145232372903,0.031031031031031032,0.6511162435571162,1.0,84/293,24.50%,LITAF;S100A8;ADAM33;S100A9;ANPEP;MMP8;EEA1;MMP12;P2RX4;EPRS1;KMT2A;CD4;RNF125;SORD;ADAM8;ATP13A2;HRG;ADAMTS13;DHH;ZDHHC15;WDFY1;MMP9;HDAC4;PPARG;MSRB1;TRIM28;APIP;NAPEPLD;RASGRP1;PDXK;CHD3;TET3;BBOX1;SIRT5;RABGGTB;SHMT1;TIMM9;RNF2;SEC24A;ATAD3A;UPB1;HPF1;BLM;TMEM163;RPS27;FBXL19;SEC24D;TIMP2;CAD;QPCT;MYT1;CHORDC1;CBLB;SMPD1;GALT;BAZ1B;S100B;BMI1;ARHGEF2;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;HHIP;TIMP1;TRIM24;DUSP12;TNFSF10;TES;PITRM1;CALR;USP33;EGR1;ECE1;RXRA;TARS1;ADH5;MDM2;SIRT3;BIRC2
prerank,lipoprotein particle receptor binding (GO:0070325),0.48589941012756077,1.2354359118187868,0.18128654970760233,0.6489887790076954,1.0,6/27,16.03%,APOE;LRP1;APOA2;LRPAP1;CLU;HSPG2
prerank,adenyl ribonucleotide binding (GO:0032559),0.39574500653490635,1.235316007270632,0.018036072144288578,0.6451651503334009,1.0,87/291,22.31%,MYO9B;PEAK1;ABCG1;CDK6;ERCC6;ABCA1;MYO1F;P2RX4;AARS1;ATP7A;SRPK1;MLKL;THG1L;GCK;PTPA;EIF4G1;HSPA4;SPHK1;MAP4K5;MAP4K2;DYRK2;ABCD4;IGHMBP2;CARS1;ERN2;STK3;PI4K2A;SIK1;ERN1;MAP4K3;ATP1A3;ATP1A1;MTHFS;PAPOLA;PDXK;PFKL;P2RY1;PGK1;PIM1;LONP1;NVL;ABCD2;CDK11B;HSPA8;BLM;APRT;PFKP;DAPK1;EIF4A3;AK6;ATP1A2;CAD;HSPA9;STK38;ABCD3;DHX36;TLK1;SARS2;PRKAG1;MINK1;KIFC1;NLK;HNRNPU;EIF2B2;STK11;SLC19A1;DAPK3;OLA1;NEK6;DHX9;RTEL1;TOP1;PDK3;MCM6;TRIP13;LMTK2;MARK2;PRAG1;HSP90AB1;MARK4;RUNX3;NIM1K;SRPK2;PRPS2;TAOK1;LATS1;CNBD2
prerank,metallopeptidase activity (GO:0008237),0.40623638146919366,1.2342167475937413,0.10612244897959183,0.6446697458690874,1.0,35/113,26.52%,ADAM33;ANPEP;MMP8;MMP12;ADAM8;ADAMTS13;BMP1;MMP9;ECEL1;ADAMTS10;ADAM17;ADAMTS14;ADAMTSL5;MYSM1;COPS6;AFG3L2;ADAMTS2;PSMD14;MMP19;ADAM15;MBTPS2;ADAMTSL1;PRPF8;MMP17;MMP28;PITRM1;ADAMTSL4;ECE1;TRABD2B;NLN;EIF3H;PSMD7;METAP1D;BRCC3;LAP3
prerank,endopeptidase regulator activity (GO:0061135),0.4492880648791846,1.2340002296041945,0.18484500574052812,0.6412979535025116,1.0,9/40,13.77%,RENBP;CST7;HRG;A2M;TFPI;CAST;CSTB;PSMD14;PROS1
prerank,NADP binding (GO:0050661),-0.35155728961420196,-1.230489421692587,0.1328125,0.5317694883164071,1.0,13/32,20.19%,CRYZL1;ME3;DPYD;DHCR7;NDOR1;NOS1;CRYZ;CBR3;NOX1;QDPR;HMGCR;GMDS;GRHPR
prerank,phospholipase C activity (GO:0004629),-0.3630550167754695,-1.2290714821358228,0.17261904761904762,0.5228429158390248,1.0,6/25,5.89%,PLCL1;PLCB1;CCR5;PLCG2;CCR1;CHRM3
prerank,anion:anion antiporter activity (GO:0015301),0.5204310412022665,1.2282563819771686,0.21722846441947566,0.6576724984461914,1.0,6/17,21.80%,SLC26A1;SLC26A11;SLC26A4;SLC4A2;SLC19A1;SLC26A6
prerank,ATPase activator activity (GO:0001671),0.4922853124648977,1.2249121190681072,0.20685434516523868,0.665306548599298,1.0,9/20,28.04%,ATP1B3;TOR1AIP2;DNAJC15;DNAJC1;DNAJB1;DNAJC10;DNAJA1;ATP1B2;DNAJB6
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5013436191641454,1.222929625975232,0.22139303482587064,0.6680163572532418,1.0,2/21,2.27%,P2RX4;CHRNB2
prerank,Notch binding (GO:0005112),0.496987242132163,1.2223127420827598,0.22409638554216868,0.6660124445180671,1.0,11/22,26.43%,NCOR2;JAG1;ADAM17;DLL4;DLK2;KCTD10;CUL3;SNED1;TCIM;NOTCH4;SNW1
prerank,cGMP binding (GO:0030553),-0.4494995880196536,-1.2214112585617825,0.2392857142857143,0.5282969170906914,1.0,4/11,21.25%,PDE10A;RAPGEF2;PDE2A;PDE5A
prerank,proton transmembrane transporter activity (GO:0015078),0.45603870698653637,1.2213336105563328,0.1836734693877551,0.665485289122312,1.0,14/39,24.60%,SLC9A1;ATP6V1B2;COX7A1;SLC46A1;COX6A2;COX5B;ATP6V1F;COX10;UQCRH;CLCN4;COX7A2L;UQCR10;SLC11A2;UQCR11
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5195599732266074,1.2201628320679219,0.2240506329113924,0.6653009027425801,1.0,4/17,13.25%,ABCG1;ABCA1;PITPNC1;ABCA7
prerank,metallocarboxypeptidase activity (GO:0004181),0.47455985556913793,1.2196714046914068,0.2116527942925089,0.6630288672304819,1.0,8/26,14.37%,CPA4;CPA3;AGBL5;CPXM2;AGBL2;CPA6;AEBP1;CPD
prerank,histone deacetylase activity (GO:0004407),0.49941237022734797,1.219659594060633,0.2088998763906057,0.6589913959316828,1.0,11/19,30.96%,HDAC9;HDAC4;HDAC1;SUDS3;MIER2;SIRT3;HDAC11;HDAC2;HDAC3;SIRT1;SIRT2
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.47913668443279017,1.2191906611827006,0.19221698113207547,0.6564374668203843,1.0,8/27,21.80%,ANKH;SLC26A1;SLC26A11;SLC25A14;SLC26A4;XPR1;GET3;SLC26A6
prerank,hormone receptor binding (GO:0051427),0.536250553892816,1.2182193416801284,0.22036082474226804,0.6558351934067227,1.0,6/14,24.20%,NPPA;JAK1;VIP;NPPC;SOCS2;JAK2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.43753665653446094,1.217836324945684,0.18376550169109357,0.6531887525015795,1.0,9/46,9.06%,MGAT5;LARGE1;GCNT2;B4GAT1;B3GNT3;PIGQ;HEXA;PIGA;EXTL2
prerank,sodium channel regulator activity (GO:0017080),0.44587991730134646,1.2165995025193541,0.20044543429844097,0.6537152237814878,1.0,11/37,16.74%,FGF13;SGK1;SGK3;SGK2;PRSS8;FXYD5;RANGRF;SCN1B;FXYD4;SCN3B;PKP2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.4100678578876294,-1.2152315868778327,0.1759656652360515,0.5304920422159468,1.0,5/16,15.59%,ALOX5;BCO2;ETHE1;HAAO;ALOXE3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5872174469070534,1.2151050203765006,0.2313937753721245,0.6549091421122463,1.0,4/10,21.76%,SIRPA;JUP;PKP2;CD47
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.45940160460567003,-1.2129690879368824,0.20774647887323944,0.5239735841606857,1.0,4/11,16.76%,SLC25A47;SLC22A5;SLC25A20;SLC25A29
prerank,protease binding (GO:0002020),0.4027637568736597,1.2126362027724142,0.12926577042399173,0.6599617067052743,1.0,31/99,24.21%,BCL2;FN1;DERL3;A2M;PSAP;CD28;SERPINB9;SELL;CSTB;VCP;SRI;SERPINE1;RIOK3;ECM1;TIMP4;BFAR;TWNK;DERL1;TIMP2;FURIN;ITGA3;SERPINF2;POLG;UBC;CRADD;TIMP1;GSK3B;INSL3;ADAMTSL4;SUMO1;TNF
prerank,potassium:proton antiporter activity (GO:0015386),0.5776436142040907,1.211185815690213,0.24320652173913043,0.6610527297329006,1.0,4/10,14.73%,SLC9A1;SLC9A8;SLC9A6;SLC9A7
prerank,endopeptidase inhibitor activity (GO:0004866),0.4078236688439625,1.2104215776963467,0.16298633017875921,0.6596157912105538,1.0,21/82,17.53%,LTF;RENBP;CST7;HRG;SERPINA10;A2M;SERPINB9;TFPI;CAST;CSTB;SERPINE2;SERPINE1;TFPI2;BIRC6;TIMP4;ROCK1;PROS1;TIMP2;FURIN;SPINK5;SERPINF2
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5439085986990417,1.2096217130555715,0.24262734584450402,0.6585160014494752,1.0,1/12,0.06%,IGF1
prerank,deoxyribonuclease activity (GO:0004536),0.5351226636177504,1.2090072974997452,0.22845953002610966,0.6569339769332881,1.0,6/14,21.04%,ZRANB3;MBD4;ERCC4;DFFB;RPS3;DNASE1L1
prerank,mRNA 3'-UTR binding (GO:0003730),0.4112972944584675,1.207346158309674,0.158004158004158,0.6586395208760751,1.0,38/79,33.23%,PABPC5;CPEB4;EXOSC4;RPS7;RPL41;CPEB2;CELF1;HNRNPC;PABPC1;LARP4;CPEB3;EXOSC9;LARP1;PCBP4;ILF3;YBX3;HNRNPA2B1;DHX36;PUM1;FXR2;HNRNPU;TARDBP;RNF20;CCT5;PABPC4;RBMS2;CPEB1;KHSRP;GEMIN5;RC3H1;NUDT21;RSL1D1;CIRBP;SECISBP2L;ZC3H12A;TUT1;ANGEL2;DAZAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4630174568547517,-1.2058862037054865,0.22264150943396227,0.5276264591439689,1.0,7/11,37.96%,PADI2;DDAH2;ARG2;ARG1;AGMAT;PADI1;PADI4
prerank,chloride transmembrane transporter activity (GO:0015108),0.5249932192029236,1.205689680387009,0.22538860103626943,0.6608767299870224,1.0,2/16,1.47%,SLC26A1;CLCN7
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4538123679035225,1.204314692985966,0.20551090700344432,0.661875031177179,1.0,13/33,20.59%,AGO2;LLPH;ZNF326;WDR43;ELOF1;SMYD2;TBP;HNRNPU;PAF1;DHX9;RPRD1A;CCAR2;RECQL5
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5537031023360076,1.2040396664766315,0.24299065420560748,0.6590920308095192,1.0,5/12,19.65%,STAP1;BLNK;TRAT1;SH2B1;GAB2
prerank,hexose transmembrane transporter activity (GO:0015149),0.5464834614212537,1.2031572000837076,0.24596774193548387,0.6581262525863991,1.0,5/12,21.79%,SLC5A1;SLC2A1;SLC2A8;SLC5A3;SLC2A6
prerank,galactosyltransferase activity (GO:0008378),0.5542974488808579,1.2028175899767273,0.2449255751014885,0.6555492445889788,1.0,5/11,19.88%,B4GALT5;B4GALT7;B3GALT6;B4GALT3;B4GALT1
prerank,protein homodimerization activity (GO:0042803),0.38068732115093934,1.201152839945582,0.014,0.6574298109873349,1.0,136/589,18.55%,BCL2;LPL;MYO9B;APOE;ABCG1;IKZF3;ZHX2;EEA1;CSF1;MYOM3;BCL2L1;ATF3;PLEK;FLNA;ATG7;EPRS1;KMT2A;TBC1D22A;RABEP1;CD4;ADCY8;NECTIN1;SYNE1;IRAK2;XDH;MCL1;PDGFA;CST7;PTPA;ALS2;GZMA;TYRP1;TRIM6;APOA2;GIMAP7;PON1;TPM2;NR4A3;TBX18;GLIPR2;PSAP;TMEM192;NUDT5;S100A11;S100A6;RBM44;GLB1;HSPB1;GYG1;MGLL;ACTN1;ZBTB7B;ERN1;VEGFA;CADM1;TPD52;KLHL7;CHMP4A;CHMP4B;BHLHE40;NECTIN3;PDCD6IP;GTF2A2;HOOK1;PDXK;BHLHE41;LILRB1;LRRFIP1;RACK1;TPM4;MMUT;B2M;BAX;JUP;HMOX1;HIP1;GLA;MASP1;SHMT1;NRF1;TIMM9;JAML;RBPMS;CEBPA;ENO1;S100A16;XPA;CCL5;VPS4B;ABCD2;UPB1;PRDM9;MAP3K12;PPCS;ZBTB16;TFAP4;GHR;BLM;ATIC;EFEMP2;FZD4;QTRT1;RBM11;CLCN1;DDIT3;GCA;SLC8B1;TPST1;LRP6;TPR;SPPL3;ACP3;VAPB;SRF;CAT;PRMT2;APPL2;BARD1;TFRC;ABCD3;GBP2;SARS1;ST6GAL1;FXR2;ODC1;TKT;XPNPEP1;DGKD;SERPINF2;HIP1R;DAPK3;S100B;USF2;ALDH3A2;SP1;JCHAIN
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.38011154395581276,1.1990943041686604,0.021,0.6609643844112018,1.0,126/431,21.99%,MYO9B;PEAK1;ABCG1;CDK6;ERCC6;ABCA1;TSR1;RRAGD;MYO1F;P2RX4;RAP2A;AARS1;ARF3;REM1;ATP7A;SRPK1;MLKL;THG1L;GCK;PTPA;EIF4G1;HSPA4;GIMAP7;GTPBP4;SPHK1;MAP4K5;MAP4K2;DYRK2;ARL8B;MFHAS1;ABCD4;IGHMBP2;CARS1;ERN2;EEF1A1;ARL1;STK3;PI4K2A;SIK1;ERN1;MAP4K3;ATP1A3;ATP1A1;RASL12;ANXA6;RHOD;RHOQ;MTHFS;PAPOLA;PDXK;GEM;PFKL;P2RY1;PGK1;BMS1;RAB32;ARL11;RAB8A;KRAS;NRAS;DNM2;PIM1;LONP1;RHOG;RAB7A;NVL;DRG1;ABCD2;RHOA;RHOU;CDK11B;RAB5A;HSPA8;CDC42;BLM;PFKP;DAPK1;EIF4A3;AK6;ATP1A2;CAD;HSPA9;STK38;ARL8A;PSMA6;ABCD3;DHX36;RAB22A;GBP2;TLK1;SARS2;PRKAG1;RIT1;MINK1;KIFC1;RALB;TUBB;NLK;HNRNPU;EIF2B2;STK11;DRG2;DAPK3;OLA1;NEK6;GNL3;DHX9;RTEL1;RRAD;ADSS1;RHOT2;TOP1;PDK3;MCM6;TRIP13;LMTK2;MARK2;ARL4C;PRAG1;HSP90AB1;MARK4;RUNX3;NIM1K;SRPK2;PRPS2;TAOK1
prerank,carboxylic acid binding (GO:0031406),-0.32515524240212607,-1.1979497205565228,0.1792452830188679,0.5347806168261977,1.0,12/38,14.29%,GRM7;GLRA3;GLUD1;GRIN2B;SESN1;EPDR1;NOS1;GRIN1;GLRA2;MAG;CASTOR1;GLRA1
prerank,P-type ion transporter activity (GO:0015662),0.545197718774459,1.1958821047004287,0.24453024453024452,0.6682347205197404,1.0,2/12,2.26%,ATP7A;ATP2B1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.48077504695480255,1.1951870067260935,0.22614840989399293,0.6669818382269407,1.0,6/24,26.18%,OSBPL8;SESTD1;PLEKHF1;OSBP;GOLPH3;GOLPH3L
prerank,acetylation-dependent protein binding (GO:0140033),0.490726095802062,1.1948477295752276,0.22756005056890014,0.6608831140460834,1.0,7/20,25.84%,KMT2A;BRD4;THAP7;CARM1;TRIM24;ATAD2B;SMARCA4
prerank,lysine-acetylated histone binding (GO:0070577),0.490726095802062,1.1948477295752276,0.22756005056890014,0.6608831140460834,1.0,7/20,25.84%,KMT2A;BRD4;THAP7;CARM1;TRIM24;ATAD2B;SMARCA4
prerank,protein tyrosine kinase activity (GO:0004713),0.39169531453237405,1.1906833142607447,0.15631469979296067,0.671754463007589,1.0,18/108,11.45%,FLT1;LCK;PEAK1;ABL2;ITK;FGR;TEC;AXL;PTK2B;DYRK2;TXK;IGF1R;SCYL1;PKDCC;WEE1;FYN;HIPK1;JAK1
prerank,insulin-like growth factor I binding (GO:0031994),-0.4319674841271845,-1.1902821198155356,0.2489451476793249,0.5403555821610296,1.0,6/13,17.22%,ITGA6;IGFBP5;ITGB4;IGFBP3;LRP2;IGFBP6
prerank,snRNA binding (GO:0017069),0.43299219631847946,1.1897494553321266,0.21099887766554434,0.6714621883871523,1.0,23/42,32.73%,SNRNP35;DDX21;SF3B3;PRPF4;DDX39B;ISG20;HNRNPU;CCNT2;SNRPB2;EIF5A;PRPF8;LSM4;SNU13;RBM22;GEMIN5;SNRPA;PRPF31;LSM11;HEXIM1;EFTUD2;TOE1;TUT1;SART3
prerank,sulfate transmembrane transporter activity (GO:0015116),0.5362797092816565,1.189233664593558,0.2753623188405797,0.6698171179740748,1.0,5/14,21.80%,SLC26A1;SLC26A11;SLC25A14;SLC26A4;SLC26A6
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.4097115530518469,-1.1887586165691344,0.2336065573770492,0.5331830906561966,1.0,3/15,5.17%,P2RY12;GPR34;P2RY13
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.44025090117152127,1.1887301139181923,0.22072072072072071,0.6679551202122688,1.0,10/40,14.27%,DNMT3A;AS3MT;PEMT;GNMT;DNMT1;DPH5;PRMT7;METTL9;METTL2B;METTL2A
prerank,potassium ion antiporter activity (GO:0022821),0.5154144105841111,1.18842982163224,0.25097024579560157,0.6654548563407682,1.0,5/15,14.73%,SLC9A1;SLC24A4;SLC9A8;SLC9A6;SLC9A7
prerank,1-phosphatidylinositol binding (GO:0005545),0.5117255119027683,1.188363851307431,0.24744897959183673,0.6621717636641381,1.0,5/15,12.20%,EEA1;SCIN;WDFY1;SNX10;SESTD1
prerank,magnesium ion binding (GO:0000287),0.38783036185741937,1.187084980558243,0.14285714285714285,0.6631108846559187,1.0,44/135,26.57%,ABL2;RAP2A;DCTPP1;CERK;SRPK1;THG1L;FIGNL1;SPHK1;MTHFD2;DYRK2;NUDT5;ERN2;STK3;PI4K2A;SIK1;ERN1;PAPOLA;PDXK;GEM;DXO;ADPRS;STK38;DHX36;TKT;NLK;STK11;NEK6;CLYBL;IDH3A;AASDHPPT;DUT;MARK2;NIM1K;SRPK2;LATS1;STK38L;GEN1;SIK3;RRAGC;MAPK12;HMGCL;HPRT1;MTPAP;SRR
prerank,Hsp90 protein binding (GO:0051879),0.4506149310863937,1.1865791133163062,0.22632794457274827,0.661245731908552,1.0,12/33,26.92%,HIF1A;ERN1;KDR;CHORDC1;PTGES3;NR3C1;RPS3;HSF1;AHR;UNC45A;USP19;PACRG
prerank,nuclear receptor binding (GO:0016922),0.3939791177385941,1.1846644465112637,0.1554192229038855,0.6642396811812592,1.0,44/111,30.26%,CTNNB1;HIF1A;LEF1;JMJD1C;NR4A3;NCOR2;RNF14;TRIP12;DAXX;RNF6;PRKCB;KDM3A;JUP;MED17;PPARGC1B;MED13;ASXL1;PRMT2;NR4A2;TACC2;PRPF6;GTF2H1;WBP2;TAF7;TMF1;LATS1;CALR;ACTN4;STAT5B;RXRA;SMARCA4;NSD1;SNW1;KDM1A;OASL;BRD8;MED1;SIRT1;TRIP6;TRIM68;TGFB1I1;MED30;TRIP4;DCAF13
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.38317994371346564,1.1836122483192544,0.10742971887550201,0.6645834128941442,1.0,59/188,25.20%,TCF7;ATF3;FOXN1;NFYA;NFE2L2;ARID5B;TBX21;TBX18;TFEB;HDAC4;PPARG;FOXJ1;RUNX1;GATA3;EGR2;CHD3;BASP1;NKX2-1;SOX7;BRCA1;ATF5;CREB3L2;RBBP5;JUN;CEBPA;ARID4B;PRDM9;CARM1;TFAP4;MAFK;YY1;NFYB;DDIT3;NFKB1;DHX36;PSPC1;TBP;GABPB1;GABPB2;TCF12;DHX9;SP1;TAF7;HMGB1;PBX1;HSF1;KLF11;EGR1;AHR;CREBZF;KMT2D;ZNF568;RXRA;SOX10;TNF;GLIS2;ATF4;HNRNPL;GRHL1
prerank,kinase inhibitor activity (GO:0019210),0.4484200147700388,1.181742849988218,0.24480369515011546,0.6674896108792345,1.0,10/33,21.66%,SMCR8;TAOK3;NCK1;PARVA;SPRY4;LRP6;GSKIP;YWHAB;ITPRIP;NPM1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.5700380952860339,1.180765588362818,0.2547683923705722,0.6674036850299191,1.0,1/10,0.13%,APOBEC1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.40127373242175896,1.1805109564615108,0.19441571871768357,0.6648431920962035,1.0,46/83,33.96%,TANK;JOSD1;OTULIN;USP12;OTUD4;ATXN3;USP9X;USP5;BAP1;MYSM1;USP40;PSMD14;USP47;USP53;USP18;USP46;DESI2;USP28;PAN2;USP36;USP14;USP33;OTUD1;USP50;USP2;USP8;USP1;USP32;OTUD5;BRCC3;USP19;TNFAIP3;STAMBP;USP42;USP30;USP34;USP13;USP48;STAMBPL1;USP15;USP38;ZC3H12A;USP11;USP35;USP22;USP31
prerank,transcription cis-regulatory region binding (GO:0000976),0.3746246477285724,1.1797431340396862,0.042,0.6639059178904285,1.0,111/406,24.47%,HIF1A;TCF7;MMP12;ATF3;FOXN1;NFYA;NFE2L2;ARID5B;LEF1;TBX21;AGO2;DEAF1;PRDX5;TCF15;TBX18;MEF2D;NFIL3;MNT;CIC;TFEB;HDAC4;PPARG;FOXJ1;RUNX1;GATA3;CUX1;RFX5;ZBTB7B;SOX9;SATB1;EGR2;HDAC1;NFX1;ZNF395;XRN2;CHD3;BASP1;E2F3;FOXN3;NKX2-1;OTP;AEBP1;SOX7;BRCA1;ATF5;CREB3L2;LONP1;RBBP5;JUN;CEBPA;ENO1;ZFP41;ARID4B;GBX1;ASCL4;PRDM9;CARM1;TFAP4;TIPARP;MAFK;YY1;NFYB;ETV6;STOX1;DDIT3;NFKB1;MTF1;DHX36;NPAS4;ELK3;PSPC1;TBP;GABPB1;GABPB2;TCF12;PURA;SP1;ZNF177;DR1;TAF7;DACH1;NR3C1;RPS3;HMGB1;SREBF1;ZFP57;RFXANK;TCF24;PBX1;HSF1;RXRB;RUNX3;NPM1;TEAD1;ZBTB43;KLF11;ACTN4;EGR1;AHR;CREBZF;KMT2D;PBX2;ZNF568;LHX4;ZBTB4;E2F6;RXRA;SOX10;TNF;GLIS2;ATF4
prerank,SH3 domain binding (GO:0017124),0.4107706258986083,1.179148145134487,0.20877944325481798,0.6623185963261999,1.0,34/62,33.05%,CYBA;SKAP1;CD3E;SH3BP2;MICAL1;PTPN22;GRB2;WIPF1;DNM2;PTPN12;RUFY2;ADAM15;ESPN;CBL;CBLB;CASP9;EVL;VASP;ABI1;WAS;SYNJ2;MAPK15;ABI2;NCF1;GPX1;RAD9A;ADAM12;RUFY1;PLSCR1;SOCS7;ZNF106;SYNJ1;AFAP1;REPS1
prerank,3'-5' DNA helicase activity (GO:0043138),0.508933316280836,1.175762762139543,0.27848101265822783,0.6700897106621093,1.0,7/16,20.59%,MCM7;MCM2;ASCC3;BLM;DHX9;MCM6;RECQL5
prerank,deubiquitinase activity (GO:0101005),0.39716293048901385,1.1753374215948034,0.1834016393442623,0.6681415574339435,1.0,48/88,33.96%,TANK;JOSD1;OTULIN;USP12;OTUD4;ATXN3;USP9X;USP5;BAP1;MYSM1;USP40;PSMD14;USP47;USP53;USP18;USP46;DESI2;USP28;PAN2;USP36;USP14;USP33;OTUD1;USP50;USP2;USP8;EIF3H;USP1;USP32;OTUD5;BRCC3;USP19;TNFAIP3;STAMBP;USP42;USP30;USP34;USP13;USP48;MINDY2;STAMBPL1;USP15;USP38;ZC3H12A;USP11;USP35;USP22;USP31
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5379974945357302,1.175139830305959,0.28859060402684567,0.6655338329334756,1.0,3/12,10.09%,GALNS;GNS;ARSA
prerank,RNA cap binding (GO:0000339),0.5063714710914267,1.1722977699927533,0.2753807106598985,0.6716841178912752,1.0,8/16,27.39%,EIF4A1;AGO2;CYFIP2;LARP1;EIF4E2;GEMIN5;CYFIP1;EIF4E
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.47109221819704494,1.1720462728798227,0.26044226044226043,0.6691949772833152,1.0,9/22,28.57%,EXOSC4;CPEB2;CPEB3;EXOSC9;ILF3;DHX36;CPEB1;KHSRP;NUDT21
prerank,nuclease activity (GO:0004518),0.41241178465633804,1.1710795470663897,0.23903508771929824,0.6690710829995486,1.0,18/52,21.83%,RNASE3;ERN2;XRN2;RNASEH2A;RNASEL;AEN;RNASEH1;DDX1;RNASE12;ISG20L2;DFFB;RNASE7;ISG20;RNASE6;REXO5;DNASE1L1;SND1;SETMAR
prerank,actinin binding (GO:0042805),0.4778631171571723,1.1706374932911663,0.26288659793814434,0.6674364123539512,1.0,8/21,22.25%,DAG1;CSRP3;PPARG;MAGI1;CACNA1D;NFKB1;CSRP2;PROM1
prerank,glucuronosyltransferase activity (GO:0015020),0.4821925296495979,1.1682566031979853,0.2716049382716049,0.6718930582103743,1.0,2/19,3.82%,LARGE1;B4GAT1
prerank,GTPase regulator activity (GO:0030695),0.37618555802488457,1.166003141830837,0.12412412412412413,0.6759491625179401,1.0,73/212,25.73%,RGS1;IQGAP1;MYO9B;ABR;ARHGAP25;ARHGAP10;TBC1D10C;ARHGAP24;SIRPA;TBC1D22A;ASAP1;RGS3;RGPD1;RALGAPA2;ALS2;GNAQ;SIPA1L2;NRP1;TBC1D2;IPO5;RTKN;CPEB2;DLC1;RASGRP3;RIN2;GDI1;CDC42SE1;ARHGAP19;ARL2BP;NPRL2;JUN;RANBP1;ELMOD3;IQGAP2;RANBP2;LLGL2;RACGAP1;RASA1;NF1;TBC1D22B;TBC1D12;ARHGAP30;ARHGAP9;KRIT1;RAB3GAP2;TBC1D20;ARFGEF1;ELMOD2;RIC8A;ARHGAP17;BNIP2;ITGB1BP1;NPRL3;GMIP;ARFGAP3;ARFGAP1;WAS;HTR2B;ASAP2;TBC1D10A;LARS1;LLGL1;VAV3;SMAP1;CCDC88A;SGSM1;SIPA1;TBC1D16;SIPA1L3;NCKAP1L;RALGAPB;ARFGAP2;RAB3GAP1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3976095403855524,1.1616300588459454,0.22577209797657083,0.6873153985798025,1.0,24/75,25.83%,SORD;RDH12;DHRS3;MDH1B;DHRS9;AKR1B10;LDHA;HSD17B8;ME2;KDSR;AKR1A1;BDH1;DHRS11;CBR1;EHHADH;RDH10;GLYR1;HIBADH;ADH5;GFUS;KCNAB1;HADHA;HADH;ME1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5397510931514444,1.1615379638381704,0.29284750337381915,0.6843938234944826,1.0,3/11,15.56%,SASH1;MAP4K2;STK38
prerank,acetylcholine receptor activity (GO:0015464),-0.3525302776746331,-1.1613449256026942,0.22826086956521738,0.5852393341468469,1.0,11/22,33.23%,CHRM2;CHRM3;CHRFAM7A;CHRNA7;CHRNA5;HRH3;CHRNA3;CHRNA4;CHRNB4;CHRM1;CHRNB3
prerank,hormone activity (GO:0005179),0.40909192752557033,1.1612724433436563,0.2429193899782135,0.6820754799149199,1.0,11/54,23.46%,IGF1;TRH;NPPA;POMC;CRH;AGRP;VIP;NPPC;GNRH1;METRNL;AMH
prerank,pyrophosphatase activity (GO:0016462),0.40839118797864005,1.1597053598747693,0.24698133918770582,0.6840807765425788,1.0,16/50,20.95%,DCTPP1;CILP;NUDT5;NUDT1;NUDT6;DXO;ITPA;DHX29;PRUNE1;ENTPD5;NUDT9;NUDT22;DHX9;ENTPD6;BNIP2;NUDT15
prerank,GTPase binding (GO:0051020),0.37405236756707977,1.1574061358222307,0.14844533600802406,0.6884772646557088,1.0,77/194,28.58%,IQGAP1;LCP1;MYO9B;MYO5A;ABCA1;RRAGD;FLNA;EPRS1;DMXL2;RGP1;OPTN;SPHK2;AKAP13;ALS2;GOLGA4;RAF1;CAV1;RTKN;RUSC2;FGD6;RAPGEF6;RIC1;RANGRF;ATP6AP1;RANBP9;RAB8A;RABGGTB;ENO1;NDRG1;EXOC2;GCC2;RANBP1;IQGAP2;SIKE1;PAK2;YBX3;BIRC5;RANBP2;RCC1;HPS6;DOCK7;GGA2;AP1G1;RASA1;ATG16L1;AFDN;RAB3GAP2;TBC1D20;DAPK3;GNB1;STOML2;ARHGEF2;RAB11FIP4;FGD5;ARHGDIB;RNF41;TRIOBP;WAS;USP33;BNIP3;EHD1;SGSM1;AIMP1;RRAGC;ABI2;RAB3GAP1;GGA1;RILP;MAPKAP1;CYFIP1;NUTF2;EXOC4;PARD6A;LAMTOR1;ARHGAP1;AMBRA1;TMEM127
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5378097587352667,1.1560970398183301,0.3055555555555556,0.6894728110968716,1.0,1/11,2.27%,CHRNB2
prerank,protein kinase C activity (GO:0004697),0.5099829540698244,1.1559402527473617,0.29172320217096337,0.6868275901780383,1.0,4/14,8.41%,PRKCH;PRKCQ;PRKCD;PRKCB
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5417774418279543,1.155388222895234,0.30842391304347827,0.6856218332346555,1.0,3/10,10.43%,B4GALT5;B4GALT7;B3GALT6
prerank,iron ion binding (GO:0005506),0.41364703173266903,1.1542818227178513,0.26515151515151514,0.6861788499000807,1.0,17/48,22.58%,FTL;LCN2;LTF;ACP5;HEPH;NFU1;SCD5;KDM3A;ALKBH1;RIOX1;MELTF;CDO1;FTH1;EGLN1;ALKBH3;DOHH;EGLN3
prerank,C2H2 zinc finger domain binding (GO:0070742),0.5401833541400376,1.1538153825319573,0.30120481927710846,0.6847578673393349,1.0,3/11,21.70%,LEF1;THAP7;ZXDC
prerank,kinesin binding (GO:0019894),0.4521228843161548,1.1536676311020502,0.27413587604290823,0.6821061203870642,1.0,8/27,22.51%,PLEKHM2;SPAG9;ACTB;IFT88;AP1G1;NEK6;FAM83D;TOR1B
prerank,I-SMAD binding (GO:0070411),0.5190642272342132,1.1525215129933295,0.2897800776196636,0.6827471923359302,1.0,3/13,13.29%,CTNNB1;SMAD7;SMAD1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.4038724540574185,-1.1518275718135693,0.26406926406926406,0.596438756896873,1.0,10/14,32.03%,KCNJ3;KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNJ5;KCNA5;KCNE2
prerank,voltage-gated cation channel activity (GO:0022843),-0.2599456174845345,-1.149555926885318,0.1,0.5903422129103063,1.0,30/97,17.21%,CACNB2;CACNA2D1;KCND2;KCNB2;GRIN2A;KCNA6;KCND3;CACNG3;KCNB1;KCNQ3;GRIN2B;KCNH7;KCND1;HCN1;NCS1;KCNK1;KCNH1;CACNG8;KCNC2;GRIN1;KCNS3;KCNH2;CACNA1C;CACNA2D2;KCNC1;CACNA1B;KCNC3;TMC1;CACNA1E;GRIN3A
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.48743132178892196,1.1479109160755123,0.3161290322580645,0.6949624626586295,1.0,9/17,32.57%,AK8;AK4;AK3;AK5;NME6;AK7;DTYMK;CLP1;NME1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3236630125411942,-1.1475579360467698,0.2549019607843137,0.583742483197736,1.0,12/31,21.19%,SLC12A2;SLC12A9;HCN1;ABCC9;SLC12A6;KCNK1;SLC12A8;KCNK5;KCNK10;KCNK4;KCNK7;KCNG1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.3442198564427177,-1.1472924547335948,0.23529411764705882,0.5739534784281866,1.0,4/25,4.32%,FCHSD2;ADAP2;DAPP1;COMMD1
prerank,NAD+ binding (GO:0070403),-0.41592997794167375,-1.1460338679719908,0.275092936802974,0.5667197025788056,1.0,3/12,3.47%,HPGD;CRYL1;GLUD1
prerank,ligand-gated cation channel activity (GO:0099094),-0.2596640222663374,-1.1456388875420835,0.2,0.5577661034792392,1.0,24/75,19.71%,GRIA4;GRIK2;GRIK3;GRIN2A;KCNJ3;GRIA3;GRIK4;GRIN2B;TRPM4;KCNK1;KCNN3;MCOLN1;KCNN2;KCNJ13;GRIN1;KCNH2;KCNJ12;KCNK6;GRIA2;CHRNA7;GRIN3A;KCNN1;P2RX3;TRPM2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3921035673764055,1.1451734056556224,0.2426470588235294,0.7009643171374126,1.0,11/74,9.85%,FAM20C;DGKZ;PKM;GK;SPHK2;PIK3CB;SPHK1;CHKB;HK1;PDXK;GALK2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.47655944598680494,1.144195942783357,0.2858942065491184,0.7008886966508272,1.0,3/18,5.08%,ANXA1;PDLIM1;S100A11
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5252095175694099,1.1439334441787248,0.32,0.6986966052044048,1.0,2/11,8.20%,PPP1R14A;PPP1R14B
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.38388691855836815,1.1436974114889107,0.21524201853759012,0.696297457604975,1.0,34/100,26.38%,OSBPL8;SH3PXD2B;IQGAP1;MYO10;TECPR1;SNX24;RUFY4;VEPH1;ARAP2;NCF4;WDR45;HIP1;SESTD1;IQGAP2;PLEKHF1;OGT;RACGAP1;ARHGAP9;HIP1R;TTPAL;FERMT2;GAB2;LAPTM4B;ATG2B;MYO1G;SNX12;SNX11;ZFYVE19;OSBP;GOLPH3;BTK;GOLPH3L;MAPKAP1;DENND1B
prerank,cation:chloride symporter activity (GO:0015377),-0.4594657960000041,-1.1411775166740024,0.30604982206405695,0.5580283990888752,1.0,5/10,10.75%,SLC12A2;SLC12A9;SLC12A6;SLC6A1;SLC12A8
prerank,sodium:proton antiporter activity (GO:0015385),0.5291670953338012,1.1408642764277388,0.30707610146862485,0.7022006786672572,1.0,4/11,14.73%,SLC9A1;SLC9A8;SLC9A6;SLC9A7
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4460792301610923,1.1407280100297992,0.30186480186480186,0.6994877711904071,1.0,7/28,16.48%,TRAF2;TRAF3;BID;TRAF1;TRAP1;TMBIM1;TNFSF9
prerank,vinculin binding (GO:0017166),0.5480137944344419,1.1407255275337982,0.3094289508632138,0.6964375372948386,1.0,4/11,12.92%,TLN1;DAG1;ACTN1;UTRN
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3684457368069337,1.140583765898091,0.20402010050251257,0.6939230484049868,1.0,44/173,19.95%,MITF;ATF3;TBX21;DEAF1;SOX30;TBX18;NFIL3;MNT;TGIF1;CC2D1A;PPARG;KLF12;BCL6;GATA3;SATB1;NFX1;ZBTB2;BHLHE40;BHLHE41;PPARD;IRF8;LRRFIP1;OTP;AEBP1;FOXP4;ZNF148;JUN;ENO1;ZKSCAN3;ZBTB34;ZBTB16;MAFK;YY1;ETV6;NFKB1;ELK3;ZBTB25;ZNF177;ZBTB6;ZBTB39;DACH1;NR3C1;JDP2;NFATC3
prerank,single-stranded DNA binding (GO:0003697),0.38042054426834376,1.1405433239118539,0.24251805985552116,0.6910298293068537,1.0,30/93,24.69%,RAD51B;MCM7;MCM2;ERCC1;IGHMBP2;FUBP1;POLR2H;LONP1;DMC1;BLM;POLR2D;HSPD1;WBP11;TWNK;ERCC4;PCBP1;DHX36;HNRNPU;PURA;DHX9;JCHAIN;TOP1;RAD51AP1;HMGB1;MCM6;MCM8;SETMAR;WDR48;XPC;SMC6
prerank,RNA polymerase II complex binding (GO:0000993),0.4315704316621971,1.140153019899138,0.286536248561565,0.6892518178735617,1.0,17/32,29.95%,AGO2;BRD4;ZNF326;WDR43;ELOF1;SMYD2;HNRNPU;PAF1;DHX9;RPRD1A;CCAR2;RECQL5;SCAF1;SUPT4H1;CTR9;PCIF1;RTRAF
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.4353846060782194,-1.1396861180199025,0.2881944444444444,0.5517090691409758,1.0,6/10,29.16%,MGME1;POLD1;FEN1;APEX1;EXD2;DCLRE1B
prerank,nucleoside-triphosphatase activity (GO:0017111),0.36245068968407884,1.139038783463957,0.169,0.6896433457816403,1.0,65/248,19.22%,MYO1E;TSR1;RRAGD;RAP2A;GNA13;ATP2B1;GNAQ;GIMAP7;GTPBP4;ARL8B;EEF2;GPN2;ABCA4;EEF1A1;ARL1;RAB5C;IRGC;RASL12;RHOD;RHOQ;KLC1;CHD3;GEM;AGAP3;BMS1;MMUT;RAB32;RAB8A;VCP;RAB8B;KRAS;NRAS;DNM2;RHOG;RAB7A;VWA8;DRG1;VPS4B;ABCD2;RHOA;KIF1A;RHOU;DHX29;RAB5A;CDC42;EFL1;GNA11;CLU;GNG5;TBC1D24;ARL8A;NKIRAS2;RAB22A;GBP2;SAR1A;RAB1A;RIT1;RALB;DRG2;RAB11A;GSPT1;PIN1;DHX9;GNB1;RHOT2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5018843702570485,1.1365629255606582,0.3235685752330226,0.6945487947290879,1.0,6/14,26.63%,AK8;AK4;AK5;NME6;AK7;DTYMK
prerank,lysine N-methyltransferase activity (GO:0016278),0.47332987797368736,1.1347978265554999,0.3194444444444444,0.6972388588956214,1.0,6/20,20.84%,ETFBKMT;KMT5A;EEF1AKMT3;SMYD2;EHMT1;EEF2KMT
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.40563471197124035,1.1343554916149765,0.2819672131147541,0.6955856147512971,1.0,12/49,14.77%,TNIP1;OPTN;SQSTM1;IKBKE;TNIP3;AGAP3;ZRANB3;VCP;ABRAXAS1;SHARPIN;TNIP2;UBQLN1
prerank,chemokine receptor activity (GO:0004950),-0.3520379444302435,-1.13120936569122,0.28735632183908044,0.5616361058090981,1.0,10/24,22.60%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;ACKR3;CMKLR1;CCR9;CXCR5;CXCR6
prerank,inward rectifier potassium channel activity (GO:0005242),-0.33485100803229095,-1.1299389351478717,0.2342857142857143,0.555375539484991,1.0,10/24,18.67%,KCNJ3;ABCC9;KCNK1;KCNN3;KCNN2;KCNJ13;KCNH2;KCNJ12;KCNK6;KCNN1
prerank,poly-pyrimidine tract binding (GO:0008187),0.4518707850932841,1.1291424871483486,0.3183475091130012,0.7094112786078379,1.0,9/23,23.02%,PABPC5;PATL1;ATXN1;HNRNPC;PABPC1;RBM11;HNRNPU;PABPC4;RBMS2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5326121880837174,1.1284742974781259,0.32827586206896553,0.7084692778106775,1.0,4/10,20.69%,DAXX;ANKRD13B;ANKRD13A;LAPTM5
prerank,C-C chemokine binding (GO:0019957),-0.356394284023498,-1.1284242960360087,0.24404761904761904,0.5498268268696285,1.0,9/22,22.60%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;ACKR3;CCR9;CXCR5;CXCR6
prerank,receptor ligand activity (GO:0048018),0.3609909074933972,1.1282656160217288,0.18756268806419257,0.7060814953710249,1.0,53/245,26.13%,LGALS3;GPNMB;IGF1;CSF1;CCL4;PDGFA;FAM3D;BMP8B;NRG1;GDF6;NPPA;POMC;FGF2;JAG1;VEGFA;TAFA4;KITLG;WNT6;CRH;DEFB130A;LRPAP1;FGF7;CCL5;FGF20;GAS6;OSGIN2;VIP;FAM3C;BMP6;IL6;DAND5;IL2;NPPC;HMGB1;GNRH1;TIMP1;EPO;TNFRSF11B;METRNL;BMP4;FGF18;CSPG5;IL34;AMH;MIF;IL17D;TNF;AIMP1;BMP5;MDK;NDP;FGF1;CX3CL1
prerank,myosin V binding (GO:0031489),-0.382446678938723,-1.1269327550468542,0.2743362831858407,0.5439632595031428,1.0,6/15,16.42%,RAB6B;RAB3A;RAB27B;RAB10;RAB39B;RAB3B
prerank,store-operated calcium channel activity (GO:0015279),0.5296301125267161,1.1263806851473306,0.3145275035260931,0.7087822880103588,1.0,1/10,0.25%,TRPC4
prerank,omega peptidase activity (GO:0008242),0.37943976052509254,1.1259527624774048,0.26741803278688525,0.7071644517534611,1.0,47/89,33.96%,TANK;JOSD1;OTULIN;USP12;OTUD4;ATXN3;USP9X;USP5;BAP1;MYSM1;USP40;PSMD14;USP47;GGH;USP53;USP18;USP46;DESI2;USP28;PAN2;USP36;USP14;USP33;OTUD1;USP50;USP2;USP8;USP1;USP32;OTUD5;BRCC3;USP19;TNFAIP3;STAMBP;USP42;USP30;USP34;USP13;USP48;STAMBPL1;USP15;USP38;ZC3H12A;USP11;USP35;USP22;USP31
prerank,regulatory RNA binding (GO:0061980),0.418223366260093,1.1256057107390751,0.3013392857142857,0.7053078332981702,1.0,9/38,19.10%,AGO2;ZC3H7B;ZNF346;DDX21;PIWIL2;HNRNPA2B1;PUM1;DHX9;AGO3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5249644096821677,1.125343280975037,0.3478854024556617,0.7032761342213331,1.0,2/11,5.40%,NUDT5;NUDT1
prerank,protein serine/threonine kinase activity (GO:0004674),0.36009791045638057,1.124300147328785,0.131,0.703612702794123,1.0,97/334,22.26%,FAM20C;CDK14;CDK6;PRKCH;CDK8;PRKCQ;SGK1;IRAK2;SRPK1;MAPK13;MAP4K5;MAP4K2;PTK2B;DYRK2;PAK6;SGK3;SGK2;RAF1;SQSTM1;CDK5;PRKCD;TAOK3;ERN2;PDPK1;STK24;STK3;SIK1;ERN1;IKBKE;BRD4;MAP4K3;SBK1;PLK2;PRKCB;MAPKAPK3;ILK;MAPKAPK2;CSNK1G1;CDK13;STK32A;NEK4;GAK;PIM1;HIPK1;RIOK3;MAP3K12;CDK11B;LIMK1;CDK2;PKN2;PAK2;CPNE3;ROCK1;MAP3K1;STKLD1;PRKD2;FASTK;DAPK1;CSNK1D;MAPK9;STK38;CDC7;HTATIP2;SYK;PLK4;KALRN;TLK1;RPS6KA2;MINK1;CAMK4;RIPK3;NLK;STK11;MAP3K8;DAPK3;NEK6;CLK4;TESK1;ATM;TP53RK;PIKFYVE;CSNK2A2;CDK16;TOP1;MAP3K9;PDK3;MAK;LMTK2;MARK2;GSK3B;RPS6KC1;MARK4;NIM1K;SRPK2;MELK;TAOK1;LATS1
prerank,methylated histone binding (GO:0035064),0.3937268817904747,1.1242414344644645,0.2886266094420601,0.7008693639719743,1.0,18/62,18.91%,CXXC1;TTLL12;NCAPG2;MSL3;ING4;BPTF;MTF2;THAP7;RBBP5;WDR5;PHF1;ING3;ING2;CHD5;ING5;ATRX;CBX2;TAF7
prerank,glucose transmembrane transporter activity (GO:0005355),0.4700181360687045,1.1232481077783296,0.32004981320049813,0.7013410070344857,1.0,5/17,21.79%,SLC5A1;SLC2A1;SLC2A8;SLC5A3;SLC2A6
prerank,aspartic-type endopeptidase activity (GO:0004190),0.508457244289991,1.1201186339245872,0.34523809523809523,0.7083795226816808,1.0,4/12,14.95%,NAPSA;CTSE;DDI2;SPPL3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3595507057761478,1.118745179926674,0.1941941941941942,0.7097417596017985,1.0,67/254,24.47%,LITAF;MITF;HIF1A;ATF3;ELF4;NFIC;LEF1;MYBL2;MAFF;SOX30;NR4A3;FOXJ1;KLF6;RUNX1;GATA3;RFX5;SOX9;EGR2;ZNF395;PRDM15;E2F3;HOXA7;MEF2B;ATF5;NRF1;JUN;CEBPA;IRF5;ZBTB16;ELK4;TFAP4;FOXJ3;SMAD1;YY1;EHF;NFYB;DDIT3;PRRX1;NFKB1;SP7;SRF;CEBPG;FOXO1;MTF1;NR4A2;NPAS4;ELK3;GMEB1;TCF12;SP1;NR3C1;NFATC3;SPIB;MEIS3;RFXANK;RXRB;ETV4;RLF;SMARCD2;EGR1;PBX2;REL;LHX4;MDM2;SOX10;GLIS2;ATF4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4222088901950901,1.117594849893282,0.3218785796105384,0.7105673528077103,1.0,12/33,20.59%,AGO2;MAF1;ZNF326;WDR43;ELOF1;SMYD2;HNRNPU;PAF1;DHX9;RPRD1A;CCAR2;RECQL5
prerank,calcium-dependent phospholipid binding (GO:0005544),0.39787340108306074,1.1159270705696882,0.3244444444444444,0.7130319388919374,1.0,7/49,7.33%,ANXA5;ANXA1;ESYT1;MCTP1;ANXA4;FER1L5;ANXA6
prerank,low-density lipoprotein particle binding (GO:0030169),0.4820226837036393,1.1157842371295392,0.35125,0.7106421066537332,1.0,2/16,7.32%,COLEC12;TREM2
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.2811953790302263,-1.115020911829837,0.2948717948717949,0.5609080652959731,1.0,14/60,11.44%,CSF1R;EPHA6;MERTK;EPHA4;BMPR1B;EPHB1;ERBB3;EPHA5;NTRK2;EGFR;TYRO3;RET;ACVR1B;NTRK3
prerank,amyloid-beta binding (GO:0001540),0.3812156372499134,1.1149832692622008,0.3093980992608237,0.7102006036316612,1.0,19/79,18.31%,CACNA1A;APBB2;APOE;LRP1;FPR2;GSAP;ATP1A3;TREM2;LILRB1;LILRB3;LRPAP1;IAPP;FZD4;PFDN1;CLU;ITGB2;HSPG2;GRIA1;PFDN2
prerank,ubiquitin protein ligase binding (GO:0031625),0.3604375071724976,1.1141646094631124,0.188,0.7098754052344749,1.0,81/254,26.05%,BCL2;HIF1A;PSMD1;UBA52;TANK;TRAF2;RPS27A;CCT2;PRDX6;SQSTM1;FBXW7;MFHAS1;TRAF3;DAXX;PTPN22;RPL23;TRIM28;IKBKE;EGR2;ACTG1;ATXN3;UBE2L3;RPL11;VCP;TRAF1;BRCA1;JUN;JAK1;SHPRH;TNFRSF1B;MAP1LC3B;HSPA8;SMAD7;FZD4;SUMO2;UBE2L6;CLU;HSPD1;DERL1;HSPA9;FOXO1;EIF4E2;RALB;TUBB;GPI;NLK;ELOB;ATP6V0C;NEK6;WFS1;CUL3;FBXO7;UBC;RNF20;LAPTM4B;SPART;LAPTM5;CUL1;GSK3B;HSP90AB1;PRKAR1A;MAP1LC3A;TRIOBP;TRIB2;CUL2;GABARAP;CALR;DNAJA1;PSMA3;SCAMP3;USP2;MDM2;SUMO1;PRR5L;SMC6;HSPA5;YWHAZ;ABI2;CUL4A;PIAS4;HM13
prerank,poly(U) RNA binding (GO:0008266),0.454405314759957,1.1121671587989348,0.34516523867809057,0.7131602425608063,1.0,8/20,23.02%,PABPC5;PATL1;ATXN1;HNRNPC;PABPC1;RBM11;PABPC4;RBMS2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3660517110312055,-1.1104890148394397,0.29245283018867924,0.5620255231150173,1.0,6/19,11.54%,GRIN2A;RYR3;GRIN2B;TRPM4;MCOLN1;GRIN1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4562161185883237,1.1079367756689062,0.34863523573200994,0.7233782537777115,1.0,4/20,6.83%,AK8;TJP2;AK4;AK3
prerank,voltage-gated chloride channel activity (GO:0005247),0.5282338814125069,1.1060962419601734,0.3662551440329218,0.7264924132066927,1.0,3/10,18.22%,CLCN1;ANO6;CLCN4
prerank,histone demethylase activity (GO:0032452),0.42602141032646257,1.1058179317650507,0.3286549707602339,0.7244391751757663,1.0,8/27,16.18%,JMJD1C;HR;KDM3A;RIOX1;KDM3B;RIOX2;FBXL19;KDM4D
prerank,metal ion binding (GO:0046872),0.3495131969116328,1.1053129466310117,0.143,0.7233097675444877,1.0,115/477,22.42%,IQGAP1;LCP1;LPL;S100A8;S100A9;APOE;LRP1;ABL2;ASPH;MMP12;POSTN;MAN1C1;RAP2A;DCTPP1;ANXA5;ANXA1;PLSCR2;SLC25A24;CERK;ESYT1;SRPK1;THG1L;ANXA11;ADAM8;GJB2;FIGNL1;MCTP1;ANXA4;SCIN;HRG;S100A7A;FER1L5;ADAMTS13;PON1;DHH;SPHK1;MTHFD2;DYRK2;NUDT5;S100A11;S100A6;ERN2;CRACR2A;DSG3;STK3;TPT1;PI4K2A;SIK1;ERN1;SELL;TPD52;ANXA6;CAPN1;RASGRP1;RASGRP3;PRF1;CDH1;PAPOLA;PDXK;GEM;TPM4;SRI;ARSA;MASP1;S100A16;EFHD2;DXO;FBLN1;GSN;ADPRS;PIR;GCA;RCN3;RASGRP2;CLEC6A;STK38;MCTP2;DHX36;CHP1;ANXA3;CLEC4E;TKT;NUDT22;NLK;STK11;NEK6;S100B;MEX3B;CLYBL;IDH3A;ITPR3;BNIP2;AASDHPPT;SPARCL1;SYT8;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;DUT;ANXA7;MARK2;CALU;CPNE6;NIM1K;SRPK2;MELK;LATS1;ATP2A2;CALR;CANX
prerank,GTPase activity (GO:0003924),0.3545734603926585,1.1034809108743622,0.2520080321285141,0.7261791181207973,1.0,50/192,17.92%,TSR1;RRAGD;RAP2A;GNA13;GNAQ;GIMAP7;GTPBP4;ARL8B;EEF2;GPN2;ABCA4;EEF1A1;ARL1;RAB5C;IRGC;RASL12;RHOD;RHOQ;GEM;AGAP3;BMS1;MMUT;RAB32;RAB8A;RAB8B;KRAS;NRAS;DNM2;RHOG;RAB7A;DRG1;RHOA;RHOU;RAB5A;CDC42;EFL1;GNA11;GNG5;TBC1D24;ARL8A;NKIRAS2;RAB22A;GBP2;SAR1A;RAB1A;RIT1;RALB;DRG2;RAB11A;GSPT1
prerank,phosphatidylinositol binding (GO:0035091),0.37182083989729847,1.1029164168210743,0.31386861313868614,0.7252750459107754,1.0,42/91,31.26%,MYO1E;EEA1;SNX24;SNX8;ESYT1;SCIN;WDFY1;SNX10;WDR45;HIP1;PITPNC1;SESTD1;GPAA1;PLEKHF1;NUMA1;ING2;APPL2;SNX4;HIP1R;ITPR3;SNX31;SNX12;SNX11;PLEKHF2;SNX1;CCDC88A;WDFY3;ESYT2;NCF1;DENND1B;MREG;PITPNM1;ITPR1;SNX27;EPB41;SNX17;AIDA;SH3YL1;PIGU;FES;PLEKHN1;RNF34
prerank,protein kinase regulator activity (GO:0019887),0.36972738929371096,1.1008554935853876,0.30687830687830686,0.7286201820831896,1.0,28/95,23.44%,FGF13;CCNY;SMCR8;TAOK3;DAXX;CCNL1;NCK1;CCNC;CCNB1;GPRC5C;CCNL2;PARVA;GPRC5B;SPRY4;CAB39;CCND2;PRKAG1;GSKIP;STK11;YWHAB;CCNT2;ITPRIP;EPO;MARK2;PRKAR1A;NPM1;ELP3;KIDINS220
prerank,calcium channel regulator activity (GO:0005246),0.40646511031690674,1.0974943412222158,0.35447338618346547,0.7363161325123235,1.0,15/37,29.45%,SGK1;REM1;SGK3;GEM;SRI;PHPT1;CACNG7;CACNB3;RRAD;INAFM2;FKBP1B;ITPR1;PRKG1;FKBP1A;STIM1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.5001902651158642,1.096259942924854,0.35657894736842105,0.7373297939029241,1.0,4/12,14.73%,SLC9A1;SLC9A8;SLC9A6;SLC9A7
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5024279249064615,1.0939876357856504,0.37231182795698925,0.7415083591790498,1.0,6/12,26.46%,SLC25A24;SLC25A25;SLC19A1;SLC17A9;SLC35B3;SLC25A23
prerank,G protein-coupled receptor binding (GO:0001664),0.3567509990189442,1.0935054939004523,0.2945973496432212,0.7402106690633448,1.0,23/132,15.78%,SDCBP;CCDC88C;FLNA;GNA13;GNAQ;NPPA;POMC;NPB;SAG;PDCD6IP;ZNRF3;WNT6;BAMBI;MYOC;CCL5;HSPA8;FZD1;GPRC5B;GNA11;HOMER2;LRP6;ARHGEF11;C1QBP
prerank,exoribonuclease activity (GO:0004532),0.5029319796218923,1.092791554032229,0.3825136612021858,0.7395258415957062,1.0,5/12,20.73%,EXOSC4;EXOSC9;EXOSC10;EXOSC5;CNOT6
prerank,microtubule minus-end binding (GO:0051011),0.4912325565073299,1.0921934916933864,0.3867924528301887,0.7383743133395451,1.0,3/13,14.48%,MACF1;TUBGCP4;NUMA1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.43430494049782675,1.0914109428787746,0.3592814371257485,0.7380246217372805,1.0,4/25,5.50%,MICAL2;CYP27B1;MICAL1;POR
prerank,single-stranded RNA binding (GO:0003727),0.39952741550825516,1.090884686270138,0.3389261744966443,0.7370006576396071,1.0,13/43,19.10%,PUS1;AGO2;ZFR;LONP1;EXOSC10;ILF3;RBM11;POLR2D;HNRNPU;CNBP;HNRNPF;DHX9;AGO3
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5134659688724286,1.0879388737152018,0.3693181818181818,0.743198166680699,1.0,5/10,21.23%,CACNA1A;CACNA1D;CACNB3;CACNB1;CACNB4
prerank,small GTPase binding (GO:0031267),0.3533292665124988,1.0878892261663387,0.3038229376257545,0.7406264311134136,1.0,43/169,17.91%,IQGAP1;MYO9B;MYO5A;ABCA1;FLNA;DMXL2;RGP1;OPTN;SPHK2;AKAP13;ALS2;GOLGA4;RAF1;CAV1;RTKN;RUSC2;FGD6;RAPGEF6;RIC1;RANGRF;ATP6AP1;RANBP9;RAB8A;RABGGTB;NDRG1;EXOC2;GCC2;RANBP1;IQGAP2;SIKE1;PAK2;YBX3;BIRC5;RANBP2;RCC1;HPS6;DOCK7;GGA2;AP1G1;AFDN;RAB3GAP2;TBC1D20;DAPK3
prerank,C-C chemokine receptor activity (GO:0016493),-0.34991068463746755,-1.0878467855180753,0.2994652406417112,0.6028010203397857,1.0,9/21,22.60%,CX3CR1;CCR5;CCR1;CCR6;CCRL2;ACKR3;CCR9;CXCR5;CXCR6
prerank,AMP binding (GO:0016208),0.5002006074008473,1.0852058317630542,0.38133333333333336,0.746330830286179,1.0,4/11,16.88%,PFKL;APRT;PFKP;PRKAG1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.4363236710455293,1.082203938397205,0.38760631834750914,0.7527180764619034,1.0,5/23,12.20%,SH3PXD2B;ATP13A2;WDR45;HIP1;SESTD1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.43229428030367545,1.0798249429643023,0.3918918918918919,0.75739201053112,1.0,12/24,32.57%,AK8;ITPKB;AK4;AK3;AK5;NME6;PMVK;AK7;DTYMK;ITPKC;IP6K2;NME1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.508179583999503,1.0793615237918763,0.385989010989011,0.7560622767615007,1.0,6/11,26.46%,SLC25A24;SLC25A25;SLC19A1;SLC17A9;SLC35B3;SLC25A23
prerank,filamin binding (GO:0031005),0.5030724221989727,1.0778584966766542,0.39892183288409705,0.7578624068854496,1.0,1/11,0.29%,FBLIM1
prerank,ribosomal small subunit binding (GO:0043024),0.4633299874585459,1.0771161046614068,0.37300613496932516,0.7573471299319839,1.0,8/17,26.80%,EIF1;CPEB2;PIM1;LARP1;DHX29;NPM1;EIF4B;EIF1B
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.49635154307631457,1.0764929017576204,0.3797814207650273,0.7565417134035971,1.0,1/11,0.25%,TRPC4
prerank,miRNA binding (GO:0035198),0.4171559276589154,1.0761123684832186,0.37749120750293086,0.7550294889676769,1.0,7/30,19.10%,AGO2;ZC3H7B;ZNF346;DDX21;HNRNPA2B1;PUM1;AGO3
prerank,metal ion:proton antiporter activity (GO:0051139),0.4809386449074466,1.0749646225588707,0.3924380704041721,0.7560026490280469,1.0,5/13,19.31%,SLC9A1;SLC9A8;SLC9A6;SLC9A7;SLC11A1
prerank,tubulin binding (GO:0015631),0.34245143951576446,1.073850658861249,0.26,0.7565345697675251,1.0,78/295,22.11%,FMN1;FGF13;GAS2L3;S100A8;S100A9;UXT;CCDC88C;KIF13B;MAP10;DAG1;ALDOA;TUBGCP4;FAM110C;TTLL12;CDK5;ARL8B;AGBL5;CLIP2;EML4;HTT;HOOK1;HAUS8;TBCA;CFAP157;RMDN2;ABRAXAS1;FYN;REEP3;BRCA1;DNM2;ATF5;DCTN1;NDRG1;DRG1;KIF1A;MAP1LC3B;PRUNE1;GPAA1;CRIPT;DCX;KIF20A;BIRC5;GIT1;INO80;NUMA1;TPR;SMC3;VAPB;RACGAP1;ARL8A;CHP1;IFT74;POLB;CEP44;RAE1;HOOK3;KIFC1;KRIT1;RAB11A;KIF21B;REEP1;GJB6;CCSAP;AGTPBP1;FAM83D;MDM1;ARHGEF2;TERF1;DST;RPS3;CCT5;CEP57L1;TOGARAM2;ARL4C;MARK4;MAP1LC3A;TAOK1;GABARAP
prerank,transcription coregulator binding (GO:0001221),0.38598559848568625,1.0729176410315353,0.38833883388338836,0.756574103570079,1.0,15/50,22.92%,CTNNB1;RPL23;MTF2;PPARD;THAP7;ZBTB16;PHF1;EED;CHD6;NEK6;CCNT2;FAM89B;EHMT1;TERT;AHR
prerank,pentosyltransferase activity (GO:0016763),0.4040461230236402,1.0707570181568595,0.38391845979614947,0.7605119389251763,1.0,15/36,26.04%,UMPS;LARGE1;PARP4;TNKS2;SIRT5;ART4;TIPARP;QTRT1;ZC3HAV1;SIRT4;PARP3;PPAT;PARP2;SIRT3;PARP16
prerank,DNA polymerase binding (GO:0070182),0.45194919865077177,1.0690803320410427,0.38701622971285893,0.7629942467377755,1.0,9/18,26.17%,LONP1;POLG2;RTEL1;PTGES3;HMGB1;HSP90AB1;ACD;SMARCA4;NAT10
prerank,microtubule binding (GO:0008017),0.3421807149001445,1.066290139814327,0.316950852557673,0.7690402746433904,1.0,56/222,21.65%,FMN1;FGF13;GAS2L3;S100A8;S100A9;UXT;CCDC88C;KIF13B;MAP10;MACF1;TUBGCP4;CDK5;CLIP2;EML4;HOOK1;HAUS8;CFAP157;RMDN2;ABRAXAS1;REEP3;DNM2;DCTN1;NDRG1;DRG1;KIF1A;MAP1LC3B;CRIPT;DCX;KIF20A;BIRC5;NUMA1;VAPB;RACGAP1;CHP1;POLB;CEP44;RAE1;HOOK3;KIFC1;KRIT1;RAB11A;KIF21B;REEP1;GJB6;CCSAP;FAM83D;MDM1;ARHGEF2;TERF1;DST;RPS3;FBXW11;CEP57L1;TOGARAM2;MARK4;MAP1LC3A
prerank,DNA binding (GO:0003677),0.33453362517613744,1.0617569323153788,0.243,0.779861829442452,1.0,187/694,25.90%,BCL2;HIF1A;IKZF3;ERCC6;DNMT3A;CSRNP1;C1D;MMP12;NFYA;NFE2L2;ARID5B;LEF1;DEDD2;TBX21;PARP4;RAD51B;MAFF;EOMES;SOX3;IRF6;NR4A3;SPHK1;VDR;POU3F1;MCM7;MCM2;HDAC4;ERCC1;IGHMBP2;PPARG;SNAPC1;FOXJ1;KLF12;BCL6;GATA3;APLP2;CUX1;TAF4B;RFX5;TRIM28;SOX9;FUBP1;MSL3;SATB1;EGR2;DNMT1;BPTF;SDE2;HES7;TFPT;POLR2H;ZNF395;MTF2;TRIM16;POLE;CHD3;HMGN1;PPARD;E2F3;DDB2;HOXA7;LRRFIP1;NKX2-1;OTP;DDB1;POGK;SMARCB1;BRCA1;ATF5;ZNF148;FOSB;LONP1;JUN;CEBPA;HUWE1;RAD50;XPA;IRF5;HP1BP3;DMC1;ZKSCAN3;PRDM9;SAFB2;ZBTB16;ELK4;CHCHD2;TFAP4;PHF1;FOXJ3;MBD4;ZDHHC1;ILF3;H1-0;MAFK;BLM;YY1;EHF;JRK;DNASE2;NFYB;POLR2D;DDIT3;CENPX;INO80;HSPD1;RPS27;WBP11;TWNK;SP7;SPATA24;ERCC4;ING2;PCBP1;CEBPG;FOXO1;MTF1;NR4A2;PMS1;DHX36;MYBBP1A;ZNF638;POLG2;HNRNPU;RFC1;CNBP;PURA;USF2;KIN;DHX9;SP1;JCHAIN;RAD1;ZBTB6;LYAR;AIFM2;TAF6;YAF2;POLG;TARDBP;TOP1;TERF1;TCF7L1;RAD51AP1;RPS3;HMGB1;MCM6;SREBF1;MEIS3;CHD2;DNASE1L1;MCM8;DCLRE1A;PBX1;HSF1;ZMYM4;SETMAR;SNAPC4;GLYR1;TEAD1;CALR;TERT;RLF;WDR48;EGR1;AHR;CREBZF;KMT2D;LHX4;XPC;ZBTB4;XRN1;RXRA;SOX10;SIRT3;ATF4;SMC6;ZGPAT;POU2F1;HDAC2;PALB2;GRHL1;AIM2;CSRNP3;MYRF;HIC2;SMARCA4;TFCP2
prerank,leucine zipper domain binding (GO:0043522),0.5006595582822124,1.0610107114548433,0.4256198347107438,0.7792158380491518,1.0,5/10,28.84%,MRTFA;DDIT3;DAPK3;ATF4;PAWR
prerank,calcium ion binding (GO:0005509),0.3379445707474203,1.060733342376712,0.302,0.7773235669692843,1.0,46/323,12.03%,IQGAP1;LCP1;LPL;S100A8;S100A9;LRP1;ASPH;MMP12;MAN1C1;ANXA5;ANXA1;PLSCR2;SLC25A24;ESYT1;ANXA11;ADAM8;GJB2;MCTP1;ANXA4;SCIN;S100A7A;FER1L5;ADAMTS13;PON1;DHH;S100A11;S100A6;CRACR2A;DSG3;TPT1;SELL;TPD52;ANXA6;CAPN1;RASGRP1;RASGRP3;PRF1;CDH1;TPM4;SRI;ARSA;MASP1;S100A16;EFHD2;FBLN1;GSN
prerank,GDP binding (GO:0019003),0.3685708800278948,1.0601470365072319,0.3882978723404255,0.7764762782459831,1.0,15/63,17.43%,RRAGD;RAP2A;ARL8B;RAB5C;RASL12;GEM;RAB8A;RAB8B;KRAS;NRAS;RAB7A;RAB5A;RAB22A;RIT1;RALB
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4354879362783454,1.0594290957948513,0.40417690417690416,0.7758961573797513,1.0,4/21,11.66%,NPTN;FGF2;FGF7;FGF20
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4100096398431686,1.0585875761680226,0.41135573580533025,0.7757529403183416,1.0,10/29,20.46%,GAA;GALC;GLA;GUSB;NEU1;ADPRS;MGAM;IDUA;GBA2;ABHD10
prerank,DNA-binding transcription factor binding (GO:0140297),0.34332533958953737,1.0583681490931158,0.354062186559679,0.7736995858303954,1.0,63/189,29.59%,BCL2;CTNNB1;NFE2L2;HDAC9;HDAC7;ID2;EOMES;MEF2D;BBS10;HDAC4;HSPB1;PPARG;NOC2L;SIK1;EGR2;HDAC1;BHLHE40;BHLHE41;PPARD;CRTC1;JUN;TLE5;CHCHD2;NFYB;DDIT3;PRRX1;NHLH2;SRF;TBP;MKKS;TCF12;DAPK3;PURA;NEK6;USF2;DHX9;SP1;LYAR;MIER2;PIAS1;HMGB1;MTDH;GSK3B;NPM1;MTA3;ATF4;ATN1;HDAC2;YWHAZ;PIAS4;BBS7;HCFC1;KDM1A;HES1;EIF4E;DACT1;CRTC3;ZBTB17;CRTC2;WWP2;SIRT1;PURB;TLE1
prerank,calcium:sodium antiporter activity (GO:0005432),0.49435329602985023,1.0578602574054354,0.4038199181446112,0.7726343792929468,1.0,2/10,1.51%,SLC3A2;SLC24A4
prerank,cytokine receptor binding (GO:0005126),0.36396408824942905,1.05775256311355,0.38140020898641586,0.7703712650520567,1.0,23/83,24.20%,CSF1;SDCBP;CD300LF;OSMR;IL27;IL12RB1;VEGFA;IL27RA;KITLG;ADAM17;JAK1;CCL5;TGFBRAP1;SYK;TNFSF9;IL6;IL2;SPRED2;EPO;IL34;MIF;SOCS2;JAK2
prerank,pyridoxal phosphate binding (GO:0030170),0.4348075487340009,1.056959873983877,0.4094775212636695,0.7701085936793018,1.0,12/20,36.36%,PDXK;SHMT1;OAT;PSAT1;PYGM;PLPBP;SRR;SHMT2;PNPO;CBS;CTH;PYGB
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.39330820055823196,-1.0562910784575787,0.37969924812030076,0.6659242565628467,1.0,3/11,6.88%,CASP2;CASP3;CASP6
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3334144004524222,1.055635462864075,0.264,0.7715434628012037,1.0,137/597,23.40%,TCF7;ATF3;ELF4;FOXN1;NFYA;NFIC;NFE2L2;ARID5B;ORC3;LEF1;TBX21;MYBL2;BCL11B;MAFF;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;TBX18;MEF2D;POU3F1;MCM7;MCM2;TGIF1;GRWD1;TFEB;HDAC4;PPARG;SHOX2;FOXJ1;KLF12;KLF6;RUNX1;BCL6;GATA3;CUX1;RFX5;ZBTB7B;SOX9;EGR2;HES7;ZBTB2;BHLHE40;CHD3;BHLHE41;BASP1;PPARD;IRF8;E2F3;HOXA7;NKX2-1;SOX7;KLF13;IRX5;BRCA1;MEF2B;ATF5;CREB3L2;FOSB;ELF2;RBBP5;JUN;CEBPA;XPA;IRF5;ZFP41;ARID4B;PRDM9;CARM1;MAFG;ELK4;TFAP4;FOXJ3;MBD4;MAFK;YY1;NFYB;DDIT3;NFKB1;MBNL2;HSPD1;NHLH2;SRF;CEBPG;MTF1;NR4A2;ZNF296;DHX36;ELK3;GMEB2;GMEB1;DMRTA2;PSPC1;TBP;HNRNPU;DHX33;GABPB1;GABPB2;TCF12;KAT7;USF2;DHX9;SP1;ZNF177;TAF7;HOXB4;SP9;TCF7L1;NR3C1;JDP2;NFATC3;HMGB1;MCM6;SREBF1;SPIB;MEIS3;MCM8;HOXC9;PBX1;HSF1;RXRB;RUNX3;ETV4;TEAD1;ZBTB43;FOXR2;ARNT2;KLF11;PRRX2;EGR1;AHR;CREBZF;KMT2D;ZNF568;LHX4
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.340478607590598,1.0536765637130856,0.342,0.7747216884161308,1.0,83/269,26.05%,BCL2;HIF1A;PSMD1;UBA52;TANK;TRAF2;RPS27A;CCT2;PRDX6;SQSTM1;FBXW7;MFHAS1;TRAF3;DAXX;PTPN22;RPL23;TRIM28;IKBKE;EGR2;ACTG1;ATXN3;UBE2L3;RPL11;VCP;CCNB1;TRAF1;BRCA1;JUN;JAK1;SHPRH;TNFRSF1B;MAP1LC3B;HSPA8;SMAD7;FZD4;SUMO2;UBE2L6;CLU;HSPD1;DERL1;HSPA9;FOXO1;EIF4E2;RALB;TUBB;GPI;NLK;ELOB;ATP6V0C;NEK6;WFS1;CUL3;FBXO7;UBC;RNF20;LAPTM4B;SPART;LAPTM5;CUL1;GSK3B;HSP90AB1;PRKAR1A;MAP1LC3A;TRIOBP;TRIB2;CUL2;GABARAP;CALR;DNAJA1;PSMA3;SCAMP3;USP2;MDM2;SUMO1;PRR5L;SMC6;HSPA5;YWHAZ;ABI2;CUL4A;PIAS4;UBE2C;HM13
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4814175222874786,1.0530828399654497,0.41120218579234974,0.7738624820740021,1.0,5/12,16.18%,JMJD1C;HR;KDM3A;KDM3B;KDM4D
prerank,sequence-specific DNA binding (GO:0043565),0.33223214921816824,1.052880555259652,0.287,0.771903022064059,1.0,141/590,25.99%,BCL2;CXXC1;HIF1A;IKZF3;CSRNP1;TCF7;MMP12;ATF3;ELF4;KMT2A;NFIC;NFE2L2;LEF1;TBX21;MYBL2;BCL11B;MAFF;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;TBX18;MEF2D;POU3F1;NCL;TGIF1;TFEB;HDAC4;PPARG;SHOX2;SNAPC1;KLF12;KLF6;BCL6;GATA3;CUX1;RFX5;ZBTB7B;SOX9;SATB1;EGR2;BPTF;HES7;ZBTB2;BHLHE40;BHLHE41;PPARD;IRF8;E2F3;HOXA7;TET3;SOX7;KLF13;PRMT5;IRX5;MEF2B;ATF5;ZNF148;FOSB;LONP1;ELF2;JUN;XPA;IRF5;ZFP41;ZKSCAN3;PRDM9;SAFB2;MAFG;ELK4;CHCHD2;TFAP4;FOXJ3;MAFK;YY1;MBNL2;FBXL19;NHLH2;SRF;CEBPG;FOXO1;MTF1;NR4A2;ZNF296;CHTOP;ELK3;GMEB2;GMEB1;MYBBP1A;DMRTA2;HNRNPU;TCF12;USF2;SP1;ZNF177;UPF3A;HOXB4;SP9;TERF1;TCF7L1;NR3C1;JDP2;NFATC3;SREBF1;SPIB;MEIS3;HOXC9;PBX1;HSF1;RXRB;RUNX3;ACD;ETV4;TEAD1;TERT;ZBTB43;FOXR2;ARNT2;KLF11;PRRX2;EGR1;AHR;LHX4;ZBTB4;RXRA;SOX10;GLIS2;SIRT3;ATF4;ZGPAT;POU2F1;HDAC2;GRHL1;CREB5;CSRNP3;MYRF;TLR9;TFCP2;ZBTB12
prerank,acylglycerol lipase activity (GO:0047372),0.4930579243906008,1.0526929585765887,0.4319682959048877,0.7697761867848878,1.0,2/11,5.88%,ABHD12;MGLL
prerank,diacylglycerol kinase activity (GO:0004143),0.49706870231687544,1.0472719030358464,0.43529411764705883,0.7827764882332279,1.0,4/11,17.29%,DGKZ;DGKA;DGKH;DGKD
prerank,CoA hydrolase activity (GO:0016289),0.44736375518216565,1.0456035828728343,0.4260204081632653,0.7849426101054736,1.0,6/16,27.19%,ACSBG2;ACOT9;ACOT6;ACOT1;ACAA2;ACOT8
prerank,clathrin adaptor activity (GO:0035615),0.4570176840233197,1.045129549332363,0.44129032258064516,0.7837650139030783,1.0,8/15,33.15%,DAB2;HIP1;AP1G1;HIP1R;AP1M1;STON1;LDLRAP1;AP2B1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.3875562020240466,-1.0440537728647465,0.3865546218487395,0.6850383248962169,1.0,7/12,35.24%,BMPR1B;ENG;LTBP1;BMPR2;TGFBR1;BMPR1A;LTBP4
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.46648392037927416,1.0423151570724063,0.4444444444444444,0.7891479256658539,1.0,5/13,28.53%,SLC7A1;SLC7A6;SLC38A7;SLC7A2;SLC7A3
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.3986337853812958,-1.0422076951165575,0.38721804511278196,0.6793312524051823,1.0,8/12,32.83%,ELOVL4;OPN3;GPR88;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,ubiquitin binding (GO:0043130),0.35389547158814727,1.0419909797826774,0.4196242171189979,0.7874705454757295,1.0,35/73,33.74%,SQSTM1;FBXW7;HSPB1;USPL1;PLAA;USP5;SHARPIN;DDI2;ILRUN;UBAP1;UBE2L6;MVB12A;RNFT1;RAE1;FBXO7;MARK4;CKS2;WDR48;USP33;MDM2;BIRC2;VPS28;ASCC2;CXCR4;TNFAIP3;UBAP1L;FAF1;USP13;RNF19B;MVB12B;SIRT2;NEDD4;FAF2;NUP62;RBCK1
prerank,glycine binding (GO:0016594),-0.40315094314243743,-1.0414961751143628,0.37815126050420167,0.6714933118615916,1.0,6/11,17.21%,GLRA3;GRIN2B;GRIN1;GLRA2;GLRA1;GRIN3A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.324745867805193,-1.0408927072552467,0.3812154696132597,0.6636635737803053,1.0,4/21,5.24%,PDE3B;PDE10A;PDE1A;PDE8B
prerank,carbohydrate kinase activity (GO:0019200),0.4736525210861688,1.0395452590934429,0.4166666666666667,0.7920728329538871,1.0,4/11,17.34%,HK1;GALK2;NAGK;HK3
prerank,transcription corepressor binding (GO:0001222),0.41160609480237337,1.0389713354044192,0.4362980769230769,0.791268855792159,1.0,11/27,29.61%,MTF2;THAP7;ZBTB16;PHF1;EED;NEK6;FAM89B;EHMT1;HDAC3;PER3;HDGF
prerank,nuclear receptor coactivator activity (GO:0030374),0.37197512836918906,1.036137768164465,0.4452871072589382,0.79701445071438,1.0,23/52,30.10%,ZMIZ1;FGF2;ZMIZ2;ACTN1;PRKCB;MED17;SLC30A9;CARM1;PPARGC1B;HELZ2;MED13;CCAR2;CCAR1;TMF1;CNOT6;PPRC1;ACTN4;DCAF6;KDM1A;BRD8;MED1;CNOT9;MED30
prerank,methylation-dependent protein binding (GO:0140034),0.36519594473527306,1.0340100933509144,0.44264069264069267,0.8005537751171407,1.0,15/57,18.54%,CXXC1;NCAPG2;MSL3;ING4;BPTF;MTF2;THAP7;RBBP5;WDR5;PHF1;ING3;ING2;ING5;ATRX;CBX2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4721304300055982,1.0336380093785449,0.4474393530997305,0.798974601898234,1.0,7/12,35.66%,TENT5C;PAPOLA;MTPAP;PAPOLG;TENT4B;TUT1;TENT4A
prerank,endoribonuclease activity (GO:0004521),0.3885587957753503,1.0331612260462595,0.43944636678200694,0.7977568613388755,1.0,9/32,21.77%,AGO2;ERN2;PIWIL2;ERN1;RNASEL;ZC3H12B;AGO3;ZC3H12D;SND1
prerank,endopeptidase activator activity (GO:0061133),-0.40772681218219003,-1.0307437553752936,0.39144736842105265,0.6789124739127403,1.0,3/10,10.05%,VSIR;APH1B;ADRM1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.34380053648706,-1.0304648861421157,0.3803418803418803,0.67040779180857,1.0,7/16,17.56%,MACROD2;MACROD1;TDG;NEIL1;NEIL3;BST1;NTHL1
prerank,monocarboxylic acid binding (GO:0033293),0.4360343862633872,1.0277495602158329,0.44458281444582815,0.8108715856129041,1.0,2/18,7.18%,PSAP;NAPEPLD
prerank,amino acid binding (GO:0016597),-0.2909778717807814,-1.02591572761486,0.373134328358209,0.6727039808440587,1.0,10/31,14.69%,GRM7;GLRA3;GRIN2B;AGXT;NOS1;GRIN1;GLRA2;CASTOR1;GLRA1;DDAH2
prerank,calcium-activated potassium channel activity (GO:0015269),0.4686183715173299,1.0249587055230445,0.45874125874125876,0.8162803919327746,1.0,3/11,11.95%,KCNN4;KCNMA1;KCNMB4
prerank,ion gated channel activity (GO:0022839),0.408626036076963,1.0246245096696651,0.468187274909964,0.8145740836622675,1.0,3/24,5.36%,TTYH2;ANO9;ANO8
prerank,transferrin receptor binding (GO:1990459),-0.40778098704014726,-1.0241357687744532,0.42424242424242425,0.667808251547756,1.0,2/10,6.02%,SNX2;CD81
prerank,platelet-derived growth factor binding (GO:0048407),0.48345161655388397,1.0228041220293866,0.45691906005221933,0.8173434815121732,1.0,2/11,6.74%,PDGFA;COL4A1
prerank,chemokine binding (GO:0019956),0.39069133344832546,1.022202280337974,0.4577625570776256,0.816516692470872,1.0,5/30,5.11%,CXCR2;PDPN;FGF2;PLP2;ITGA4
prerank,endonuclease activity (GO:0004519),0.3637765824234318,1.0208919160680354,0.45414847161572053,0.8176511189323602,1.0,14/49,21.83%,AGO2;ERN2;PIWIL2;ERN1;RNASEL;ZRANB3;MBD4;ERCC4;ZC3H12B;AGO3;RPS3;ZC3H12D;SND1;SETMAR
prerank,acyl-CoA hydrolase activity (GO:0047617),0.43575540295350923,1.0207108007981278,0.44923857868020306,0.8155627085596722,1.0,6/17,27.19%,ACSBG2;ACOT9;ACOT6;ACOT1;ACAA2;ACOT8
prerank,U6 snRNA binding (GO:0017070),0.45078919366886633,1.0201204510271709,0.46143790849673205,0.8146196949342214,1.0,10/14,34.20%,PRPF4;DDX39B;EIF5A;PRPF8;LSM4;RBM22;LSM3;TUT1;SART3;LSM8
prerank,chemorepellent activity (GO:0045499),-0.3011548735795541,-1.0194654678174209,0.41721854304635764,0.6703164539740415,1.0,3/25,3.34%,SEMA6D;NRG3;SEMA6A
prerank,retinoic acid binding (GO:0001972),-0.3782110805257993,-1.018743099277102,0.4269230769230769,0.6633113070706605,1.0,8/12,37.66%,CYP26C1;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;CYP26B1;NR2F2
prerank,thyroid hormone receptor binding (GO:0046966),0.4005075722679824,1.0157465374437213,0.46199524940617576,0.8245242535688467,1.0,13/28,30.10%,JMJD1C;TRIP12;MED17;MED13;PRMT2;GTF2H1;TAF7;NSD1;OASL;BRD8;MED1;TRIP6;MED30
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3702072021554686,-1.0147024050535478,0.430327868852459,0.6643125873781442,1.0,2/13,4.40%,SREBF2;IDI1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.39854771389912025,-1.0145827318283476,0.4641509433962264,0.6562645914396887,1.0,3/10,6.88%,CASP2;CASP3;CASP6
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4017161730865439,1.0111568834342994,0.47287735849056606,0.8347656909150362,1.0,14/25,32.07%,PARP4;TNKS2;SIRT5;ART4;TIPARP;ZC3HAV1;SIRT4;PARP3;PARP2;SIRT3;PARP16;SIRT1;SIRT2;PARP9
prerank,pre-mRNA binding (GO:0036002),-0.3006433118637257,-1.010407449671145,0.40476190476190477,0.6579799793807576,1.0,7/28,10.82%,CELF2;RNPC3;RBM7;RBM41;CELF4;CELF5;RBM4
prerank,nuclear localization sequence binding (GO:0008139),0.42634051313313304,1.0082522476373632,0.4665841584158416,0.8403923138749031,1.0,4/18,10.94%,BRAP;IPO5;KPNA4;KPNA6
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.30454287053140877,-1.0081914629332749,0.463855421686747,0.6550149290777553,1.0,4/23,5.24%,PDE3B;PDE10A;PDE1A;PDE8B
prerank,sulfotransferase activity (GO:0008146),0.3800427491193653,1.005466305587349,0.472,0.8452924083121407,1.0,9/33,27.84%,CHST11;SULT6B1;TPST1;CHST12;HS6ST1;SULT2B1;CHST2;CHST3;HS3ST2
prerank,growth factor receptor binding (GO:0070851),0.3376102775836134,1.003648899594343,0.4887295081967213,0.8476804687127849,1.0,15/95,11.66%,SDCBP;CD300LF;ITGA5;PDGFA;FGF2;IL12RB1;ERN1;GRB2;VEGFA;IL27RA;ADAM17;FGF7;HIP1;FYN;FGF20
prerank,transforming growth factor beta receptor binding (GO:0005160),0.423547208169366,1.0032602075234855,0.48314606741573035,0.8461230536075719,1.0,10/18,39.18%,BAMBI;TGFBRAP1;SMAD7;FERMT2;TGFBR2;FKBP1A;USP15;TGFB1;TGFB2;SMAD6
prerank,exonuclease activity (GO:0004527),0.3587635783301826,0.9991714356987194,0.4966367713004484,0.854906369754948,1.0,14/46,20.73%,EXOSC4;XRN2;AEN;RAD50;DXO;EXOSC9;EXOSC10;ISG20L2;ISG20;RAD1;REXO5;POLG;EXOSC5;CNOT6
prerank,protein kinase inhibitor activity (GO:0004860),0.36711436149523724,0.997207725348286,0.49665924276169265,0.8575591512975054,1.0,12/42,23.59%,SMCR8;TAOK3;NCK1;RACK1;PARVA;SPRY4;GSKIP;YWHAB;SPRED2;ITPRIP;NPM1;INKA2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4338046559309303,0.9965967168543496,0.4937185929648241,0.8566580057115144,1.0,3/14,14.03%,SDHB;NFU1;RSAD2
prerank,GTP binding (GO:0005525),0.32449537331186873,0.9959660729946311,0.5141987829614605,0.8557713127653036,1.0,43/172,19.22%,TSR1;RRAGD;RAP2A;ARF3;REM1;THG1L;GIMAP7;GTPBP4;ARL8B;MFHAS1;EEF1A1;ARL1;RASL12;ANXA6;RHOD;RHOQ;GEM;BMS1;RAB32;ARL11;RAB8A;KRAS;NRAS;DNM2;RHOG;RAB7A;DRG1;RHOA;RHOU;RAB5A;CDC42;ARL8A;RAB22A;GBP2;RIT1;RALB;TUBB;EIF2B2;DRG2;GNL3;RRAD;ADSS1;RHOT2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.45038873701211374,0.9946665229052566,0.49667994687915007,0.8567659559193619,1.0,8/13,35.54%,METTL1;TRMT10C;TARBP1;THUMPD2;TRMT5;WDR4;TRMT10A;TRMT1L
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.44492948023354933,0.9941281653912156,0.4896103896103896,0.8556672332782931,1.0,4/13,25.16%,BMP8B;BMP6;BMP4;BMP5
prerank,chloride channel activity (GO:0005254),0.3507140758582155,0.9939928737174129,0.5161987041036717,0.8534367671097233,1.0,11/59,18.22%,PACC1;TTYH2;CLCN7;GABRP;ANO9;CLIC4;CLCN1;GABRA4;ANO5;ANO6;CLCN4
prerank,phosphatidylinositol kinase activity (GO:0052742),0.42947492053526837,0.9936966460599216,0.5026041666666666,0.8515714114992942,1.0,7/15,26.73%,PIK3CB;PI4K2A;ATM;PIKFYVE;PI4KA;PIK3C2A;PI4K2B
prerank,carboxy-lyase activity (GO:0016831),0.40049518363312,0.9932383667890794,0.49939975990396157,0.8501445020909033,1.0,5/23,17.17%,UMPS;AZIN1;PCK2;ACOD1;ODC1
prerank,ubiquitin-specific protease binding (GO:1990381),0.40333645085241643,0.9918865090833431,0.49748110831234255,0.8512145447152157,1.0,11/19,39.75%,DERL3;VCP;DERL1;SUMO1;PTEN;SYVN1;SART3;LCOR;CHMP3;RAD23A;RHBDD2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3126558234668647,0.9914586709295842,0.532,0.8497181026870608,1.0,168/731,24.21%,LITAF;MITF;HIF1A;IKZF3;DNMT3A;TCF7;ATF3;ELF4;NFYA;NFIC;NFE2L2;LEF1;ZNF697;TBX21;MYBL2;BCL11B;MAFF;MUC1;STAT4;EOMES;SOX3;IRF6;TCF15;OVOL1;HOXA4;SOX30;NR4A3;TBX18;VDR;MEF2D;SIX5;POU3F1;NFIL3;MNT;TGIF1;CC2D1A;TFEB;HDAC4;PPARG;FOXJ1;ZFHX2;KLF12;KLF6;ZKSCAN4;RUNX1;BCL6;GATA3;ZBTB42;RFX5;ZBTB7B;SOX9;SATB1;EGR2;BPTF;HDAC1;HES7;ZBTB2;BHLHE40;ZNF395;ZNF160;PRDM15;BHLHE41;PPARD;IRF8;E2F3;HOXA7;LRRFIP1;NKX2-1;SOX7;KLF13;PRMT5;IRX5;FOXP4;MEF2B;CREB3L2;NFE2L1;NRF1;ZNF148;FOSB;JUN;CEBPA;IRF5;DACH2;ZNF83;ZKSCAN3;ZBTB34;ZSCAN12;ZNF569;MAFG;ZBTB16;ELK4;TFAP4;FOXJ3;SMAD1;MAFK;YY1;EHF;NFYB;MGA;DDIT3;PRRX1;NFKB1;SP7;NHLH2;SRF;CEBPG;ZBTB40;FOXO1;MYT1;MTF1;NR4A2;ZNF296;DHX36;HOXC5;NPAS4;ELK3;GMEB2;SARS1;GMEB1;DMRTA2;ZBTB25;HNRNPU;TCF12;USF2;DHX9;WBP2;SP1;CCAR1;ZBTB6;HOXB4;ZBTB39;SP9;DACH1;TOP1;TCF7L1;NR3C1;JDP2;NFATC3;SREBF1;SPIB;MEIS3;CHD2;NLRC5;TRIM24;HOXC9;ZNF18;PBX1;HSF1;RXRB;RUNX3;ETV4;TEAD1;ARNT2;KLF11;PRRX2;EGR1;AHR;STAT5B;PBX2;REL;ZNF568;ZBTB4;ZSCAN22;E2F6;RXRA;SOX10;ZSCAN20;GLIS2
prerank,ribosomal large subunit binding (GO:0043023),0.46247738479590594,0.9912592624655479,0.4940079893475366,0.8477720228385308,1.0,5/11,25.37%,EIF6;CPEB2;DHX33;NPM1;MALSU1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.34071001061848694,0.9906066575289972,0.5224191866527633,0.846973084146039,1.0,31/78,28.52%,CTSB;CTSZ;CAPN15;MALT1;CTSW;USP12;CAPN1;USP9X;USP5;GPAA1;USP40;CASP7;USP47;CASP4;CAPNS1;USP18;USP46;CASP9;USP28;USP36;USP14;USP33;USP2;USP8;SFRP1;USP1;ESPL1;USP42;CTSL;USP30;USP34
prerank,tRNA methyltransferase activity (GO:0008175),0.4331911453646652,0.9882131639663907,0.5081555834378921,0.8510650652219987,1.0,9/16,30.99%,METTL2B;METTL2A;TRMT13;TARBP1;THUMPD2;TRMT5;ALKBH8;TRMT12;LCMT2
prerank,hyaluronic acid binding (GO:0005540),0.4736052355796816,0.9876291449873911,0.4943820224719101,0.8501714040375629,1.0,3/10,15.78%,CD44;CHODL;C1QBP
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.4193363940954029,0.986561446569017,0.5093632958801498,0.8504923203823492,1.0,7/18,28.32%,PRDX5;SERPINB9;GAS6;BIRC5;BIRC2;NOL3;PRDX3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.4015186873308936,0.9832112906505868,0.5124378109452736,0.8570331731389508,1.0,11/22,31.45%,OPTN;SQSTM1;IKBKE;ZRANB3;UIMC1;PRPF8;TNFAIP3;RNF169;TAB2;MINDY2;ZBTB1
prerank,chloride channel regulator activity (GO:0017081),0.4370653959300239,0.9827855126170901,0.5076335877862596,0.8555933480272738,1.0,2/14,4.46%,SGK1;SGK3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.30895673164837617,0.9826986871794793,0.597,0.8533550714113689,1.0,188/831,24.21%,LITAF;MITF;HIF1A;IKZF3;DNMT3A;TCF7;ATF3;ELF4;NFYA;NFIC;NFE2L2;LEF1;ZNF697;TBX21;MYBL2;DEAF1;BCL11B;MAFF;MUC1;STAT4;EOMES;SOX3;IRF6;TCF15;OVOL1;HOXA4;SOX30;NR4A3;TBX18;VDR;MEF2D;SIX5;POU3F1;NFIL3;MNT;TGIF1;CC2D1A;CIC;TFEB;HDAC4;PPARG;FOXJ1;ZFHX2;KLF12;KLF6;ZKSCAN4;RUNX1;BCL6;GATA3;CUX1;ZBTB42;RFX5;ZBTB7B;SOX9;SATB1;EGR2;BPTF;HDAC1;NFX1;HES7;ZBTB2;BHLHE40;ZNF395;ZNF160;PRDM15;BHLHE41;PPARD;IRF8;E2F3;HOXA7;LRRFIP1;NKX2-1;OTP;AEBP1;SOX7;KLF13;IRX5;FOXP4;MEF2B;ATF5;TBPL1;NFE2L1;NRF1;ZNF148;FOSB;JUN;CEBPA;ENO1;IRF5;ZFP41;DACH2;GBX1;ZNF83;ZKSCAN3;ASCL4;ZBTB34;ZSCAN12;ZNF569;MAFG;ZBTB16;ELK4;TFAP4;FOXJ3;SMAD1;MAFK;YY1;EHF;NFYB;ETV6;MGA;STOX1;DDIT3;PRRX1;NFKB1;SP7;NHLH2;SRF;CEBPG;ZBTB40;FOXO1;MYT1;MTF1;NR4A2;ZNF296;DHX36;HOXC5;NPAS4;ELK3;GMEB2;SARS1;GMEB1;DMRTA2;ZBTB25;TBP;HNRNPU;TCF12;PURA;USF2;DHX9;WBP2;SP1;ZNF177;CCAR1;ZBTB6;HOXB4;ZBTB39;SP9;DACH1;TOP1;TCF7L1;NR3C1;JDP2;RPS3;NFATC3;SREBF1;SPIB;MEIS3;CHD2;ZFP57;RFXANK;NLRC5;TCF24;HOXC9;ZNF18;PBX1;HSF1;RXRB;RUNX3;ETV4;TEAD1;ZBTB43;ARNT2;KLF11;PRRX2;ACTN4;EGR1;STAT5B;PBX2;REL;ZNF568;LHX4;ZBTB4;ZSCAN22;E2F6;RXRA;SOX10;ZSCAN20;GLIS2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.33947418654796935,0.9825153831216197,0.5327004219409283,0.8513522871532626,1.0,12/69,15.52%,PLAAT3;SPHK1;ZDHHC15;ZDHHC18;SOAT1;CERS6;NAA16;LPGAT1;SOAT2;LPCAT3;ZDHHC1;GLYAT
prerank,CXCR chemokine receptor binding (GO:0045236),-0.37342297656679646,-0.9803179445287634,0.4326530612244898,0.7119821999761994,1.0,3/11,21.64%,ITCH;PF4;CXCL12
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.36808726650098256,0.9799189997333927,0.5237543453070683,0.855584922232679,1.0,8/33,20.78%,RNF125;RNF14;SIAH2;RNF180;DCUN1D2;RPS3;RNF19A;DCUN1D4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3087231869558809,0.9789893534957346,0.597,0.8554734197402212,1.0,166/732,24.21%,LITAF;MITF;HIF1A;IKZF3;DNMT3A;TCF7;ATF3;ELF4;NFYA;NFIC;NFE2L2;LEF1;ZNF697;TBX21;MYBL2;BCL11B;MAFF;MUC1;STAT4;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;NR4A3;TBX18;VDR;MEF2D;SIX5;POU3F1;NFIL3;MNT;TGIF1;CC2D1A;TFEB;HDAC4;PPARG;FOXJ1;ZFHX2;KLF12;KLF6;ZKSCAN4;RUNX1;BCL6;GATA3;ZBTB42;RFX5;ZBTB7B;SOX9;SATB1;EGR2;BPTF;HDAC1;HES7;ZBTB2;BHLHE40;ZNF395;ZNF160;PRDM15;BHLHE41;PPARD;IRF8;E2F3;HOXA7;LRRFIP1;FOXN3;NKX2-1;SOX7;KLF13;IRX5;FOXP4;MEF2B;NFE2L1;NRF1;ZNF148;FOSB;JUN;CEBPA;IRF5;DACH2;ZNF83;ZKSCAN3;ZBTB34;ZSCAN12;ZNF569;MAFG;ZBTB16;ELK4;TFAP4;TIPARP;FOXJ3;SMAD1;MAFK;YY1;EHF;NFYB;MGA;DDIT3;PRRX1;NFKB1;SP7;NHLH2;SRF;CEBPG;ZBTB40;FOXO1;MYT1;MTF1;NR4A2;ZNF296;DHX36;HOXC5;NPAS4;ELK3;GMEB2;SARS1;GMEB1;DMRTA2;ZBTB25;HNRNPU;TCF12;USF2;DHX9;WBP2;SP1;CCAR1;ZBTB6;HOXB4;ZBTB39;SP9;DACH1;TOP1;TCF7L1;NR3C1;JDP2;NFATC3;SREBF1;SPIB;MEIS3;CHD2;NLRC5;HOXC9;ZNF18;PBX1;HSF1;RXRB;RUNX3;ETV4;TEAD1;ARNT2;KLF11;PRRX2;EGR1;AHR;STAT5B;PBX2;REL;ZNF568;ZBTB4;ZSCAN22;E2F6;RXRA;SOX10;ZSCAN20;GLIS2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.37867236549865996,0.9781710443461757,0.5047846889952153,0.8551249903516271,1.0,7/27,20.78%,RNF125;RNF14;SIAH2;RNF180;DCUN1D2;RNF19A;DCUN1D4
prerank,guanyl ribonucleotide binding (GO:0032561),0.3163838473560028,0.9768987818782269,0.5604838709677419,0.8557881475488596,1.0,47/196,19.22%,TSR1;RRAGD;RAP2A;ARF3;REM1;THG1L;GIMAP7;GTPBP4;ARL8B;MFHAS1;EEF1A1;ARL1;RAB5C;RASL12;ANXA6;RHOD;RHOQ;GEM;BMS1;RAB32;ARL11;RAB8A;RAB8B;KRAS;NRAS;DNM2;RHOG;RAB7A;DRG1;RHOA;RHOU;RAB5A;CNGB1;CDC42;ARL8A;RAB22A;GBP2;RIT1;RALB;TUBB;EIF2B2;DRG2;SLC19A1;GNL3;RRAD;ADSS1;RHOT2
prerank,GTPase activator activity (GO:0005096),0.3122761839619539,0.9763576791813193,0.578,0.8548306003177838,1.0,99/313,25.45%,RGS1;IQGAP1;MYO9B;ABR;ARHGAP25;ARHGAP10;TBC1D10C;ARHGAP24;CCDC88C;CYTH1;SMCR8;DOCK2;TBC1D22A;ASAP1;RGS3;RGP1;RGPD1;THG1L;RALGAPA2;AKAP13;ALS2;GNAQ;PCP2;SIPA1L2;DENND2D;NRP1;TBC1D2;FGD6;RAPGEF6;DENND4C;DLC1;RASGRP1;RASGRP3;RIC1;RANGRF;RIN2;SERGEF;RASGEF1B;EEF1D;RCC1L;DNMBP;MON1A;ARFGEF2;ARHGAP19;NPRL2;JUN;ARHGEF18;HPS1;RANBP1;ELMOD3;IQGAP2;DOCK5;RANBP2;RCC1;ARHGEF11;RASGRP2;LLGL2;RACGAP1;KALRN;RASA1;NF1;TBC1D22B;TBC1D12;ARHGAP30;ARHGAP9;EIF2B2;RAB3GAP2;TBC1D20;ARFGEF1;ELMOD2;RIC8A;ARHGAP17;BNIP2;ARHGEF2;NPRL3;GMIP;FGD5;ARFGAP3;ARFGAP1;DENND4B;ARHGEF5;HTR2B;ASAP2;TBC1D10A;LARS1;LLGL1;VAV3;SMAP1;EIF2B4;CCDC88A;SGSM1;SIPA1;DOCK11;TBC1D16;SIPA1L3;NCKAP1L;VAV1;RALGAPB;ARFGAP2
prerank,chemokine receptor binding (GO:0042379),0.3675448473949368,0.9762581942750803,0.5255391600454029,0.8526363307529203,1.0,7/35,13.89%,CCL4;CCL13;CCL7;CCL5;CCL28;CCL14;CXCL16
prerank,retinoic acid receptor binding (GO:0042974),0.4159697365304302,0.9745986972934528,0.5088161209068011,0.8544976148963176,1.0,10/17,31.79%,VDR;PPARG;ASXL1;PRMT2;NR4A2;ACTN4;NSD1;SNW1;MED1;RARG
prerank,BMP receptor binding (GO:0070700),0.4449452714306525,0.974496794057523,0.5045751633986928,0.8523864239495341,1.0,4/12,25.16%,BMP8B;BMP6;BMP4;BMP5
prerank,metalloexopeptidase activity (GO:0008235),0.34449587078566934,0.9704382859612891,0.5339265850945495,0.8601792962184,1.0,8/51,9.74%,ANPEP;CPA4;CPA3;AGBL5;CPXM2;AGBL2;CPA6;AEBP1
prerank,Wnt-activated receptor activity (GO:0042813),-0.3284680561100982,-0.9702807311007433,0.42448979591836733,0.7272116988070296,1.0,2/15,4.52%,LRP5;TSPAN12
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3154045454735362,0.9702596173126314,0.5814889336016097,0.8582442018699604,1.0,52/181,27.44%,MDFIC;CTNNB1;HIF1A;NFE2L2;ANXA4;ID2;EOMES;NCOR2;BBS10;HDAC4;HSPB1;PPARG;TAF4B;EGR2;HDAC1;BHLHE40;BHLHE41;PPARD;JUP;SMARCB1;JUN;ACTB;PRRX1;NHLH2;PSMA6;TACC2;TBP;MKKS;DHX9;SP1;MIER2;TAF6;PIAS1;MTDH;GSK3B;NPM1;ARNT2;ACTN4;DNAJA1;RXRA;MTA3;ATF4;ATN1;HDAC2;HDAC3;PIAS4;SMARCA4;BBS7;SNW1;KDM1A;HES1;DACT1
prerank,cysteine-type peptidase activity (GO:0008234),0.3386500555599753,0.9699144725960877,0.5559071729957806,0.8567319090534808,1.0,33/73,28.52%,CTSB;CTSZ;MALT1;CTSW;ATG4D;OTULIN;USP12;USP9X;USP5;USP40;BLMH;CASP7;ATG4A;USP47;CASP4;GGH;USP18;USP46;CASP9;USP28;USP36;USP14;USP33;USP50;USP2;USP8;SFRP1;USP1;ESPL1;USP42;CTSL;USP30;USP34
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.40520195591773495,0.9680351946059929,0.5320987654320988,0.8588892360616304,1.0,8/18,33.10%,WDR91;PIK3R5;SOCS5;PIK3R2;SOCS2;SOCS4;SOCS7;SOCS6
prerank,Hsp70 protein binding (GO:0030544),0.36899299522873724,0.967215688220739,0.5209790209790209,0.8585464963260394,1.0,12/31,28.87%,SPN;DNAJB14;ERN1;DNAJC8;DNAJB1;RPS3;DNAJC10;DNAJA1;PACRG;DNAJB12;DNAJC2;IQCG
prerank,steroid hydroxylase activity (GO:0008395),-0.3156711383383799,-0.9664672652873654,0.4975845410628019,0.7279736605806644,1.0,5/16,16.35%,CYP27A1;CYP2U1;CYP7B1;CYP39A1;CYP46A1
prerank,heme binding (GO:0020037),0.33125987912356913,0.965528315762788,0.5694591728525981,0.8603276098687979,1.0,25/65,34.76%,CYBB;SLC48A1;HRG;CYP19A1;CYB5R4;CYP2A6;HMOX1;CYP1B1;CAT;PTGIS;SDHC;FLVCR2;STEAP4;JAK2;FLVCR1;TBXAS1;NOX4;CYCS;HCCS;CYB561D1;HEBP1;CBS;PXDNL;CYB5A;CYP2R1
prerank,telomeric DNA binding (GO:0042162),0.3669603851388604,0.9649473713197921,0.5464285714285714,0.859405922867813,1.0,13/32,29.46%,NCL;RAD50;BLM;HNRNPA2B1;PURA;UPF3A;TERF1;ACD;TERT;TERF2IP;KDM1A;SMG1;XRCC5
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4183747688223219,0.9623641193794961,0.5261146496815287,0.8631677433421607,1.0,6/16,20.42%,SLC1A5;SLC25A14;SLC38A7;SLC13A3;SLC25A18;SLC13A5
prerank,phosphatidate phosphatase activity (GO:0008195),-0.34805954670138817,-0.9621457107877023,0.5059288537549407,0.7295323082491665,1.0,5/13,16.34%,PLPPR4;PLPP1;LPIN2;PLPP4;PLPP2
prerank,motor activity (GO:0003774),0.33217849383017173,0.9602560065480488,0.5507399577167019,0.8659544780792481,1.0,11/60,18.13%,MYO1E;KIF13B;DNAH8;KLC1;KIF1A;DNAH3;KIF20A;SMC3;KIFC1;KIF21B;PIN1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3033648605682067,-0.9598843136031668,0.5091743119266054,0.725828525426003,1.0,6/20,18.00%,LPCAT2;PLA2G15;GPAT3;PNPLA3;MOGAT3;AGPAT4
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.31711720921369324,-0.959036543832412,0.527363184079602,0.7193314467633534,1.0,3/17,5.41%,PECR;DPYD;DHCR7
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2729796909403817,-0.9585713295414492,0.5695364238410596,0.7122297367739592,1.0,10/28,18.44%,MAPK14;RPS6KA1;LRRK2;PRKCG;MAP2K6;PAK3;AURKB;TTK;AURKA;MAP2K4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3589042399829009,0.9580362168665799,0.5404157043879908,0.8688316003800551,1.0,11/34,21.40%,IQGAP1;MYO10;ARAP2;IQGAP2;OGT;RACGAP1;ARHGAP9;HIP1R;FERMT2;GAB2;MYO1G
prerank,double-stranded DNA binding (GO:0003690),0.3022085433766688,0.9557862420403307,0.686,0.8721336453169957,1.0,112/531,22.92%,TCF7;ATF3;ELF4;NFIC;LEF1;TBX21;MYBL2;RAD51B;BCL11B;MAFF;EOMES;SOX3;IRF6;OVOL1;HOXA4;SOX30;TBX18;MEF2D;POU3F1;TGIF1;TFEB;PPARG;SHOX2;KLF12;KLF6;BCL6;GATA3;CUX1;RFX5;ZBTB7B;SOX9;SATB1;EGR2;HES7;ZBTB2;BHLHE40;BHLHE41;PPARD;IRF8;E2F3;HOXA7;SOX7;KLF13;IRX5;MEF2B;FOSB;ELF2;JUN;RAD50;XPA;IRF5;ZFP41;DMC1;MAFG;ELK4;TFAP4;FOXJ3;H1-0;YY1;CENPX;MBNL2;NHLH2;SRF;CEBPG;MTF1;NR4A2;ZNF296;ELK3;GMEB2;GMEB1;ZNF638;DMRTA2;POLG2;HNRNPU;TCF12;PURA;USF2;KIN;DHX9;SP1;ZNF177;HOXB4;SP9;TARDBP;TOP1;TERF1;TCF7L1;NR3C1;RAD51AP1;JDP2;RPS3;NFATC3;HMGB1;SREBF1;SPIB;MEIS3;HOXC9;PBX1;HSF1;RXRB;RUNX3;ETV4;SETMAR;TEAD1;ZBTB43;FOXR2;ARNT2;KLF11;WDR48;PRRX2;EGR1;AHR
prerank,sodium channel activity (GO:0005272),-0.2606040676420435,-0.9552703367336295,0.5578947368421052,0.7119784495659981,1.0,6/37,8.44%,GRIK2;GRIK3;GRIK4;SCN2A;HCN1;KCNK1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3434468358399844,-0.953821320015207,0.5201465201465202,0.7074818028424733,1.0,4/13,18.00%,LPCAT2;GPAT3;PNPLA3;AGPAT4
prerank,flavin adenine dinucleotide binding (GO:0050660),0.34041457339126435,0.953760468584591,0.5621562156215621,0.8746329260361309,1.0,19/53,28.01%,MICAL2;CYBB;XDH;MICAL1;POR;GSR;CYB5R1;MTRR;GCDH;AIFM2;CYB5R3;GFER;ACADL;ACOX3;STEAP4;MTHFR;NOX4;KDM1A;ACOXL
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4332737677900579,0.95291935854722,0.5492577597840755,0.8743111333473167,1.0,4/13,24.61%,SLX4;ZGRF1;DNASE1L1;GEN1
prerank,vitamin D receptor binding (GO:0042809),0.4151559465275811,0.9516372207497723,0.5486842105263158,0.8751335277544428,1.0,7/14,30.10%,MED17;MED13;TAF7;RXRA;SNW1;MED1;MED30
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.44205084788243265,0.9513010895356491,0.5521796565389696,0.8735524429327235,1.0,2/12,3.88%,B4GAT1;B3GNT3
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.38376161484713645,0.9507947035138,0.5506172839506173,0.8724173539454295,1.0,9/22,30.01%,DUSP9;DUSP6;DUSP3;CDKN3;DUSP15;DUSP12;DUSP16;DUSP5;DUSP23
prerank,leak channel activity (GO:0022840),0.3951756692448609,0.9464366403992903,0.5773067331670823,0.8803138640718009,1.0,2/18,4.38%,KCNK13;PANX1
prerank,metalloaminopeptidase activity (GO:0070006),-0.3193997496818074,-0.9463127797109133,0.5024154589371981,0.7173600718347801,1.0,3/16,3.91%,RNPEP;TRHDE;MMP16
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.41005896142407366,0.9452911763312898,0.5719844357976653,0.8806734907950519,1.0,3/15,21.80%,SLC26A1;SLC26A4;SLC26A6
prerank,N-acyltransferase activity (GO:0016410),0.3608421862311235,0.9445949338580009,0.5688073394495413,0.8798882315319843,1.0,5/32,10.31%,SAT1;PLAAT3;GNPNAT1;CERS6;NAT8
prerank,G protein-coupled receptor activity (GO:0004930),-0.18038520925101592,-0.9429024384248881,1.0,0.7170964845371773,1.0,29/239,9.30%,P2RY12;CX3CR1;GPR34;ADGRL3;ADGRB3;GPR37;CALCRL;CYSLTR1;GRM1;ADGRG6;P2RY13;GRM5;PAX8;GRM3;GABBR1;GPR22;C5AR2;ADRB1;ADGRG1;LGR5;ADGRE1;ELOVL4;TAPT1;GPR173;RXFP1;ADGRV1;NTSR2;PDGFRL;P2RY6
prerank,tau protein binding (GO:0048156),0.351357019985537,0.9420402216972777,0.5752808988764045,0.8835479975843222,1.0,14/40,21.99%,APOE;CDK5;FYN;DCTN1;ROCK1;ACTB;CLU;PIN1;S100B;MARK2;GSK3B;HSP90AB1;MARK4;TAOK1
prerank,myosin II binding (GO:0045159),0.4533759361161105,0.9416811475650995,0.5803324099722992,0.8819960949287871,1.0,5/10,24.25%,GSN;LLGL2;TRIOBP;LLGL1;MYL4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3316180257467703,0.9370945214156476,0.6037321624588364,0.8900609745121777,1.0,18/54,25.66%,HDAC9;HDAC4;HDAC1;SIRT5;SUDS3;UPB1;GLS2;GLS;PIGL;SIRT4;KLK3;MIER2;ASAH1;AGA;AMDHD2;HDAC11;HDAC2;HDAC3
prerank,histone acetyltransferase binding (GO:0035035),0.3880094759343797,0.9366027128119458,0.5654320987654321,0.888924052450877,1.0,12/21,33.61%,HIF1A;ECD;TAF7;KANSL1L;EGR1;KANSL1;TRIM68;TRIP4;SIRT2;GLI3;EPAS1;PCNA
prerank,protein phosphatase activator activity (GO:0072542),0.42370045891784747,0.9357557440357184,0.5812080536912752,0.8885502457334555,1.0,8/13,37.05%,PTPA;PPP2R5C;PPP1R15A;CALM3;PPP2R5E;CALM1;B3GAT3;PPP2R5D
prerank,acid-thiol ligase activity (GO:0016878),0.4170669631937446,0.9353844136960421,0.5873221216041398,0.8870327766010311,1.0,3/13,15.04%,SLC27A5;ACSL1;AACS
prerank,phosphoric diester hydrolase activity (GO:0008081),0.34392606493600836,0.9325298559119359,0.6059564719358533,0.8913402766876146,1.0,6/35,8.59%,PLD3;PLCB4;GDPD3;NAPEPLD;PLCB2;SMPD4
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.44562993652546845,0.9307592915507618,0.5757575757575758,0.8931542228621644,1.0,7/10,31.11%,OTUD4;ATXN3;DESI2;OTUD5;TNFAIP3;STAMBP;STAMBPL1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.31427337303687397,-0.9275903961886458,0.5670995670995671,0.7445560317652379,1.0,3/15,5.72%,HS3ST5;HS6ST2;HS3ST4
prerank,cation channel activity (GO:0005261),-0.21419692119405878,-0.9256153732379778,0.6595744680851063,0.7414256683312592,1.0,28/94,21.19%,CACNB2;SLC24A3;TRPM3;UNC80;CALHM2;TMEM63A;PSEN1;HCN1;ABCC9;TRPM4;KCNK1;MCOLN1;TRPM6;TRPV4;GRIN1;KCNK5;KCNK10;CHRNA7;CACNA1E;KCNK4;CALHM5;CUL5;TRPC6;TRPM2;ANO1;PKD1;KCNK7;KCNG1
prerank,tau-protein kinase activity (GO:0050321),0.38698156869586764,0.9251846178148496,0.5928217821782178,0.9029278992134031,1.0,11/20,30.75%,CDK5;FYN;ROCK1;MARK2;GSK3B;MARK4;TAOK1;SIK3;GSK3A;MARK3;TTBK2
prerank,hexosyltransferase activity (GO:0016758),0.30513163460616954,0.9223079151206547,0.6535677352637022,0.9068301731524921,1.0,10/101,5.75%,B4GALT5;LARGE1;B4GALT7;GCNT2;B4GAT1;B3GNT3;HEXA;GYG1;PIGZ;B3GALNT2
prerank,glutathione transferase activity (GO:0004364),0.3651932324873024,0.9198785654049254,0.5990279465370595,0.909820371093156,1.0,2/23,3.91%,PTGES;GSTA2
prerank,symporter activity (GO:0015293),0.4315863887199379,0.9196490193174567,0.5928571428571429,0.9079200843618174,1.0,5/10,34.41%,SLC28A2;SLC46A2;SLC5A6;SLC4A4;MFSD2A
prerank,voltage-gated ion channel activity (GO:0005244),0.4106869865330039,0.917339879491651,0.590728476821192,0.9105953769432644,1.0,5/14,20.34%,VDAC2;KCNA3;ANO6;GPR89A;GPR89B
prerank,calcium channel activity (GO:0005262),0.3093579179520631,0.9165411099739312,0.6433862433862434,0.9099905595532704,1.0,20/84,25.50%,CACNA1A;TRPC4;P2RX4;SLC24A4;PANX1;ANXA6;TPCN2;CACNA1D;TRPM7;CACNG7;CACNB3;CACNB1;ORAI2;ORAI3;CACNB4;GRIN3B;PKD1L2;ORAI1;CACHD1;TMCO1
prerank,phospholipid transfer activity (GO:0120014),0.3728889597808578,0.9151943741774463,0.6093943139678616,0.9105460129065955,1.0,5/21,13.26%,GLTP;TRIAP1;PITPNC1;OSBPL2;PRELID2
prerank,NF-kappaB binding (GO:0051059),0.362556997881802,0.9143493290114952,0.598780487804878,0.9101017108860388,1.0,9/24,25.66%,ANXA4;TAF4B;HDAC1;PSMA6;MTDH;GSK3B;NPM1;HDAC2;HDAC3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.3122936373240777,-0.913386205713167,0.5864661654135338,0.7612129601915595,1.0,1/15,0.08%,LPCAT2
prerank,adrenergic receptor binding (GO:0031690),-0.3145977565123786,-0.9132246412770727,0.5736040609137056,0.7537542003906479,1.0,4/16,7.19%,RAPGEF2;UCHL1;APLP1;ADRB1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.3517937824863878,-0.9123802280137038,0.5776173285198556,0.7478660305786488,1.0,2/11,9.48%,RYR3;MCOLN1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4322570949208907,0.9112055590264843,0.5889655172413794,0.9147021835461651,1.0,5/10,32.03%,ANKRD13B;ANKRD13A;LAPTM5;DNAJC2;USP15
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.37003892928127946,0.9104064868126122,0.6067146282973621,0.9140072362930403,1.0,9/22,32.61%,APOE;LRPAP1;CLU;HSPG2;DNAJA1;HSP90B1;SNX17;MESD;LDLRAP1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3567910719573773,0.9096465070056251,0.608540925266904,0.9132403289922144,1.0,9/26,24.09%,SLC27A1;SLC6A6;SLC16A9;SLC16A3;SLC16A2;SLC26A6;SLC16A13;MPC2;SLC16A1
prerank,histone deacetylase binding (GO:0042826),0.30720944751179924,0.9094992339180766,0.6714876033057852,0.9112294979395955,1.0,32/88,31.08%,IKZF3;LEF1;HDAC9;NCOR2;MEF2D;HDAC4;HDAC1;BHLHE41;GMNN;THAP7;MEF2B;SUDS3;TFAP4;PKN2;DHX36;YWHAB;SP1;MIER2;HSP90AB1;NIPBL;MTA3;HDAC2;KCTD21;HDAC3;HES1;DACT1;RAD9A;NUDT21;CCND1;SATB2;SIRT2;GLI3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.3192742221621716,-0.9090649004513581,0.5502392344497608,0.7474082337895568,1.0,7/15,32.14%,PLA2G4C;PLA2G4E;PLA2G3;PLA2G4F;PLA2G2D;PLA2G4B;PLA2G10
prerank,acetyltransferase activity (GO:0016407),0.3467488938399187,0.9080139635995517,0.6270207852193995,0.9120387795541147,1.0,6/31,10.76%,SAT1;SPHK1;GNPNAT1;NAA16;NAT8;PAFAH2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.33110340660033555,0.9052543899069982,0.631578947368421,0.9155118092934258,1.0,11/42,21.94%,SIRPA;ANXA1;PDLIM1;NPTN;S100A11;EMB;PALLD;DSCAM;BAIAP2;CD47;IGSF9
prerank,nucleotidyltransferase activity (GO:0016779),0.3752072162249704,0.9043203054446711,0.6211180124223602,0.9150927093665904,1.0,8/19,28.79%,THG1L;NUDT5;YRDC;TERT;REV1;MTPAP;MOCS3;TENT4B
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.32534056924100396,0.903227878612151,0.6511111111111111,0.9150584740914233,1.0,13/48,22.37%,CALHM6;ATP6V1B2;ASIC3;PIEZO1;SLC46A1;PIEZO2;SLC12A4;ATP6V1F;TRPM7;TMEM165;SLC12A7;GRIN3B;SLC39A1
prerank,MAP kinase phosphatase activity (GO:0033549),0.415361430525496,0.8999619599148214,0.6052980132450331,0.919509132372757,1.0,7/12,36.06%,DUSP9;DUSP6;DUSP3;DUSP16;DUSP5;DUSP10;DUSP2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3017483977601441,0.8978892406646534,0.6832298136645962,0.9212667073620742,1.0,23/91,22.85%,SH3PXD2B;SDCBP;SLC9A1;CAPG;ATP13A2;SCIN;KCNJ2;WDR45;HIP1;GSN;SESTD1;OSBPL2;SYTL2;TIRAP;SVIL;KRIT1;HIP1R;TTPAL;ACTN2;LAPTM4B;MYO1G;PFN1;SDCBP2
prerank,potassium channel regulator activity (GO:0015459),0.3210981022227803,0.8974691216488262,0.647887323943662,0.9198038427398572,1.0,10/49,17.31%,FLNA;SGK1;LRRC52;SGK3;SGK2;AMIGO1;KCNMB4;CHP1;RASA1;SLC5A3
prerank,phosphatase activity (GO:0016791),0.3071844740779015,0.8955739019036913,0.6944151738672286,0.9213993406669977,1.0,20/73,24.16%,PLPP6;ACP5;PON1;CILP;ENOPH1;PTPN22;PLPP3;NOCT;PRUNE1;ACP3;ATP1A2;DUSP11;DUSP3;NANP;DUSP15;DUSP12;PHOSPHO2;PTPMT1;DUSP16;LPIN3
prerank,mechanosensitive ion channel activity (GO:0008381),0.409203469397778,0.8938971368686975,0.6401617250673854,0.9224812773184925,1.0,2/12,7.11%,PIEZO1;PIEZO2
prerank,telomerase RNA binding (GO:0070034),0.3668568330546275,0.89282315944859,0.6390243902439025,0.9223018628647847,1.0,11/22,31.99%,HNRNPC;EXOSC10;GAR1;DHX36;HNRNPU;DKC1;TERT;XRN1;TENT4B;TEP1;DCP2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.25983186602663927,-0.8902429631639334,0.6513157894736842,0.7796192756659683,1.0,8/29,11.67%,RPTOR;PKIG;KAT2B;SPRED1;PRKAR2A;CDKN2C;CDKN2D;PRKAR2B
prerank,neuropeptide hormone activity (GO:0005184),0.3598757086635535,0.8897915002948278,0.6322815533980582,0.9261847277433913,1.0,4/22,15.59%,NPPA;CRH;AGRP;VIP
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3161303561009308,0.888633186729552,0.667032967032967,0.9261188425811303,1.0,14/51,25.56%,ANKH;SLC35D2;SLC16A10;SLCO5A1;SLC25A3;SLC25A14;SLC7A8;CLCN4;SLC28A2;SLC16A2;SLC46A2;SLCO2A1;SLC20A1;SLC35A1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.28741979376494353,0.8884776587681174,0.7903711133400201,0.9241091660266029,1.0,74/232,30.55%,MYLIP;RNF125;NSMCE2;TRIM6;TRIM43;RNF14;NEURL2;TRIP12;BRAP;NHLRC1;RNF7;SIAH2;RNF6;UBR4;EGR2;NFX1;RNF128;RNF180;ZNRF3;VPS18;RNF111;NHLRC3;HUWE1;SHPRH;RNF2;UBE3B;CDC42;VPS11;DTX2;MKRN2;BFAR;DTX4;CBL;RNF157;RNF121;UBE3C;CBLB;ASB1;RNFT1;UBR2;RNF167;RNF149;CUL3;HECTD1;DTX3;PIAS1;RNF19A;TRIM24;RNF41;RNF216;ZNRF2;TRIM21;RNF145;NSMCE1;MDM2;TRIM72;BIRC2;TRIM7;PIAS4;PELI1;CBLL1;RNF24;RC3H1;UFL1;RNF13;TRIM3;WWP2;MEX3C;TRIM68;MUL1;RNF19B;RCHY1;KCMF1;TRIM37
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.2907045136612937,0.8883047555647047,0.7520161290322581,0.9221869624880279,1.0,27/147,11.69%,ABR;CCDC88C;CYTH1;SMCR8;DOCK2;RGP1;THG1L;AKAP13;ALS2;PCP2;DENND2D;FGD6;RAPGEF6;DENND4C;RASGRP1;RIC1;RANGRF;RIN2;SERGEF;RASGEF1B;EEF1D;RCC1L;DNMBP;MON1A;ARFGEF2;ARHGEF18;HPS1
prerank,peptidoglycan binding (GO:0042834),0.4251393357996319,0.8858885700931359,0.6292749658002736,0.9248687926276701,1.0,4/10,18.55%,HK1;RNASE7;PGLYRP2;JCHAIN
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3367317800801048,0.8856175868952332,0.6513233601841196,0.923159193389148,1.0,18/33,33.75%,EXOSC4;NOCT;XRN2;EXOSC9;EXOSC10;ISG20;EXOSC5;CNOT6;USB1;PAN2;XRN1;CNOT6L;ERI2;ERI3;DCP2;TOE1;ANGEL2;ERI1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.24663862925660268,-0.8845439608693159,0.6842105263157895,0.7841050731831638,1.0,7/32,10.34%,PHYHD1;PHF8;TET1;KDM4A;JMJD4;KDM7A;TYW5
prerank,neurexin family protein binding (GO:0042043),0.42800948870206923,0.8843685029482122,0.6463245492371706,0.9232531129549939,1.0,3/10,12.75%,SYTL1;CEL;SYTL2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.40612462706095304,0.883451231753444,0.6407103825136612,0.9226984366731651,1.0,5/11,31.97%,RAD50;HNRNPA2B1;TERF1;TERF2IP;TERF2
prerank,four-way junction DNA binding (GO:0000400),0.3667874217835452,0.8792380457788913,0.6445859872611465,0.9287533522986908,1.0,7/17,29.67%,RAD51B;BLM;YY1;HMGB1;GEN1;HMGB3;HMGB2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.36852313324624253,0.8786919416269776,0.6691729323308271,0.9276863585438508,1.0,3/18,16.95%,DHRS9;HSD17B8;DHRS11
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.21576880905296245,-0.8783974681367301,0.7586206896551724,0.7890733665510502,1.0,22/49,23.27%,PLCXD3;PTPRO;PTPRJ;SACM1L;ENPP6;PXYLP1;PPP1CB;ACP2;FRA10AC1;PDXP;HDHD2;EPHX2;PPP1CA;APEX1;ACP6;LHPP;MPPED2;SMPDL3A;DUSP18;DUSP28;PPP1CC;DUSP8
prerank,calcium channel inhibitor activity (GO:0019855),0.4091752199390316,0.8775239836300588,0.6421768707482993,0.9277088299957765,1.0,5/11,31.41%,PHPT1;FKBP1B;ITPR1;FKBP1A;CALM1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.30641588216594373,0.8769738259875112,0.6970684039087948,0.9264973655333935,1.0,5/60,4.72%,FLT1;NRP2;IGF2R;AXL;NRP1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3665985601852953,0.8764755792712969,0.660024906600249,0.9252846246893456,1.0,9/20,26.33%,USP9X;COPS2;USP47;SENP5;DESI2;SENP1;USP50;EIF3H;OTUD5
prerank,LRR domain binding (GO:0030275),0.3877035636185872,0.8762281264767826,0.6428571428571429,0.9234483883157161,1.0,6/14,24.47%,MRTFA;DDIT3;DAPK3;LRRFIP2;ZXDC;ATF4
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2804602220271226,0.8758740239480627,0.864,0.922005673661275,1.0,79/346,22.07%,MYLIP;MALT1;RNF125;TRAF2;CNOT4;TRIM6;TRIM43;RNF14;NEURL2;TRIP12;BRAP;TRAF3;NHLRC1;RNF7;SIAH2;TTC3;RNF6;TRIM28;UBR4;TSPAN17;NFX1;RNF128;UBE2L3;UBE2H;RNF180;ZNRF3;VPS18;DDB2;TRAF1;OBI1;RNF111;NHLRC3;KLHL13;BRCA1;HUWE1;SHPRH;RNF2;UBE3B;SHARPIN;UBE2R2;BIRC6;CDC42;UBE2Q1;VPS11;KCTD10;UBE2L6;DTX2;MKRN2;BFAR;DTX4;CBL;RNF157;BARD1;RNF121;UBE3C;CBLB;RMND5B;ASB1;RNFT1;UBR2;FBXL6;RNF167;RNF149;CUL3;HECTD1;DTX3;FBXO7;RNF19A;RNF20;FBXW11;CUL1;TRIM24;RNF41;CDC34;RNF216;ZNRF2;FBXO11;TRIM21;CUL2
prerank,cAMP response element binding (GO:0035497),0.42196959486927255,0.8736886180451532,0.6515353805073432,0.9239109928576599,1.0,3/10,11.15%,NR4A3;CREB3L2;JUN
prerank,single-stranded DNA helicase activity (GO:0017116),0.36073424835722384,0.8736799769838959,0.6683168316831684,0.9217130015317841,1.0,9/19,33.84%,MCM7;MCM2;DHX9;MCM6;RFC2;RFC4;RFC5;MCM5;RAD51
prerank,mRNA methyltransferase activity (GO:0008174),0.3952395342773586,0.8703606509927994,0.6583769633507853,0.92556898940845,1.0,6/12,29.54%,TRMT10C;METTL3;NSUN2;RNMT;METTL8;PCIF1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3980515752657069,0.8692945356262487,0.6482213438735178,0.9253412442452896,1.0,6/12,27.83%,HDAC1;TBPL1;TBP;POU2F1;H3-3A;RUVBL2
prerank,ubiquitin protein ligase activity (GO:0061630),0.28108723900610505,0.8690898420724421,0.8306613226452906,0.9235449748226491,1.0,56/228,24.50%,MYLIP;RNF125;TRIM6;TRIM43;RNF14;NEURL2;TRIP12;BRAP;NHLRC1;RNF7;SIAH2;RNF6;UBR4;NFX1;RNF128;RNF180;ZNRF3;VPS18;RNF111;NHLRC3;UBE4A;HUWE1;SHPRH;RNF2;UBE3B;CDC42;VPS11;DTX2;MKRN2;BFAR;DTX4;CBL;RNF157;RNF121;UBE3C;CBLB;ASB1;RNFT1;UBE4B;UBR2;RNF167;RNF149;CUL3;HECTD1;DTX3;RNF19A;TRIM24;RNF41;RNF216;ZNRF2;TRIM21;RNF145;NSMCE1;MDM2;TRIM72;BIRC2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.3849327416148009,0.8679148728499185,0.6636942675159235,0.9234673489725785,1.0,7/14,32.03%,ATXN3;USP9X;DESI2;OTUD5;USP13;MINDY2;USP15
prerank,syntaxin binding (GO:0019905),0.30432933820962327,0.8673927583843994,0.7195767195767195,0.9222271440894291,1.0,12/61,17.84%,CACNA1A;ABCA1;STX6;NAPA;VPS18;PTPN2;CPLX2;VPS11;DAPK1;SYPL1;VAMP2;RAB11A
prerank,metal ion transmembrane transporter activity (GO:0046873),0.339993298037148,0.8664723117381848,0.6795774647887324,0.9217662480319662,1.0,7/27,19.31%,ATP2B1;SLC23A1;MAGT1;CNNM2;TUSC3;TMEM165;SLC11A1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.3759325707498707,0.8662991082188702,0.6829268292682927,0.9177899727427663,1.0,2/16,1.51%,PTPRA;PTPRC
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.3759325707498707,0.8662991082188702,0.6829268292682927,0.9177899727427663,1.0,2/16,1.51%,PTPRA;PTPRC
prerank,phosphatase activator activity (GO:0019211),0.3792002179415413,0.8630970236342838,0.6662371134020618,0.9213507970823909,1.0,9/14,39.46%,PPP2R5C;GTF2F1;PPP1R15A;CALM3;PPP2R5E;CALM1;B3GAT3;PPP2R5D;CALM2
prerank,adenylate cyclase binding (GO:0008179),-0.32873984065983836,-0.8623981700627705,0.6218181818181818,0.8142193343659099,1.0,4/10,10.46%,ADCY2;ADCY5;AKAP6;AKAP12
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3893548682654468,0.8616225162017287,0.6529562982005142,0.9217955651286371,1.0,6/13,29.87%,GDI1;RANBP1;ITGB1BP1;ARHGDIB;CCDC88A;EIF5
prerank,phosphatidic acid binding (GO:0070300),0.34841989730825196,0.8613250639044296,0.6886446886446886,0.9200775821715352,1.0,5/19,15.14%,ATP13A2;RAPGEF6;PITPNC1;SESTD1;GRAMD1B
prerank,epidermal growth factor receptor binding (GO:0005154),-0.25842994793958546,-0.8612845598440965,0.6783216783216783,0.8086075104183454,1.0,5/25,9.32%,SNX2;FER;EFEMP1;EGF;HBEGF
prerank,insulin-like growth factor binding (GO:0005520),0.3740833306459289,0.860898785995196,0.6824146981627297,0.9187009692730859,1.0,2/15,8.10%,IGF2R;IGF1R
prerank,growth factor activity (GO:0008083),0.2952065041479942,0.8602024178922724,0.7404661016949152,0.9177430949715012,1.0,8/74,11.66%,CSF1;PDGFA;NRG1;FGF2;JAG1;VEGFA;FGF7;FGF20
prerank,active ion transmembrane transporter activity (GO:0022853),-0.22824766929358553,-0.8591578469685411,0.7878787878787878,0.8052370975328172,1.0,4/37,3.59%,SLCO2B1;SLC16A7;COX6A1;SLCO1B1
prerank,solute:proton symporter activity (GO:0015295),0.371422903464263,0.8590404506290505,0.6782051282051282,0.9176352011220013,1.0,3/16,12.13%,SLC17A5;SLC36A3;SLC25A3
prerank,nucleotide diphosphatase activity (GO:0004551),0.3749953795322819,0.85898688103794,0.6684636118598383,0.915638757970735,1.0,2/14,6.80%,CILP;NUDT6
prerank,fatty acid synthase activity (GO:0004312),-0.3359671448716828,-0.8582442858924249,0.6339622641509434,0.7991754812986734,1.0,2/10,7.70%,ELOVL6;ELOVL4
prerank,damaged DNA binding (GO:0003684),0.31381741094745164,0.8577401509152622,0.7211328976034859,0.9157172017146122,1.0,18/44,31.85%,ERCC1;SDE2;DDB2;DDB1;XPA;ERCC4;RAD1;RPS3;HMGB1;DCLRE1A;XPC;SMC6;APTX;HMGB2;PNKP;ERCC2;EP300;CREBBP
prerank,nuclear import signal receptor activity (GO:0061608),0.374715566397312,0.855954278248174,0.6692406692406693,0.9166463104703884,1.0,5/15,24.53%,IPO5;KPNA4;KPNA6;TNPO2;TNPO1
prerank,cytochrome-c oxidase activity (GO:0004129),0.381217631124302,0.8550198141062016,0.6692913385826772,0.9161905716311436,1.0,5/15,21.90%,COX7A1;COX6A2;COX5B;COX10;COX7A2L
prerank,phospholipase A2 activity (GO:0004623),0.3353766290489736,0.85476965913136,0.6814469078179697,0.9144942936194799,1.0,2/26,3.21%,PLAAT3;PRDX6
prerank,ephrin receptor binding (GO:0046875),0.3449794894208723,0.8520556687110289,0.7046004842615012,0.9172784022159675,1.0,5/21,15.96%,GRB2;FYN;EFNA1;CBL;EFNB2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.4085983832816832,0.851715463353173,0.6794520547945205,0.9136830464318267,1.0,6/10,36.06%,DUSP9;DUSP6;DUSP16;DUSP5;DUSP10;DUSP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.4085983832816832,0.851715463353173,0.6794520547945205,0.9136830464318267,1.0,6/10,36.06%,DUSP9;DUSP6;DUSP16;DUSP5;DUSP10;DUSP2
prerank,anion channel activity (GO:0005253),0.2980321509141243,0.8513098664015255,0.724622030237581,0.912252731403924,1.0,6/61,6.00%,LRRC8C;CLCN7;VDAC2;GABRP;ANO9;CLIC4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.39756722759829,0.8497311994511224,0.6859838274932615,0.9126950942054977,1.0,5/11,34.29%,UBE4A;UBE4B;UBE2K;UBR5;ANAPC11
prerank,3'-5' exonuclease activity (GO:0008408),0.30833196431921406,0.8480126914662269,0.7277777777777777,0.9133615664735834,1.0,22/45,34.47%,EXOSC4;NOCT;XRN2;RAD50;EXOSC9;EXOSC10;ISG20;RAD1;POLG;EXOSC5;CNOT6;USB1;PAN2;CNOT6L;ERI2;TRIR;RAD9A;ERI3;TOE1;ANGEL2;ERI1;REV3L
prerank,alpha-tubulin binding (GO:0043014),0.3260435598395287,0.8470656764961916,0.7244186046511628,0.9129678479622507,1.0,10/31,23.54%,FAM110C;ARL8B;EML4;FYN;INO80;RACGAP1;ARL8A;ARL4C;TAOK1;EFHC1
prerank,gamma-tubulin binding (GO:0043015),0.3455035684790783,0.8443922024693983,0.6889428918590522,0.9152924004051197,1.0,5/21,21.35%,TUBGCP4;NDRG1;GIT1;RACGAP1;MARK4
prerank,hydro-lyase activity (GO:0016836),0.30415258504231973,0.8426882314282027,0.7177777777777777,0.9161005140719923,1.0,12/41,26.78%,HACD2;ECHDC3;APIP;PCBD2;ENO1;HACD1;ENO2;TGDS;EHHADH;HADHA;TBXAS1;CDYL
prerank,mitogen-activated protein kinase binding (GO:0051019),0.32174022263531366,0.8423193537481087,0.7044392523364486,0.9146707775438571,1.0,6/29,14.94%,TNIP1;DUSP9;MAPKAPK3;MAPKAPK2;DUSP6;TPR
prerank,bHLH transcription factor binding (GO:0043425),0.35036689984561387,0.8422148290199765,0.7061068702290076,0.9127936650430525,1.0,10/19,34.62%,BHLHE40;BHLHE41;TCF12;USF2;SP1;KDM1A;SIRT1;CREBBP;LMO2;SCX
prerank,RNA polymerase binding (GO:0070063),0.356705999188376,0.8419360511283364,0.7082818294190358,0.9112617134916003,1.0,8/18,26.75%,PHRF1;PABPN1;BRCA1;PKN2;DHX9;CCNT2;ANP32B;STOM
prerank,lipid phosphatase activity (GO:0042577),0.3709392386531399,0.8418295737314697,0.6701708278580815,0.909431036060701,1.0,3/14,14.10%,PLPP6;PLPP3;PLPP7
prerank,fibroblast growth factor binding (GO:0017134),0.34429023631979605,0.8410451428678478,0.7060975609756097,0.9087189603964708,1.0,10/21,34.22%,GLG1;RPS2;RPS19;FGFRL1;FGFR3;FGFR2;FGFBP3;CEP57;ITGAV;FIBP
prerank,microtubule plus-end binding (GO:0051010),0.34348337545323826,0.8401467119504582,0.6919315403422983,0.9081881856107356,1.0,8/20,30.75%,CLIP2;DCTN1;NUMA1;DST;FBXW11;MAPRE1;STIM1;TTBK2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3630458970287046,0.8401119210493859,0.7023498694516971,0.9062484712260132,1.0,2/14,7.60%,CAPN15;CAPN1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3271612574258519,-0.8387898046935044,0.6411960132890365,0.8279092666306747,1.0,3/10,10.09%,PHF8;KDM4A;KDM7A
prerank,exopeptidase activity (GO:0008238),0.29624544178480716,0.8343723521648448,0.749185667752443,0.9132876460461316,1.0,9/50,17.42%,ANPEP;CTSZ;CTSA;DPP7;CNDP2;BLMH;GGH;XPNPEP1;DPEP2
prerank,peptidase activator activity (GO:0016504),0.3331569357195989,0.8324690057905858,0.717283950617284,0.9143086752355967,1.0,4/22,13.51%,TANK;CAV1;VCP;PSMD14
prerank,cell adhesion mediator activity (GO:0098631),0.3332507634974851,0.8320030638242617,0.7209302325581395,0.9130617704469723,1.0,8/24,21.94%,SIRPA;NPTN;EMB;PALLD;NINJ1;DSCAM;CD47;IGSF9
prerank,RNA methyltransferase activity (GO:0008173),0.3438974607634118,0.8284150618898013,0.7185554171855542,0.9167177179736771,1.0,8/19,30.99%,MRM2;METTL3;FTSJ3;TRMT13;METTL8;TRMT5;TRMT12;LCMT2
prerank,hexosaminidase activity (GO:0015929),0.3777154959192861,0.8269414465391349,0.714095744680851,0.9170341534999975,1.0,2/12,9.08%,HEXA;OGA
prerank,antiporter activity (GO:0015297),0.3385717181380352,0.8238910629143906,0.7345454545454545,0.9197070359022365,1.0,4/20,18.22%,SLC35D2;ATP1A3;SLC25A14;CLCN4
prerank,WW domain binding (GO:0050699),0.32284532185892284,0.8188266398200514,0.7338804220398594,0.9256454610631307,1.0,1/26,0.22%,LITAF
prerank,DNA polymerase activity (GO:0034061),0.3308029046313545,0.8162366188528692,0.7245508982035929,0.9275297384570725,1.0,11/22,35.67%,POLE;POLB;POLG;TERT;POLE4;REV1;POLD4;POLM;POLA1;REV3L;POLK
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3582063540021803,0.812634191979306,0.7415584415584415,0.9310299277335543,1.0,7/15,33.10%,PIK3R5;SOCS5;PIK3R2;SOCS2;SOCS4;SOCS7;SOCS6
prerank,kinase activity (GO:0016301),0.2719995402445641,0.8108075023175875,0.8526100307062436,0.9317342150369251,1.0,28/109,25.30%,DGKZ;CERK;ITPKB;GK;SPHK2;PIK3CB;SPHK1;CDK5;CHKB;PDXK;PGK1;PKN2;CDC7;DGKA;DGKH;DGKD;GSK3B;PI4KA;CERKL;TAOK1;COASY;PMVK;PRKD3;COQ8B;PIK3C2A;MAPK15;ADPGK;NADK
prerank,protein tyrosine phosphatase activity (GO:0004725),0.27869101488085585,0.8105833554573925,0.8045112781954887,0.9300881873460622,1.0,28/71,32.46%,PTPRA;PTPRC;EYA4;HACD2;PTPN23;PTPN22;PTPN2;PTPN12;PTPN13;DUSP11;DUSP3;CDKN3;PTP4A2;PTPN21;DUSP15;PTPN9;CDC25B;PTPN18;PTPN6;PTPRM;MTMR6;CDC25A;DUSP23;PTEN;PTPRZ1;PTPN1;PTPRN2;PALD1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.30467621483301666,0.8101930930099099,0.7748267898383372,0.9286731000426183,1.0,7/34,14.35%,UBE2L3;UBE2H;UBE2R2;BIRC6;UBE2Q1;UBE2F;UBE2L6
prerank,FAD binding (GO:0071949),0.321094651591459,0.8100383321173031,0.7334137515078407,0.9268868280384652,1.0,7/24,24.75%,MICAL2;MICAL1;CYB5R1;MTRR;CYB5R3;STEAP4;MTHFR
prerank,protein phosphatase 1 binding (GO:0008157),0.33544654338915086,0.8090588401569118,0.7268292682926829,0.9263216269696372,1.0,5/21,23.91%,PPP1R9B;LILRB1;PPP1R3F;PPP1R15A;AKAP11
prerank,MAP kinase kinase activity (GO:0004708),-0.27733081345203076,-0.807750765762094,0.7436974789915967,0.8773321360869999,1.0,4/15,12.96%,MAPK14;LRRK2;MAP2K6;PAK3
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.37870755148775176,0.8069014007994117,0.7259158751696065,0.927456544383277,1.0,5/10,29.81%,RENBP;FUOM;GFUS;DSEL;DSE
prerank,general transcription initiation factor binding (GO:0140296),0.31992571196386055,0.806249965467516,0.7473053892215569,0.9264862882492919,1.0,6/25,22.92%,GTF2A2;THAP7;TBP;DR1;YEATS2;AHR
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2743612385927784,0.8025372444483301,0.8071654373024236,0.9298143128446861,1.0,18/72,22.85%,SDCBP;SLC9A1;CAPG;SCIN;KCNJ2;HIP1;GSN;SESTD1;OSBPL2;SYTL2;TIRAP;SVIL;KRIT1;HIP1R;ACTN2;MYO1G;PFN1;SDCBP2
prerank,NADPH binding (GO:0070402),-0.28712139323250874,-0.8004097934873766,0.7654320987654321,0.8818477135615607,1.0,6/13,20.19%,NDOR1;CRYZ;CBR3;QDPR;HMGCR;GRHPR
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.32264792911683127,0.7980751406708283,0.752157829839704,0.9342354708843429,1.0,4/23,11.60%,PLCB4;EDNRA;PLCB2;CCL5
prerank,cytokine receptor activity (GO:0004896),0.2723511410528604,0.7974728145216515,0.8507306889352818,0.9331217861035509,1.0,14/83,14.16%,IL2RB;IL18R1;CD4;IL18RAP;CSF2RA;CD44;OSMR;IL3RA;IL12RB1;IL27RA;CCR2;GHR;FZD4;IL31RA
prerank,calcium-release channel activity (GO:0015278),0.3428316335529516,0.79558544835197,0.7628205128205128,0.9338960866139293,1.0,4/17,18.96%,MCOLN2;TPCN2;MCOLN3;ITPR3
prerank,PDZ domain binding (GO:0030165),0.2774239638360755,0.7950178365089406,0.8080260303687635,0.9326489802410969,1.0,17/61,24.80%,GNG12;CCDC88C;ATP2B1;CADM1;PLEKHA1;ADAM17;FZD1;CRIPT;FZD4;GNG5;LLGL2;GRIA1;SLC26A6;MAP2K2;TBC1D10A;KIDINS220;SYNJ2
prerank,"DNA binding, bending (GO:0008301)",0.3508249416362652,0.7944196523410821,0.7339449541284404,0.9314794821275691,1.0,5/14,29.67%,LEF1;TERF1;HMGB1;HMGB3;HMGB2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.23366989911123298,-0.7940330580864622,0.7549668874172185,0.8842143070936845,1.0,9/27,19.91%,POLR3F;POLR3K;PRIM1;POLR2C;POLR2L;POLR2J;POLR2G;POLR1B;MED20
prerank,retinoid X receptor binding (GO:0046965),0.3698759013306296,0.7902602254892349,0.7414965986394558,0.935260693073767,1.0,3/11,15.88%,VDR;PPARG;NR4A2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.36513901563398715,0.7878391910389461,0.7614080834419817,0.934645238775944,1.0,6/11,36.33%,SIL1;PFN1;BAG3;GRPEL2;BAG1;BAG2
prerank,adenyl nucleotide binding (GO:0030554),0.36513901563398715,0.7878391910389461,0.7614080834419817,0.934645238775944,1.0,6/11,36.33%,SIL1;PFN1;BAG3;GRPEL2;BAG1;BAG2
prerank,estrogen receptor binding (GO:0030331),0.30103744546717304,0.7868217989593935,0.7770114942528735,0.9340123904377843,1.0,2/32,2.01%,CTNNB1;LEF1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3042343260247018,0.7867886223340498,0.7796208530805687,0.932109454018994,1.0,9/28,30.12%,AGO2;RNASEH2A;RNASEH1;PRORP;AGO3;RPP38;EDC3;POP1;DBR1
prerank,muscle alpha-actinin binding (GO:0051371),0.3417548366187714,0.7850057400926329,0.7631224764468372,0.932597343116082,1.0,2/15,13.27%,PDLIM1;PALLD
prerank,N-acetyltransferase activity (GO:0008080),0.3263884615829797,0.7849104326267612,0.7608966376089664,0.93077857325619,1.0,3/19,10.31%,SAT1;GNPNAT1;NAT8
prerank,solute:sodium symporter activity (GO:0015370),0.30387925450661135,0.7828356148173947,0.7776484284051223,0.9318060708562892,1.0,7/27,28.50%,SLC5A1;SLC4A9;SLC5A3;SLC28A2;SLC13A5;SLC20A1;SLC5A6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.34413627875224606,0.7827942164599229,0.758800521512386,0.9299375829508871,1.0,5/14,26.58%,PYCR3;MTHFD1;ALDH1L2;MTHFR;PYCR2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.31261452855294836,-0.782107959354036,0.7276119402985075,0.8963718582395626,1.0,3/10,16.97%,DPYSL2;CRMP1;DPYS
prerank,phosphate ion binding (GO:0042301),-0.29907877827318585,-0.7809478402714126,0.7444444444444445,0.8902253388634712,1.0,2/10,4.59%,PNP;RELA
prerank,MAP kinase activity (GO:0004707),0.33889024080339225,0.7804479496255717,0.7653061224489796,0.9311023159900127,1.0,9/14,32.13%,MAPK13;MAPK9;NLK;MAPK7;MAPK15;MAPK12;MAPK3;MAPK1;MAPK6
prerank,ribonuclease P RNA binding (GO:0033204),-0.31222665502303215,-0.7789180734615263,0.717607973421927,0.8856179459808811,1.0,7/10,38.40%,RPP30;POP4;RPP21;RPP14;RPP25;POP7;RPP40
prerank,calcium activated cation channel activity (GO:0005227),0.32882225624244804,0.7739378046184914,0.7828348504551366,0.9379775498166995,1.0,4/17,18.11%,KCNN4;KCNMA1;KCNMB4;ANO6
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3630650894931513,0.7732516858834902,0.7727272727272727,0.9369347990381509,1.0,3/10,24.73%,PIK3CB;ATM;PIK3C2A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3478425334044253,0.7681281332046132,0.7877984084880637,0.9415177773649077,1.0,3/12,24.73%,PIK3CB;ATM;PIK3C2A
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2898721123367497,0.7678479714556845,0.7976878612716763,0.9399679016651211,1.0,16/34,33.75%,EXOSC4;NOCT;XRN2;EXOSC9;EXOSC10;ISG20;EXOSC5;CNOT6;USB1;PAN2;CNOT6L;ERI2;ERI3;TOE1;ANGEL2;ERI1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.292646359697826,0.7656052247572176,0.8145539906103286,0.9409099181076932,1.0,6/31,14.35%,UBE2L3;UBE2H;UBE2R2;BIRC6;UBE2Q1;UBE2L6
prerank,CARD domain binding (GO:0050700),0.33374912835222736,0.7630218153898997,0.7687338501291989,0.9421661727918265,1.0,7/14,37.27%,CARD10;CASP4;CARD19;MAVS;NOD1;IRGM;CASP1
prerank,phosphatidylglycerol binding (GO:1901611),-0.2750477122486276,-0.7598406282661917,0.7935222672064778,0.9074623103703586,1.0,5/13,21.42%,PLTP;UQCC3;GSDMD;PITPNA;MME
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.34436832908049675,0.7549933806811522,0.8038961038961039,0.9502908239059302,1.0,3/12,19.23%,NDUFS7;CBR1;AIFM2
prerank,neuropeptide receptor binding (GO:0071855),0.3314665206531503,0.7547544075341724,0.7986577181208053,0.948630145318857,1.0,2/14,13.13%,NPPA;AGRP
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.34520568886306263,0.7536782105318142,0.798140770252324,0.9480140697825106,1.0,2/12,3.88%,PDE1B;PDE4C
prerank,RNA stem-loop binding (GO:0035613),0.34582439305246526,0.7522051219666712,0.7910643889618922,0.9478965515594363,1.0,8/12,37.46%,EPRS1;CPEB3;DHX9;RC3H1;CSDE1;ZC3H12A;DDX3X;FMR1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2986399380426461,0.7517501588423943,0.812128418549346,0.9465477596401575,1.0,5/24,17.11%,PTK2B;MAPKAPK3;MAPKAPK2;DAPK1;CAMK4
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3500436108456872,0.7516353755506884,0.7798295454545454,0.9447676170614014,1.0,3/10,25.07%,ECHDC3;EHHADH;HADHA
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.26131449794219536,0.7495657332864211,0.8654467168998924,0.9453101634099201,1.0,6/60,8.06%,LCK;PPP4C;PPM1J;PPM1H;CTDNEP1;TAB1
prerank,signal sequence binding (GO:0005048),0.2824300611265984,0.7462745851466138,0.8386363636363636,0.9472756743574333,1.0,18/35,37.98%,BRAP;IPO5;KPNA4;KPNA6;CAT;TNPO2;TNPO1;NUP214;KDELR2;AP2B1;BABAM2;SEC61A1;NFKBIA;NUP153;IPO4;CEMIP;KDELR1;TIMM22
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3074739812024293,0.7461191091336005,0.806060606060606,0.9455833179607704,1.0,10/21,35.67%,POLE;POLB;POLG;POLE4;REV1;POLD4;POLM;POLA1;REV3L;POLK
prerank,ion channel inhibitor activity (GO:0008200),-0.20762280029113578,-0.7446296059743561,0.905511811023622,0.9217120622568094,1.0,6/35,10.51%,WNK1;COMMD1;SLC30A1;WNK3;KCNMB2;STX1A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.25396282724833746,0.7441382829224491,0.881427072402938,0.9458974914448622,1.0,9/70,13.96%,LARGE1;GCNT2;B4GAT1;B3GNT3;HEXA;B3GALNT2;B3GALT6;OGT;B4GALNT1
prerank,O-methyltransferase activity (GO:0008171),0.3518049839861568,0.7437223474803604,0.8220108695652174,0.944463102149733,1.0,2/10,16.79%,FTSJ3;COQ3
prerank,myosin binding (GO:0017022),0.2648336796726836,0.7437096639947725,0.8625541125541125,0.9426028369941516,1.0,18/55,26.53%,TRAK1;RAB8A;MYOC;RHOA;GSN;LLGL2;SPATA6;RAB11A;ARFGEF1;LMTK2;TRIOBP;RAB3D;LLGL1;GIPC1;KIRREL1;NCKIPSD;NPHS1;CXCR4
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.2583412775098971,-0.7411279662139583,0.8591549295774648,0.9182714240006606,1.0,2/15,4.25%,SLC1A3;SLC25A12
prerank,cardiolipin binding (GO:1901612),-0.2879599664969221,-0.739881751264254,0.7793103448275862,0.9120622568093385,1.0,3/10,21.42%,UQCC3;GSDMD;MME
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2542032968833385,0.7395422094375567,0.8996832101372756,0.9455910786657563,1.0,7/73,9.28%,FPR2;EDNRA;BDKRB1;HCRTR1;SCTR;KISS1R;LTB4R
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.21648888485314588,-0.7350299380571087,0.896551724137931,0.910387126558069,1.0,9/27,19.91%,POLR3F;TENT2;POLR3K;POLR2C;POLR2L;POLR2J;POLR2G;POLR1B;MED20
prerank,BMP binding (GO:0036122),-0.27750925867804904,-0.7349797932805683,0.8333333333333334,0.902818307808008,1.0,11/11,72.27%,ENG;BMPR2;NBL1;HJV;SOSTDC1;TCAP;SOST;GDF5;UCMA;GREM1;GREM2
prerank,DNA secondary structure binding (GO:0000217),0.2779135416480204,0.7349253309000622,0.8530465949820788,0.9489176230164128,1.0,9/31,26.35%,KMT2A;RAD51B;BLM;YY1;RAD51AP1;HMGB1;XPC;GEN1;HMGB3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2558601072359111,0.72489096532031,0.8859934853420195,0.9581790068340439,1.0,13/57,24.60%,NDUFS7;COX7A1;NDUFA1;CYBRD1;COX6A2;COX5B;COX10;NDUFA9;UQCRH;NDUFA2;COX7A2L;UQCR10;UQCR11
prerank,peptide hormone receptor binding (GO:0051428),0.33550247700454755,0.7232664703462638,0.8248663101604278,0.9579435090994592,1.0,2/11,20.32%,VIP;GNRH1
prerank,transaminase activity (GO:0008483),0.3346092066213603,0.7230793071840468,0.8324538258575198,0.9562896646305378,1.0,2/11,19.55%,OAT;PSAT1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.27461766409731103,-0.720153205271232,0.84,0.913882071236157,1.0,3/11,17.43%,MAP3K7;EGFR;MAP3K5
prerank,death receptor binding (GO:0005123),0.31295000716489757,0.7188414875277195,0.8274967574578469,0.9590307205425088,1.0,4/15,27.83%,BID;TMBIM1;CASP8AP2;RIPK1
prerank,GABA receptor binding (GO:0050811),0.33490186189258,0.7175753981370017,0.8282967032967034,0.9585098839271408,1.0,2/11,10.32%,TRAK1;ARFGEF2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.32419286549923865,0.7162395128131389,0.8353096179183136,0.9581217971015913,1.0,4/13,24.73%,PIK3CB;PIKFYVE;PIP5K1B;PIK3C2A
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.32010903463849427,0.7159248182081931,0.8440860215053764,0.9566320649312811,1.0,5/13,29.04%,SOX9;GSK3B;PRKAR1A;GSK3A;PRKAR1B
prerank,voltage-gated calcium channel activity (GO:0005245),0.2670490808785432,0.7150555605169641,0.8691695108077361,0.9556574671701821,1.0,7/37,21.23%,CACNA1A;TPCN2;CACNA1D;CACNG7;CACNB3;CACNB1;CACNB4
prerank,nuclear export signal receptor activity (GO:0005049),0.33150915640440415,0.7136847589594416,0.8150594451783355,0.9552083806348171,1.0,5/11,29.19%,XPO1;EIF4ENIF1;XPO6;NUP42;NUP214
prerank,histone acetyltransferase activity (GO:0004402),-0.19815575179011433,-0.7080084300409325,0.9477611940298507,0.9202035318766836,1.0,13/30,29.76%,NAA60;KAT2B;KAT5;BRCA2;KAT6B;TADA2A;ARRB1;KAT14;TAF1;CLOCK;NCOA3;KAT6A;KAT2A
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.24993137600534274,-0.7077108428310124,0.8695652173913043,0.9129346764736188,1.0,1/14,0.34%,SPOCK3
prerank,anion transmembrane transporter activity (GO:0008509),0.32035316116958684,0.7075220387642629,0.8405797101449275,0.9595828964078225,1.0,4/12,17.82%,SLC22A3;SLC26A11;SLC4A2;SLC19A1
prerank,TBP-class protein binding (GO:0017025),0.28901381246020014,0.7065660201478022,0.8392638036809816,0.9586882014401991,1.0,5/21,27.83%,GTF2A2;DR1;YEATS2;AHR;RUVBL2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2698470745629952,0.7037563517317463,0.8808411214953271,0.9597710791565146,1.0,8/30,24.51%,ATP7A;SLC39A6;SLC39A7;TMEM165;SLC11A1;SLC39A11;SLC39A1;SLC11A2
prerank,amino acid:sodium symporter activity (GO:0005283),0.3257971062270483,0.702869589423302,0.841886269070735,0.9588548167299672,1.0,1/11,1.43%,SLC38A1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.30871104790444254,0.7019669329559248,0.8440366972477065,0.9577811980551653,1.0,7/14,31.71%,MTMR14;MTMR12;MTMR10;MTMR6;MTMR1;PTEN;SYNJ1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.27895073583471275,0.6922141764024924,0.8690176322418136,0.9652049908477565,1.0,5/21,21.26%,AKAP1;ARFGEF2;GSKIP;ARFGEF1;PRRC1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.31935319026033593,0.6915464575700541,0.85809906291834,0.9639649420932449,1.0,4/12,20.95%,NUDT5;ENTPD5;ENTPD6;NUDT15
prerank,SUMO binding (GO:0032183),0.3078675844260237,0.6907123963082535,0.8487179487179487,0.9629347573731124,1.0,2/13,9.99%,USPL1;RNF111
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.28037225450412956,0.6903960428791792,0.8839177750906893,0.9613732000851302,1.0,1/21,2.27%,CHRNB2
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.23669964576946806,-0.6847428449411844,0.8679245283018868,0.9279213905578146,1.0,2/16,5.19%,SLC25A17;SLC22A5
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.25115068659782247,0.6839764324684818,0.9005649717514125,0.9654941347690427,1.0,5/42,10.70%,CCNY;CCNL1;CCNC;CCNB1;CCNL2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.27216190709037613,0.6787867062790264,0.8958579881656805,0.9684280793973497,1.0,11/24,38.33%,ZDHHC15;ZDHHC18;ZDHHC1;YKT6;ZDHHC21;ZDHHC6;GOLGA7;GOLGA7B;ZDHHC2;ZDHHC8;ZDHHC17
prerank,transcription coactivator binding (GO:0001223),0.27628077840182547,0.6668106725704255,0.8992718446601942,0.9767593706661128,1.0,5/20,22.92%,RPL23;PPARD;CCNT2;TERT;AHR
prerank,5'-3' exonuclease activity (GO:0008409),0.29201803170855034,0.6638205588221417,0.8987012987012987,0.9772842248884814,1.0,6/14,31.99%,XRN2;DXO;DCLRE1A;XRN1;TRIR;DCP2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.31634964044043956,0.6583636279868168,0.8840782122905028,0.9797308607864154,1.0,4/10,30.32%,EHMT1;SETDB1;ASH1L;SUV39H2
prerank,aminopeptidase activity (GO:0004177),0.25482815573170203,0.652371293932616,0.9069212410501193,0.9826362276706224,1.0,7/26,26.88%,ANPEP;BLMH;XPNPEP1;MMP17;METAP1D;LAP3;RNPEPL1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2540532435635048,0.6491664581776478,0.9308323563892146,0.9833323992015642,1.0,4/26,13.96%,B3GNT3;B3GALNT2;EXTL2;B4GALNT1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.2606297574324669,-0.6479138709841754,0.9020979020979021,0.950834693109075,1.0,3/10,11.67%,PKIG;PRKAR2A;PRKAR2B
prerank,glutamate receptor binding (GO:0035254),0.276633534856054,0.6427386855030992,0.9158291457286433,0.986223773879055,1.0,3/17,14.36%,SQSTM1;HIP1;HOMER2
prerank,N-methyltransferase activity (GO:0008170),0.2649811317884301,0.6416897001393453,0.9180124223602485,0.9851176059532256,1.0,6/20,27.17%,PEMT;GNMT;METTL15;RNMT;DIMT1;FDXACB1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3057833462050132,0.6400189431714396,0.9061224489795918,0.9844394912672034,1.0,7/10,38.36%,MSL3;HAT1;EP300;NAA50;USP22;KAT8;NAA40
prerank,NAD binding (GO:0051287),0.25191159962028775,0.6398000381750781,0.933649289099526,0.9827502681931146,1.0,11/26,32.07%,SORD;NUDT6;SIRT5;HSD17B8;ZC3HAV1;SIRT3;HADH;ME1;SIRT1;SIRT2;PARP9
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.2820131182620119,0.6348722134185933,0.9152542372881356,0.9843045882135922,1.0,6/14,32.62%,SLC7A11;SLC38A7;SLC25A18;SLC17A8;SLC25A22;SLC25A13
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.22249130237617393,0.632976106298178,0.9544468546637744,0.9838168878319035,1.0,14/55,28.64%,SLC24A4;ATP2B1;PANX1;ANXA6;CACNA1D;TRPM7;TMEM165;GRIN3B;ATP2A2;PKD1L2;ORAI1;TMCO1;ITPR1;PKD2L1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2380170721700379,0.628142711573951,0.9410430839002267,0.9852390489697859,1.0,10/35,30.99%,AARS1;ALKBH1;QTRT1;TRMT13;GATB;TARS2;TRMT5;NT5C3A;TRMT12;LCMT2
prerank,methyl-CpG binding (GO:0008327),0.25140551274895917,0.6247255216022232,0.9241126070991432,0.9856260741936953,1.0,10/22,37.42%,TET3;PRMT5;CHTOP;LHX4;ZBTB4;UHRF1;PRMT1;ZBTB33;MECP2;MBD1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.2716498281668759,0.61815993216008,0.9421052631578948,0.9880584564078593,1.0,3/15,19.27%,ALDH3A2;ALDH3B1;ALDH1L2
prerank,adenylyltransferase activity (GO:0070566),0.24936724695214169,0.6171283889038078,0.9320388349514563,0.9868651963565024,1.0,10/21,33.47%,FLAD1;PAPOLA;COASY;NMNAT3;MTPAP;PAPOLG;OASL;TENT4B;TUT1;GPHN
prerank,palmitoyltransferase activity (GO:0016409),0.2409778281766204,0.6170930791653563,0.9605568445475638,0.9850752818886659,1.0,12/28,38.33%,ZDHHC15;ZDHHC18;ZDHHC1;YKT6;ZDHHC21;ZDHHC6;GOLGA7;HHAT;GOLGA7B;ZDHHC2;ZDHHC8;ZDHHC17
prerank,peptide N-acetyltransferase activity (GO:0034212),0.29744592108407564,0.6157767273958036,0.9240331491712708,0.9841347911093608,1.0,5/10,32.24%,NAA16;NAA20;NAA80;NAA15;NAA50
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.2833073422791363,0.6149871128574703,0.9320905459387483,0.9827834494044281,1.0,6/12,37.27%,RACK1;APAF1;CASP8AP2;NOD1;ATP2A3;CASP1
prerank,O-acyltransferase activity (GO:0008374),0.23212129866385467,0.6147942712326322,0.9548611111111112,0.981097559757522,1.0,4/30,12.78%,PRDX6;SOAT1;SOAT2;LPCAT3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.25938445377186226,0.6128697979409253,0.9231738035264484,0.9804633423822888,1.0,4/18,24.70%,AKR1B10;ALDH3A2;ALDH3B1;HSD17B12
prerank,ionotropic glutamate receptor binding (GO:0035255),0.29017074005284904,0.6113011243468113,0.9264705882352942,0.9796191282252131,1.0,1/10,4.51%,SQSTM1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.2852544613181525,0.6027141903485892,0.921090387374462,0.9826573594981265,1.0,3/11,19.95%,NEIL2;ALKBH1;RPS3
prerank,FMN binding (GO:0010181),0.2850205548713596,0.6024310140193587,0.9410150891632373,0.9810126665619268,1.0,2/11,16.85%,POR;MTRR
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2844596055821541,0.600860343641792,0.9364005412719891,0.9801255321894972,1.0,2/11,9.78%,NAA16;NAA20
prerank,retinoid binding (GO:0005501),0.2405812785480118,0.5983453491291125,0.9336609336609336,0.979750691580658,1.0,4/22,28.80%,ABCA4;RBP4;RXRA;RBP1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.2734181619909231,0.5939552592848021,0.9460916442048517,0.9802918816823375,1.0,4/12,26.11%,NOCT;CNOT6;PAN2;CNOT6L
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.26070582356403826,0.5850089790260984,0.9440832249674902,0.9829721697467676,1.0,7/14,37.27%,RACK1;APAF1;CASP8AP2;NOD1;ATP2A3;EBAG9;CASP1
prerank,dynactin binding (GO:0034452),0.2697738101482434,0.5821109319573707,0.9461942257217848,0.9825729020170013,1.0,3/12,21.27%,HTT;HOOK3;GSK3B
prerank,death receptor activity (GO:0005035),0.2710849559741477,0.5771810720851502,0.9550408719346049,0.9831309085992789,1.0,1/11,11.68%,TNFRSF1B
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.21582322068793963,0.5732959099103341,0.9780092592592593,0.9814278752018288,1.0,2/34,6.71%,NDUFS7;NDUFA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.21582322068793963,0.5732959099103341,0.9780092592592593,0.9814278752018288,1.0,2/34,6.71%,NDUFS7;NDUFA1
prerank,transforming growth factor beta binding (GO:0050431),0.2300545752140482,0.5730115194177438,0.9565741857659831,0.9797695813735079,1.0,4/23,23.23%,WFIKKN1;NRROS;LTBP3;TGFBR2
prerank,voltage-gated sodium channel activity (GO:0005248),0.2299797199583991,0.5614896307715065,0.9730046948356808,0.9827319112526869,1.0,3/22,16.20%,SCN4A;SCN1B;SCN3B
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.23355447685768213,0.5474972912801691,0.9681122448979592,0.986166978353621,1.0,7/16,31.71%,MTMR14;MTMR12;MTMR10;MTMR6;MTMR1;PTEN;SYNJ1
prerank,microtubule motor activity (GO:0003777),0.19300737399529505,0.5447985622219398,0.9890470974808324,0.985268752833504,1.0,8/51,17.89%,KIF13B;DNAH8;KIF1A;DNAH3;KIF20A;SMC3;KIFC1;KIF21B
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.18940267930157853,-0.5232615023625059,0.9844961240310077,0.9988970966776415,1.0,5/14,23.74%,RPP30;ELAC2;POP4;RPP21;RPP14
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.1887928742730428,0.4655304696713046,0.9950920245398773,1.0,1.0,4/20,22.37%,SLC39A6;SLC39A7;SLC39A11;SLC39A1
prerank,ribonuclease P activity (GO:0004526),-0.18328003603759543,-0.46443687864034444,1.0,0.9980758541069825,1.0,4/11,23.74%,RPP30;POP4;RPP21;RPP14
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.20542869530973507,0.4540555376702929,0.9932885906040269,0.9994407463312148,1.0,3/13,23.99%,ALDH3A2;ALDH1L2;ADH5
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.20648559474173234,0.43932604998063945,0.9919678714859438,0.998871028826214,1.0,1/11,12.88%,CNGB1
prerank,R-SMAD binding (GO:0070412),0.17274711449145513,0.40979850918269684,0.9975308641975309,0.9987823678503306,1.0,3/18,27.06%,JUN;PMEPA1;PPM1A
